text string | url string | crawl_date timestamp[ms] | label int64 | id string |
|---|---|---|---|---|
One of the biggest mistakes you can make when it comes to protecting yourself from financial scams is thinking you’re too smart to be duped by one.
“We’re all vulnerable — we can all fall for a scam given the right set of circumstances,” says Eva Velasquez, president and CEO of the Identity Theft Resource Center, a nonprofit organization that provides advice and assistance related to identity theft. Keeping yourself safe starts with accepting that fact, she adds.
“You look at the profiles of victims who filed complaints and it runs the gamut from highly educated, high-income people all the way down to the most vulnerable people in our population,” says John Breyault, vice president of public policy, telecommunications and fraud at the National Consumers League, a nonprofit advocacy group that speaks out about consumer concerns.
While there isn’t a “foolproof solution to stay safe from all scams,” as Breyault puts it, there are strategies you can employ to reduce your risk. Here are four of the most important ones:
HANG UP AND ‘GO TO THE SOURCE’
If you’re contacted by anyone claiming to be your bank or other familiar company, end the conversation and call the institution’s verified number yourself, Velasquez says. “We always say, ‘If you did not initiate the interaction, then you need to go to the source,’” she adds.
Otherwise, you don’t actually know who’s on the other end of the line, she says, especially because scammers can spoof the number that shows up on your caller ID so it might look legitimate.
In some cases, you might want to pay your bank a visit in person to get clarification. When Thorn Roberts, owner of a small business in Elizabeth, West Virginia, received a payment request he didn’t recognize, he went to his bank to ask about it.
“They knew it was a scam,” he says. As a result, he immediately canceled his accounts and created new ones. Thanks to his quick action and the bank’s help, his money was safe.
SECURE AND MONITOR YOUR ACCOUNTS
Basic online security practices can also help protect you, Velasquez says. She recommends enabling multifactor authentication on your financial accounts, creating unique passwords and not sharing personal details such as your birthdate online.
Jason Zirkle, training director at the Association of Certified Fraud Examiners and former fraud analyst with law enforcement, suggests checking your financial accounts at least once a week and investigating any unidentified charges immediately. Even one small erroneous charge could suggest someone has access to your account, signaling the beginning of a larger problem.
GET FAMILIAR WITH COMMON SCAMS
The Federal Trade Commission reports that the top scams of 2022 include people impersonating institutions like banks, phony sweepstakes and fake job postings. “You don’t have to become an expert in each one, but you need to understand the hallmarks of most scams: They contact you first, dangle some sort of bait in front of you and create a sense of urgency,” Zirkle says. Then, they ask for either money or personal information, which they use to access your money.
That’s what happened to former government executive and security expert Ken Westbrook’s mother earlier this year. A fake tech support window popped up on her computer, which likely came from a malicious ad. It connected her to criminals who persuaded her to call them and send gift cards and cashier’s checks under the guise of protecting her bank accounts from being hacked.
“My mom knew gift cards were a red flag, but she did it anyway because they scared her,” says Westbrook, who lives in the Washington, D.C., area. Eventually, Westbrook discovered what was happening and put a stop to it, but only after his mom lost thousands of dollars.
These scammers “sound like the nicest tech support people that you’ve ever dealt with,” says Chris Pierson, founder and CEO of BlackCloak, a cybersecurity firm. “They install remote management tools to see what’s on your screen and then can suck out your files and extort you.”
REPORT SCAMS AND BE YOUR OWN ADVOCATE
Reporting fraud to government agencies and private organizations allows for better fraud tracking. While there’s no centralized source for fraud tracking, you can report it to the Federal Trade Commission, your state’s attorney general’s office, the FBI, your local police station, your bank’s fraud department, the Better Business Bureau’s Scam Tracker and the Identity Theft Resource Center, among others.
Most people who lose money to scams never see it again. “The first thing you need to do is accept your money is probably gone and you won’t get it back,” Zirkle says. He suggests “being your own advocate” with your bank and police. In some cases, your financial institution or law enforcement might be able to help you recover some or all of it.
Still, some losses are harder to quantify. “In addition to a financial crime, it’s an emotional crime,” Westbrook says. “People are affected by this for the rest of their lives. What I tell everyone, and tell my mom, is, ‘It’s not your fault. The thieves work for organized crime gangs who are very good at what they do.’”
________________________________
This column was provided to The Associated Press by the personal finance website NerdWallet. Kimberly Palmer is a personal finance expert at NerdWallet and the author of “Smart Mom, Rich Mom.” Email: kpalmer@nerdwallet.com. Twitter: @KimberlyPalmer.
RELATED LINK:
NerdWallet: How to prevent identity theft https://bit.ly/nerdwallet-how-to-prevent-identity-theft | https://www.seattletimes.com/business/kimberly-palmer-how-to-stay-safe-from-financial-scams/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business | 2023-07-31T11:54:20 | 0 | https://www.seattletimes.com/business/kimberly-palmer-how-to-stay-safe-from-financial-scams/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business |
- Cash, cash equivalents, and marketable securities totaled $349.0 million as of June 30, 2023
- Announced positive interim data from BHV-7000 EEG biomarker study demonstrating evidence of central nervous system (CNS) target engagement, confirming previously reported preclinical and clinical data, and highlighting the paradigm-changing potential of BHV-7000 in the treatment of epilepsy and mood disorders
- Brain penetrant TYK2/JAK1 inhibitor, BHV-8000, advanced into Phase 1 with projected therapeutic concentrations achieved and well-tolerated profile observed to date
- Advanced targeted extracellular protein degradation platform with potential to support numerous clinical candidates across a broad range of high unmet need indications
- Orphan drug designation (ODD) granted by the European Commission for taldefgrobep alfa a novel anti-myostatin adnectin, for the treatment of spinal muscular atrophy (SMA)
- Type A meeting planned with FDA regarding troriluzole program in Spinocerebellar Ataxia Type 3 (SCA3) and enrollment in Phase 3 obsessive compulsive disorder (OCD) trial expected to complete at end of 2023
NEW HAVEN, Conn., July 31, 2023 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the second quarter ended June 30, 2023, and provided a review of recent accomplishments and anticipated upcoming milestones.
Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven, commented, "In less than a year since our spin-off, the Biohaven team has driven strong and consistent progress across multiple drug development platforms. We were excited to recently report positive interim data from the ongoing EEG biomarker study of our lead Kv7 activator, BHV-7000. As expected, BHV-7000 demonstrated CNS activity consistent with what has been reported in EEG studies with other Kv7 channel activators in development that are clinically effective in treating epilepsy and with other approved anti-seizure medications. Importantly, BHV-7000 demonstrates CNS target engagement but is not associated with the typical CNS adverse events associated with other ASMs, like somnolence and fatigue. We look forward to completing the higher dose groups in this EEG study and initiating Phase 2/3 studies with our once daily, extended-release oral formulation later this year."
Dr. Coric continued, "We also shared a number of equally exciting announcements across our broader pipeline this quarter. We successfully administered the first three doses in the SAD portion of our ongoing SAD/MAD study evaluating BHV-8000, an oral, brain-penetrant, dual TYK2/JAK1 inhibitor. Potential therapeutic concentrations of BHV-8000 were achieved and BHV-8000 was well tolerated with only mild adverse events reported, reinforcing our plans to start a Phase 2 clinical trial with BHV-8000 in Parkinson's disease and potentially other neuroinflammatory diseases in 2024. In addition, we have advanced IND enabling preclinical studies and remain on track to submit an IND with our IgG degrader, BHV-1300, later this year. We also anticipate submitting an IND with our IgA degrader in 2024 as we continue to advance multiple clinical degrader candidates across a wide range of indications. We also shared key updates for our taldefgrobep alfa program (an anti-myostatin) with enrollment completion in our pivotal study in SMA and a planned Phase 2 trial initiation in obesity."
"Finally, I want to reaffirm Biohaven's commitment to the SCA3 patient community in spite of the recent disappointing regulatory decision by the FDA not to review our submitted NDA. Given the seriousness of SCA3 and consistent treatment benefits observed across multiple prespecified outcome measures, including an 80% delay in disease progression over the one-year study period with substantial risk reduction in falls, we believe that full consideration of all available data is warranted for this ultra-rare disease. Biohaven has built its foundation around our patient mission and we plan to continue to work with regulatory agencies to try to advance troriluzole for individuals suffering from SCA3."
Second Quarter 2023 and Recent Business Highlights
- Announced positive interim data from EEG biomarker study with BHV-7000 - In July 2023, the Company provided a preliminary data update from the ongoing electroencephalogram (EEG) biomarker study for the Kv7 Channel Activator platform. Preliminary Phase 1 data confirmed evidence of target engagement in the central nervous system for subjects with projected therapeutic concentrations of BHV-7000 (based on the EC50 from preclinical models), measured by changes from baseline in EEG spectral power that occurred after dosing. These pharmacodynamic (PD) effects were similar to those reported in the literature for anti-seizure medicines (ASMs), including Kv7 activators in development that are clinically effective in treating epilepsy. BHV-7000's PD effects were also differentiated from those reported for other Kv7 activators including, specifically, the absence of increases in EEG spectral power in frequency bands associated with drowsiness and somnolence. Results from the low-dose group validate the preclinical hypothesis, confirm the Phase 1 SAD/MAD clinical data, and provide strong support for Biohaven's plans to initiate pivotal studies with BHV-7000 in focal epilepsy and bipolar disorder in the second half of 2023. The preliminary data highlight BHV-7000's differentiation and potentially favorable clinical profile compared to other ASMs, and the Company expects to present the complete EEG results by the end of the year. Additionally, new pharmacokinetic data from multiple clinical formulations being studied has now confirmed a once daily extended-release oral formulation that will be used in the Phase 2/3 clinical programs.
- Successfully dosed three cohorts with single ascending doses of oral, brain penetrant, dual TYK2/JAK1 agent, BHV-8000 - In July 2023, the Company announced that it successfully dosed three cohorts in the SAD portion of an ongoing SAD/MAD Phase 1 study evaluating brain penetrant TYK2/JAK1 agent, BHV-8000 in healthy volunteers. The ongoing Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK) and PD of single and multiple ascending doses of BHV-8000 in healthy volunteers. Based on the preliminary data available, projected therapeutic concentrations of BHV-8000 were achieved, and BHV-8000 was well tolerated with only mild adverse events reported. These data provide support for further development of BHV-8000, and the Company anticipates beginning a Phase 2 clinical trial with BHV-8000 in Parkinson's disease and potentially other neuroinflammatory diseases in 2024. The Company had previously reported initiation of dosing with BHV-8000 in the Phase 1 study at Biohaven's R&D Day in May 2023.
- Reported on continued progress observed with Biohaven's first-in-class bispecific IgG degrader, BHV-1300, as compound advances to IND filing in 2H2023 - In July 2023, the Company shared an update on BHV-1300's highly competitive safety, manufacturable and PD profile. The Company is assembling a pipeline of partially de-risked, follow-on IgG degraders as well as antigen-specific degraders providing both optionality and a sustainable output of drug candidates for several years. An IND application for BHV-1300 is on track for submission in 2023 and an IND application for Biohaven's IgA degrader on track for submission in 2024
- Type A meeting planned to comprehensively address FDA's concerns in connection with Troriluzole program in SCA3 - In July 2023, the Company announced that the FDA informed Biohaven it would not review the recently submitted New Drug Application (NDA) for troriluzole for the treatment of spinocerebellar ataxia type 3 (SCA3), an ultra-rare, genetically-defined, neurodegenerative disease associated with progressive disability, frequent falls, loss of ambulation, speech and swallowing impairment, and premature death that is the most common SCA genotype worldwide. The FDA informed Biohaven it would not review the application given that the study's primary endpoint was not met and thus, would not permit a substantive review. Biohaven is committed to working closely with the FDA to bring troriluzole to people with SCA3 as quickly as possible given no therapy is currently approved for this ultra-rare genetic disorder. Biohaven plans to request a Type A meeting to comprehensively address FDA's concerns cited in the refusal to file letter.
- EMA orphan drug designation granted for taldefgrobep alfa for the treatment of SMA: - In July 2023, the Company announced that taldefgrobep alfa received orphan drug designation (ODD) from the European Commission for taldefgrobep for the treatment of SMA. Taldefgrobep previously received Fast-Track and ODD from the FDA. At Biohaven's R&D Day, the Company announced plans to complete randomization of approximately 180 patients in global SMA trial.
Upcoming Milestones:
Biohaven is progressing its product candidates through clinical programs in a number of common and rare disorders. The Company plans to reach significant pipeline milestones in the coming periods. Biohaven expects to:
- Announce Phase 1 EEG study results by year-end 2023: The Company expects to present complete results from its ongoing EEG study with BHV-7000 in healthy volunteers by the end of the year.
- Initiate Phase 2/3 studies with BHV-7000 in the second half of 2023: Biohaven expects to initiate pivotal trials in patients with focal epilepsy and bipolar disorder in the second half of 2023.
- Submit IND with BHV-1300, the Company's lead extracellular degrader: The Company expects to submit an IND with pan-IgG degrader BHV-1300 in the second half of 2023 and expects to initiate Phase 2 studies in 2024.
- Submit IND with selective Gd-IgA1 degrader: The Company expects to submit an IND with a Gd-IgA1 degrader indicated for IgA nephropathy in the first half of 2024.
- Initiate Phase 2 study with BHV-8000: The Company commenced Phase 1 studies with BHV-8000, an oral, brain-penetrant, dual TYK2/JAK1 inhibitor for neuroinflammatory disorders, in the first half of 2023 and expects to initiate a Phase 2 study in Parkinson's disease in 2024.
- Submit IND with BHV-2100 in chronic pain: The Company expects to submit an IND with BHV-2100, a selective TRPM3 antagonist in the Company's ion channel platform, in the second half of 2023.
- Complete enrollment in Phase 3 study of troriluzole in OCD in 2023: Two Phase 3 randomized, double-blind, placebo-controlled studies of troriluzole in OCD are expected to enroll up to 700 patients (in each trial) across nearly 200 global study sites. The Company anticipates completing enrollment in at least one Phase 3 trial by year-end 2023.
- Complete enrollment in Phase 3 clinical study of taldefgrobep alfa in SMA: The Company expects to complete enrollment in the study of taldefgrobep in SMA in the second half of 2023.
- Continue advancements across multiple neuroscience and immunoscience indications: The Company's preclinical pipeline includes a platform of bispecific degraders of extracellular proteins directed against IgG, IgA and other targets, TRPM3 and Kv7 family of ion channels, and other undisclosed targets, including those with disease-modifying potential.
Capital Position:
Cash, cash equivalents and marketable securities as of June 30, 2023 was $349.0 million, including $13.9 million of restricted cash, and excluding $40.4 million of cash payable to Biohaven Pharmaceutical Holding Company Ltd. (the Former Parent), compared to $467.9 million, including $2.5 million of restricted cash, and excluding $35.2 million of cash payable to the Former Parent, as of December 31, 20221.
Second Quarter 2023 Financial Highlights:
Research and Development (R&D) Expenses: R&D expenses, including non-cash share-based compensation costs, were $79.5 million for the three months ended June 30, 2023, compared to $177.1 million for the three months ended June 30, 2022. Non-cash share-based compensation expense was $2.5 million for the three months ended June 30, 2023, a decrease of $10.3 million as compared to the same period in 2022. Non-cash share-based compensation expense was higher in the second quarter of 2022 primarily because expense allocated from the Former Parent equity plan, prior to the spin-off, was based on equity awards with higher grant date fair values.
General and Administrative (G&A) Expenses: General and administrative expenses were $14.5 million for the three months ended June 30, 2023, compared to $20.0 million for the three months ended June 30, 2022. The decrease of $5.5 million was primarily due to decreased non-cash share-based compensation costs. Non-cash share-based compensation expense was $2.2 million for the three months ended June 30, 2023, a decrease of $5.8 million as compared to the same period in 2022. Non-cash share-based compensation expense was higher in the second quarter of 2022 primarily because expense allocated from the Former Parent equity plan, prior to the spin-off, was based on equity awards with higher grant date fair values.
Other Income (Expense), Net: Other income (expense), net was a net income of $5.8 million for the three months ended June 30, 2023, compared to net expense of $0.1 million for the three months ended June 30, 2022. The increase of $5.9 million was primarily due to an increase in net investment income and an increase of $1.7 million in other income related to our transition services provided to the Former Parent, which is largely non-recurring.
Net Loss: Biohaven reported a net loss for the three months ended June 30, 2023, of $90.3 million, or $1.32 per share, compared to $203.3 million, or $5.16 per share, for the same period in 2022. Non-GAAP adjusted net loss for the three months ended June 30, 2023 was $85.7 million, or $1.25 per share, compared to $182.5 million, or $4.63 per share for the same period in 2022. These non-GAAP adjusted net loss and non-GAAP adjusted net loss per share measures, more fully described below under "Non-GAAP Financial Measures," exclude non-cash share-based compensation charges. A reconciliation of the GAAP financial results to non-GAAP financial results is included in the tables below. For periods prior to Biohaven's spin-off from the Former Parent on October 3, 2022 (the "Spin-Off"), net loss per share and non-GAAP adjusted net loss per share were calculated based on the 39,375,944 common shares of Biohaven distributed to the Former Parent shareholders at the time of the distribution, including common shares issued in connection with the Former Parent share options that were settled on October 3, 2022 and common shares issued in connection with the Former Parent restricted share units that vested on October 3, 2022. The same number of shares is being utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Spin-Off.
Non-GAAP Financial Measures
This press release includes financial results prepared in accordance with accounting principles generally accepted in the United States (GAAP), and also certain non-GAAP financial measures. In particular, Biohaven has provided non-GAAP adjusted net loss and adjusted net loss per share, which are adjusted to exclude non-cash share-based compensation, which is substantially dependent on changes in the market price of common shares. Non-GAAP financial measures are not an alternative for financial measures prepared in accordance with GAAP. However, Biohaven believes the presentation of non-GAAP adjusted net loss and adjusted net loss per share, when viewed in conjunction with GAAP results, provides investors with a more meaningful understanding of ongoing operating performance and can assist investors in comparing Biohaven's performance between periods.
In addition, these non-GAAP financial measures are among those indicators Biohaven uses as a basis for evaluating performance, and planning and forecasting future periods. These non-GAAP financial measures are not intended to be considered in isolation or as a substitute for GAAP financial measures. A reconciliation between these non-GAAP measures and the most directly comparable GAAP measures is provided later in this news release.
About Biohaven
Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases. Biohaven's experienced management team brings with it a track record of delivering new drug approvals for products for diseases such as migraine, depression, bipolar and schizophrenia. The company is advancing a pipeline of therapies for diseases, many of which have limited or no treatment options, leveraging its proven drug development capabilities and proprietary platforms, including Kv7 ion channel modulation for epilepsy and neuronal hyperexcitability, glutamate modulation for obsessive-compulsive disorder and spinocerebellar ataxia, myostatin inhibition for neuromuscular diseases and metabolic disorders, and brain-penetrant TYK2/JAK1 inhibition for neuroinflammatory disorders. Biohaven's portfolio of early- and late-stage product candidates also includes discovery research programs focused on TRPM3 channel activation for neuropathic pain, CD-38 antibody recruiting, bispecific molecules for multiple myeloma, antibody drug conjugates (ADCs), and targeted extracellular protein degradation platform technology (MoDE™) with potential application in neurological disorders, cancer, and autoimmune diseases.
Forward-looking Statements
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including "continue", "plan", "will", "believe", "may", "expect", "anticipate" and similar expressions, is intended to identify forward-looking statements. Investors are cautioned that any forward-looking statements, including statements regarding the future development, timing and potential marketing approval and commercialization of development candidates, are not guarantees of future performance or results and involve substantial risks and uncertainties. Actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors including: the expected timing, commencement and outcomes of Biohaven's planned and ongoing clinical trials; the timing of planned interactions and filings with the FDA; the timing and outcome of expected regulatory filings; complying with applicable U.S. regulatory requirements; the potential commercialization of Biohaven's product candidates; the potential for Biohaven's product candidates to be first in class therapies; and the effectiveness and safety of Biohaven's product candidates. Additional important factors to be considered in connection with forward-looking statements are described in Biohaven's filings with the Securities and Exchange Commission, including within the sections titled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations". The forward-looking statements are made as of the date of this new release, and Biohaven does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
MoDEs is a trademark of Biohaven Therapeutics Ltd.
Investor Contact:
Jennifer Porcelli
Vice President, Investor Relations
jennifer.porcelli@biohavenpharma.com
+1 (201) 248-0741
Media Contact:
Mike Beyer
Sam Brown Inc.
mikebeyer@sambrown.com
+1 (312) 961-2502
View original content to download multimedia:
SOURCE Biohaven Ltd. | https://www.mysuncoast.com/prnewswire/2023/07/31/biohaven-reports-second-quarter-2023-financial-results-recent-business-developments/ | 2023-07-31T11:54:24 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/biohaven-reports-second-quarter-2023-financial-results-recent-business-developments/ |
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR | https://www.wvasfm.org/business/business/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction | 2023-07-31T11:54:26 | 0 | https://www.wvasfm.org/business/business/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction |
99-year old trucking company Yellow shuts down, putting 30,000 out of work
By Chris Isidore, CNN
New York (CNN) — Yellow Corp., a 99-year old trucking company that was once a dominant player in its field, halted operations Sunday and will layoff all 30,000 of its workers.
The unionized company has been in a battle with the Teamsters union, which represents about 22,000 drivers and dock workers at the company. Just a week ago the union canceled a threatened strike that had been prompted by the company failing to contribute to its pension and health insurance plans. The union granted the company an extra month to make the required payments.
But by midweek last week, the company had stopped picking up freight from its customers and was making deliveries only of freight already in its system, according to both the union and Satish Jindel, a trucking industry consultant.
While the union agreed not to go on strike against Yellow, it could not reach an agreement on a new contract with the trucking company, according to a memo sent to local unions Thursday by the Teamsters’ negotiating committee. The union said early Monday that it had been notified of the shutdown.
“Today’s news is unfortunate but not surprising. Yellow has historically proven that it could not manage itself despite billions of dollars in worker concessions and hundreds of millions in bailout funding from the federal government. This is a sad day for workers and the American freight industry,” said Teamsters President Sean O’Brien in a statement.
Company officials did nor respond to numerous requests for comment Sunday and Monday.
There were reports last week that a bankruptcy filing would come by July 31, although the company said last week only that it continued to be in talks with the Teamsters and that it was considering all of its options. The Teamsters said Monday the company is filing for bankruptcy.
The closing is bad news not only for its employees and its customers, who generally used Yellow because it offered some of the cheapest rates in the trucking sector, but also for US taxpayers. The company received a $700 million loan from the federal government in 2020, a loan that resulted in taxpayers holding 30% of its outstanding stock. And the company still owed the Treasury department more than $700 million according to its most recently quarterly report, nearly half of the long-term debt on its books.
Yellow’s stock lost 82% of its value between the time of that loan and Thursday close after reports of the bankruptcy plans, closing at only 57 cents a share. It bumped up 14 cents a share on Friday, but still remained a so-called penny stock.
The company had received that loan during the pandemic, despite the fact that at the time it was facing charges of defrauding the government by overbilling on shipments of items for the US military. The company eventually settled the dispute without admitting wrongdoing but was forced to pay a $6.85 million fine.
Yellow handles pallet-sized shipments of freight, moving shipments from numerous customers in the same truck, a segment of the trucking industry known as less-than-truckload, or LTL. The company had been claiming as recently as June that it was the nation’s third largest LTL carrier.
But the company handled only about 7% of the nation’s 720,000 daily LTL shipments last year, said Jindel. He said there is about 8% to 10% excess capacity in the LTL sector right now, so the closure of Yellow shouldn’t cause a significant disruption in supply chains. But he said it will cause higher rates for shippers who depend on LTL carriers, since it was the excess capacity that sent prices lower.
Higher prices will hit Yellow customers, Jindel said.
“The reason they were using Yellow was because they were cheap,” he said. “They’re finding out that price was below the cost of supporting a good operation.”
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/money/cnn-business-consumer/2023/07/31/99-year-old-trucking-company-yellow-shuts-down-putting-30000-out-of-work/ | 2023-07-31T11:54:25 | 1 | https://kion546.com/money/cnn-business-consumer/2023/07/31/99-year-old-trucking-company-yellow-shuts-down-putting-30000-out-of-work/ |
MANCHESTER, England (AP) — Manchester United announced a 10-year extension to its partnership with Adidas that the English club said Monday will be worth more than $1 billion.
United’s deal with the German sportswear brand as its official uniform supplier runs to 2035 and “has a minimum cash guarantee of 900 million pounds ($1.15 billion), subject to certain adjustments,” the team said, making it the most lucrative in Premier League history.
“It is very natural for us to continue our cooperation,” Adidas CEO Bjorn Gulden said. “We will combine tradition and innovation to please both the players and the fans.”
“We look forward to continuing our partnership with one of the most iconic clubs in football.”
The deal for the club’s single biggest source of revenue provides stability at a time when it is up for sale, with United’s American ownership weighing up offers from Qatari banker Sheikh Jassim bin Hamad Al Thani and English businessman Jim Ratcliffe.
Adidas supplied United’s uniform from 1980-1992 and the partnership started again at the beginning of the 2015-16 season.
___
AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports | https://www.seattletimes.com/business/man-united-renews-adidas-partnership-by-10-years-in-deal-worth-more-than-1b/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business | 2023-07-31T11:54:26 | 1 | https://www.seattletimes.com/business/man-united-renews-adidas-partnership-by-10-years-in-deal-worth-more-than-1b/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business |
The bear was spotted chilling in a Burbank jacuzzi while resting its paws on the side of the backyard spa. The California homeowners says the trespasser fled the scene as soon as the police showed up.
Copyright 2023 NPR
The bear was spotted chilling in a Burbank jacuzzi while resting its paws on the side of the backyard spa. The California homeowners says the trespasser fled the scene as soon as the police showed up.
Copyright 2023 NPR | https://www.apr.org/2023-07-31/as-temperatures-climbed-into-the-90s-a-black-bear-cooled-off-in-a-jacuzzi | 2023-07-31T11:54:31 | 0 | https://www.apr.org/2023-07-31/as-temperatures-climbed-into-the-90s-a-black-bear-cooled-off-in-a-jacuzzi |
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- Today, Blitz Insurance, a specialty insurance carrier, partners with Ascend to modernize payment experiences for insurance brokers selling in specialty markets. With this partnership, Blitz Insurance will open new customer segments by offering both direct bill and premium financing into their payments workflow.
"When we looked into the market for a solution, Ascend was the right choice. Ascend meets our needs for a better payments experience for our partners while reducing everyone's operational expenses," said Brandon Murphy, Chief Distribution Officer of Blitz Insurance. "We will now have the ability to not only expand to direct bill and a premium finance option but also simplify the movement of money between us and our partners."
With Ascend, Blitz Insurance is now able to provide a direct bill in addition to their existing agency bill workflow - allowing brokers to decide what billing method works best for them. By utilizing Ascend, Blitz Insurance not only grows their footprint of appointed brokers but also gains administrative efficiency by automating what would otherwise have been a large operational undertaking.
Ascend automatically attributes incoming payments to policies in real time, speeding up the reconciliation process. By modernizing the payments experience and speeding up the reconciliation of incoming premiums, Blitz Insurance can offer a best-in-class experience to its brokers and agents.
"We find that across the insurance ecosystem - companies want to provide a seamless payment workflow for their customers and their teams," said Andrew Wynn, co-CEO of Ascend. "Ascend is built so brokers and carriers can offer this experience without shouldering the administrative resources and costs needed to support these operations."
About Ascend
Ascend is the first insurance payments platform that automates financial operations from collections and financing to carrier and commission payables. Founded by two-time insurtech entrepreneurs Andrew Wynn and Praveen Chekuri, Ascend helps insurance brokers, MGAs, and carriers improve their bottom lines by eliminating expensive and labor-intensive payment workflows. To learn more, please visit LinkedIn, Twitter or check out https://www.useascend.com/.
About Blitz Insurance
Blitz is a tech-driven insurer revolutionizing the $60B specialty market catering to SME segment. By leveraging industry knowledge and cutting-edge technology, we deliver a simpler, smarter, and faster coverage experience.
The company is led by a veteran team of insurance and technology experts and has been funded with $25M from its founder & CEO, a Forbes-listed serial entrepreneur in the real estate and insurance industries.
Contact:
Mike Nguyen
press@useascend.com
View original content to download multimedia:
SOURCE Ascend | https://www.mysuncoast.com/prnewswire/2023/07/31/blitz-insurance-partners-with-ascend-expand-payment-financing-offerings/ | 2023-07-31T11:54:31 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/blitz-insurance-partners-with-ascend-expand-payment-financing-offerings/ |
5 things to know for July 31: Ukraine, Trump, Student loans, Typhoons, Twitter rebrand
By Alexandra Meeks, CNN
(CNN) — In times of stress or unease, many people channel their nerves through body-focused repetitive behaviors — like nail-biting, skin-picking or hair-pulling. Research shows a simple self-soothing technique may help suppress those bad habits.
Here’s what else you need to know to Get Up to Speed and On with Your Day.
1. Ukraine
Russia says it downed three Ukrainian drones trying to attack Moscow on Sunday, the second reported attack on the capital in a week. This comes as Ukrainian President Volodymyr Zelensky said the war is “gradually” being pushed back to Russian territory. “The war is returning to the territory of Russia — to its symbolic centers and military bases, and this is an inevitable, natural and absolutely fair,” Zelensky said, hours after a business and shopping development in Moscow were hit. In the wake of the attacks in Moscow, Russia launched a deadly airstrike on the Ukrainian city of Kryvyi Rih, killing at least two people and injuring 20 others. Zelensky also issued a warning that Russia may be preparing to attack Ukraine’s critical energy infrastructure by this winter, as it did last year to devastating effect.
2. Trump
An employee who worked at former President Donald Trump’s Florida resort is scheduled to be arraigned in the coming hours. According to the latest indictment, Trump “requested” that Carlos De Oliveira — a low-profile property manager at Mar-a-Lago — delete security footage after it was subpoenaed in order “to prevent the footage from being provided to a federal grand jury.” De Oliveira is scheduled to appear in a Miami court today, where he will be represented by an attorney paid for by Trump’s operation. Meanwhile, Trump’s team is creating a legal defense fund to help offset some of the enormous bills incurred as his legal troubles mount. Trump’s political action committee, Save America, has already spent more than $40 million on legal fees for him and many of his associates since the start of 2023.
3. Student loans
The Biden administration is launching a beta website today for its new income-driven student loan repayment plan, officials told CNN, allowing borrowers to begin submitting applications for the program as federal student loan payments are set to resume in October. The SAVE, or Saving on a Valuable Education, plan was finalized after the Supreme Court struck down President Joe Biden’s student debt forgiveness initiative in June. The new program will determine student loan payments based on income and family size, and around 1 million borrowers could see their payments shrink to as low as $0, the Department of Education estimates. Borrowers can access the beta website here, and the enrollment process will take an estimated 10 minutes.
4. Typhoons
A hurricane-level storm could make landfall in China this week as the region is reeling from floods brought by Typhoon Doksuri. More than 31,000 people have been evacuated from Beijing since the damaging typhoon hit the region last week, a Chinese state broadcaster reported. Another half million people in Fujian were forced to evacuate from flooding as several railroads, highways and schools remain closed. The torrential rains from Doksuri have left at least four dead, officials said, but the death toll could rise as crews search for victims. Heavy downpours are also expected to continue through Tuesday, increasing concerns about dangerous flooding and landslides. Doksuri is the most powerful typhoon to make landfall in China and the strongest storm to hit Fujian since Typhoon Saomi in 2006.
5. Twitter rebrand
A flashing “X” was installed atop the headquarters of the company formerly known as Twitter last week, prompting a complaint from the city of San Francisco that says the sign went up without a permit. A notice of violation was issued for not obtaining a permit for the new sign, as well as for denying city building inspectors to access the roof to ensure its safety. The sign was installed after owner Elon Musk rebranded Twitter from its iconic bird logo to the letter “X” last week. The social media company is also making news for reinstating Kanye West’s account over the weekend. The musician’s account was suspended in December for violating the platform’s rules on inciting violence — and for repeatedly sharing antisemitic remarks.
BREAKFAST BROWSE
Michelle Yeoh marries partner Jean Todt after 19-year engagement
Oscar-winner Michelle Yeoh has married her longtime partner — nearly two decades after the French businessman first proposed to her.
Another $1 billion lottery jackpot is up for grabs
One lucky winner could nab the $1.05 billion Mega Millions jackpot in Tuesday’s drawing.
Bear cools off in pool during sweltering heat
The record-breaking heat wave has become too hot to bear for humans and animals alike. See the unexpected visitor enjoying a California pool.
Bronny James plays piano days after cardiac arrest
NBA star LeBron James shared this video of his son Bronny James playing a piano, days after the 18-year-old suffered cardiac arrest.
Madonna says she feels lucky ‘to be alive’ after hospitalization
The queen of pop thanked her loved ones for helping her recover from a recent health scare.
TODAY’S NUMBER
50 million
That’s how many people are under heat alerts from the Plains to the Mississippi River today, as unrelenting heat waves continue to batter swaths of the US. More than 140 heat records could be broken this week, meteorologists say, with some parts of the deep South expected to see several days of temperatures exceeding 100 degrees.
TODAY’S QUOTE
“I love this movie, but I do not feel that it would be appropriate for this production to move forward during the strike.”
— Oscar-winning actor Viola Davis, announcing she is pausing work on her upcoming movie, “G20,” amid the ongoing actors’ and writers’ strikes, despite having been granted permission by the guild to move forward with the project. Most Hollywood productions have come to a halt after the Writers Guild of America went on strike on May 2 and SAG-AFTRA, the actors union, began a strike on July 14 — the first time the two guilds have been on strike simultaneously since the 1960s.
TODAY’S WEATHER
Check your local forecast here>>>
AND FINALLY…
Whales perform synchronized jump
A family saw this rare sighting while boating in Cape Cod, Massachusetts!
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/news/national-world/cnn-national/2023/07/31/5-things-to-know-for-july-31-ukraine-trump-student-loans-typhoons-twitter-rebrand/ | 2023-07-31T11:54:32 | 0 | https://kion546.com/news/national-world/cnn-national/2023/07/31/5-things-to-know-for-july-31-ukraine-trump-student-loans-typhoons-twitter-rebrand/ |
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR | https://www.wvasfm.org/politics/politics/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon | 2023-07-31T11:54:32 | 1 | https://www.wvasfm.org/politics/politics/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon |
BEIJING (AP) — China imposed restrictions Monday on exports of long-range civilian drones, citing Russia’s war in Ukraine and concern that drones might be converted to military use.
Chinese leader Xi Jinping’s government is friendly with Moscow but says it is neutral in the 18-month-old war. It has been stung by reports that both sides might be using Chinese-made drones for reconnaissance and possibly attacks.
Export controls will take effect Tuesday to prevent use of drones for “non-peaceful purposes,” the Ministry of Commerce said in a statement. It said exports still will be allowed but didn’t say what restrictions would apply.
China is a leading developer and exporter of drones. DJI Technology Co., one of the global industry’s top competitors, announced in April 2022 it was pulling out of Russia and Ukraine to prevent its drones from being used in combat.
“The risk of some high specification and high-performance civilian unmanned aerial vehicles being converted to military use is constantly increasing,” the Ministry of Commerce said.
Restrictions will apply to drones that can fly beyond the natural sight distance of operators or stay aloft more than 30 minutes, have attachments that can throw objects and weigh more than seven kilograms (15½ pounds), according to the ministry.
“Since the crisis in Ukraine, some Chinese civilian drone companies have voluntarily suspended their operations in conflict areas,” the Ministry of Commerce said. It accused the United States and Western media of spreading “false information” about Chinese drone exports.
The government on Friday defended its dealings with Russia as “normal economic and trade cooperation” after a U.S. intelligence report said Beijing possibly provided equipment used in Ukraine that might have military applications.
The report cited Russian customs data that showed Chinese state-owned military contractors supplied drones, navigation equipment, fighter jet parts and other goods.
The Biden administration has warned Beijing of unspecified consequences if it supports the Kremlin’s war effort. Last week’s report didn’t say whether any of the trade cited might trigger U.S. retaliation.
Xi and Russian President Vladimir Putin declared before the February 2022 invasion that their governments had a “no-limits” friendship. Beijing has blocked efforts to censure Moscow in the United Nations and has repeated Russian justifications for the attack.
China has “always opposed the use of civilian drones for military purposes,” the Ministry of Commerce said. “The moderate expansion of drone control by China this time is an important measure to demonstrate the responsibility of a responsible major country.”
The Ukrainian government appealed to DJI in March 2022 to stop selling drones it said the Russian ministry was using to target missile attacks. DJI rejected claims it leaked data on Ukraine’s military positions to Russia. | https://www.seattletimes.com/news/china-imposes-curbs-on-drone-exports-citing-ukraine-and-concern-about-military-use/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business | 2023-07-31T11:54:32 | 0 | https://www.seattletimes.com/news/china-imposes-curbs-on-drone-exports-citing-ukraine-and-concern-about-military-use/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_business |
News from Alabama Public Radio is a public service in association with the University of Alabama. We depend on your help to keep our programming on the air and online. Please consider supporting the news you rely on with a donation today. Every contribution, no matter the size, propels our vital coverage. Thank you. | https://www.apr.org/2023-07-31/how-beavers-are-helping-restore-wetlands-and-create-buffers-against-wildfires | 2023-07-31T11:54:37 | 1 | https://www.apr.org/2023-07-31/how-beavers-are-helping-restore-wetlands-and-create-buffers-against-wildfires |
MIAMI, July 31, 2023 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) today announced that Carnival Corporation (the "Company") intends to commence the marketing of a new senior secured first lien term loan B facility (the "New First Lien Term Loan") with an original principal amount of $1.0 billion, expected to mature in 2027. In conjunction with the New First Lien Term Loan, and subject to market and other conditions, the Company may raise $500 million of other secured debt maturing in 2029 (together with the New First Lien Term Loan, the "Refinancing Transactions"). The Company intends to use the proceeds from the Refinancing Transactions to repay a portion of the borrowings under the Company's existing first-priority senior secured term loan facility maturing in 2025.
After the closing of the Refinancing Transactions, the Company intends to redeem all of the Company's 10.500% second-priority senior secured notes due 2026 and 10.125% second-priority senior secured notes due 2026 (collectively, the "2026 Notes"), saving over $120 million in interest expense on an annualized basis. The $1.2 billion of redemptions will be conditioned on the closing of the Refinancing Transactions. The Company expects to use cash on hand to finance the redemptions. This press release does not constitute a notice of redemption with respect to the 2026 Notes.
The Company's Chief Financial Officer David Bernstein commented: "Given the confidence we have in our business and its cash flow generation, we plan to retire $1.2 billion of our highest cost debt. In connection with this retirement, we plan to extend some of the lowest cost public debt in our portfolio. This is yet another step forward in our deleveraging journey, building on the $1.4 billion we already early retired this year. With this debt repayment, we now expect our year end debt balance to be less than $32.0 billion, an improvement over the November 30, 2023 debt balance of less than $33.0 billion provided in our June guidance."
This press release shall not constitute an offer to sell or the solicitation of an offer to purchase any security and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offering, solicitation or sale would be unlawful.
About Carnival Corporation & plc
Carnival Corporation & plc is the largest global cruise company, and among the largest leisure travel companies, with a portfolio of world-class leading cruise lines - AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, P&O Cruises (Australia), P&O Cruises (UK), Princess Cruises and Seabourn.
Cautionary Note Concerning Forward-Looking Statements
Carnival Corporation and Carnival plc and their respective subsidiaries are referred to collectively in this press release, as "Carnival Corporation & plc," "our," "us" and "we." Some of the statements, estimates or projections contained in this press release are "forward-looking statements" that involve risks, uncertainties and assumptions with respect to us, including some statements concerning the refinancing transactions described herein, future results, operations, outlooks, plans, goals, reputation, cash flows, liquidity and other events which have not yet occurred. These statements are intended to qualify for the safe harbors from liability provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are statements that could be deemed forward-looking. These statements are based on current expectations, estimates, forecasts and projections about our business and the industry in which we operate and the beliefs and assumptions of our management. We have tried, whenever possible, to identify these statements by using words like "will," "may," "could," "should," "would," "believe," "depends," "expect," "goal," "aspiration," "anticipate," "forecast," "project," "future," "intend," "plan," "estimate," "target," "indicate," "outlook," and similar expressions of future intent or the negative of such terms.
Forward-looking statements include those statements that relate to our outlook and financial position including, but not limited to, statements regarding:
Because forward-looking statements involve risks and uncertainties, there are many factors that could cause our actual results, performance or achievements to differ materially from those expressed or implied by our forward-looking statements. This note contains important cautionary statements of the known factors that we consider could materially affect the accuracy of our forward-looking statements and adversely affect our business, results of operations and financial position. Additionally, many of these risks and uncertainties are currently, and in the future may continue to be, amplified by our substantial debt balance as a result of the pause of our guest cruise operations. There may be additional risks that we consider immaterial or which are unknown. These factors include, but are not limited to, the following:
- events and conditions around the world, including war and other military actions, such as the invasion of Ukraine, inflation, higher fuel prices, higher interest rates and other general concerns impacting the ability or desire of people to travel have led, and may in the future lead, to a decline in demand for cruises, impacting our operating costs and profitability;
- pandemics have in the past and may in the future have a significant negative impact on our financial condition and operations;
- incidents concerning our ships, guests or the cruise industry have in the past and may, in the future, negatively impact the satisfaction of our guests and crew and lead to reputational damage;
- changes in and non-compliance with laws and regulations under which we operate, such as those relating to health, environment, safety and security, data privacy and protection, anti-corruption, economic sanctions, trade protection, labor and employment and tax have in the past and may, in the future, lead to litigation, enforcement actions, fines, penalties and reputational damage;
- factors associated with climate change, including evolving and increasing regulations, increasing global concern about climate change and the shift in climate conscious consumerism and stakeholder scrutiny, and increasing frequency and/or severity of adverse weather conditions could adversely affect our business;
- inability to meet or achieve our sustainability related goals, aspirations, initiatives, and our public statements and disclosures regarding them, may expose us to risks that may adversely impact our business;
- breaches in data security and lapses in data privacy as well as disruptions and other damages to our principal offices, information technology operations and system networks and failure to keep pace with developments in technology may adversely impact our business operations, the satisfaction of our guests and crew and may lead to reputational damage;
- the loss of key team members, our inability to recruit or retain qualified shoreside and shipboard team members and increased labor costs could have an adverse effect on our business and results of operations;
- increases in fuel prices, changes in the types of fuel consumed and availability of fuel supply may adversely impact our scheduled itineraries and costs;
- we rely on supply chain vendors who are integral to the operations of our businesses. These vendors and service providers may be unable to deliver on their commitments, which could negatively impact our business;
- fluctuations in foreign currency exchange rates may adversely impact our financial results;
- overcapacity and competition in the cruise and land-based vacation industry may negatively impact our cruise sales, pricing and destination options;
- inability to implement our shipbuilding programs and ship repairs, maintenance and refurbishments may adversely impact our business operations and the satisfaction of our guests;
- Failure to successfully implement our business strategy following our resumption of guest cruise operations would negatively impact the occupancy levels and pricing of our cruises and could have a material adverse effect on our business. We require a significant amount of cash to service our debt and sustain our operations. Our ability to generate cash depends on many factors, including those beyond our control, and we may not be able to generate cash required to service our debt and sustain our operations; and,
- the risk factors included in Carnival Corporation's and Carnival plc's Annual Report on Form 10-K filed with the SEC on January 27, 2023 and Carnival Corporation's and Carnival plc's Quarterly Reports on Form 10-Q filed with the SEC on March 29, 2023 and June 28, 2023.
The ordering of the risk factors set forth above is not intended to reflect our indication of priority or likelihood.
Forward-looking statements should not be relied upon as a prediction of actual results. Subject to any continuing obligations under applicable law or any relevant stock exchange rules, we expressly disclaim any obligation to disseminate, after the date of this document, any updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are based.
Forward-looking and other statements in this document may also address our sustainability progress, plans and goals (including climate change and environmental-related matters). In addition, historical, current and forward-looking sustainability- and climate-related statements may be based on standards and tools for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions and predictions that are subject to change in the future and may not be generally shared.
SOURCE Carnival Corporation & plc
View original content:
SOURCE Carnival Corporation & plc | https://www.mysuncoast.com/prnewswire/2023/07/31/carnival-corporation-amp-plc-announces-anticipated-debt-pre-payment-12b-refinancing-transaction/ | 2023-07-31T11:54:38 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/carnival-corporation-amp-plc-announces-anticipated-debt-pre-payment-12b-refinancing-transaction/ |
Lori Vallow Daybell faces sentencing today for murders of her 2 children and conspiring to kill her husband’s first wife
By Dakin Andone, CNN
(CNN) — Idaho mother Lori Vallow Daybell is expected to be sentenced Monday after she was convicted earlier this year of killing two of her children and conspiring in the murder of her husband’s first wife.
Vallow Daybell faces the possibility of life in prison after a jury in May found her guilty on all charges, including two counts of first-degree murder and three counts of conspiracy in the deaths of her children, 17-year-old Tylee Ryan and 7-year-old Joshua “JJ” Vallow, as well as Tammy Daybell, the first wife of her husband, Chad Daybell.
The hearing Monday, scheduled to begin at 9 a.m. at the Fremont County Courthouse, is expected to include victim impact statements, giving the loved ones of the deceased an opportunity to underscore the lasting repercussions of Vallow Daybell’s actions. Court records also indicate the judge ordered a presentence investigation – which allows for a mental health examination, among other evaluations – to be reviewed during Monday’s hearing.
The children were last seen in September 2019, and Tammy Daybell died the following month; Vallow Daybell and Chad Daybell were married weeks later. In June 2020, law enforcement authorities discovered the remains of Tylee and JJ in Daybell’s backyard in Fremont County.
He is to be tried separately in April 2024 on two felony counts of conspiracy to commit destruction; alteration or concealment of evidence; and two felony counts of destruction, alteration or concealment of evidence. He has pleaded not guilty.
The May 2021 indictment against the couple said they “did endorse and espouse religious beliefs for the purposes of” justifying or encouraging the killings of Tammy Daybell and the children. At trial, prosecutors portrayed the couple as having apocalyptic religious beliefs, believing themselves religious figures who had a system of rating people as “light” or “dark,” East Idaho News reported.
Vallow Daybell pleaded not guilty, and while her attorney Jim Archibald acknowledged his client’s interest in religion – particularly the “end of times” – he said she was a “kind and loving mother.”
“Some people could care less about biblical prophecies; some people care a lot about it. Thankfully in this country we get the freedom to choose,” Archibald said in his own opening statement, according to East Idaho News.
Vallow Daybell was also convicted of grand theft for, according to the indictment, collecting Social Security benefits on behalf of her children after their deaths. Prosecutors said she didn’t report her children missing in order to keep collecting the money, East Idaho News reported.
In the wake of the verdict, Vallow Daybell’s attorneys filed a motion for a new trial, court records show. The state objected, and the court ultimately denied the motion.
The case – which was featured in a true crime Netflix documentary – began unfolding in late November 2019, when relatives asked police in Rexburg, Idaho, to do a welfare check on JJ because they hadn’t talked to him recently. Police didn’t locate him at the family’s house but were told by Vallow Daybell and Daybell that he was staying with a family friend in Arizona, according to authorities.
When police returned the next day to serve a search warrant, Vallow and Daybell were gone. They were found months later, in January 2020, in Hawaii.
Kay Woodcock, JJ’s grandmother, testified that her regular phone calls with her grandson dropped off after the death of Vallow Daybell’s ex-husband, Charles Vallow, East Idaho News reported.
The last conversation she had with JJ was on August 10, 2019, Woodcock said, when she spoke to him during a short call that lasted less than a minute. She attempted over the next few months to contact her grandson, but never got any response from Vallow Daybell, she said.
Vallow Daybell’s ex-husband was seen in body camera footage released by Arizona police telling authorities as early as January 2019 that he could not get in touch with the children. Their marriage had rapidly deteriorated, he said, adding, “she thinks she’s a resurrected being and a god.”
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
CNN’s Eric Levenson, Emma Tucker, Ashley R. Williams and Steve Almasy contributed to this report. | https://kion546.com/news/national-world/cnn-national/2023/07/31/lori-vallow-daybell-sentencing-idaho-mom-found-guilty-of-murder-and-conspiracy-to-kill-faces-up-to-life-in-prison/ | 2023-07-31T11:54:38 | 1 | https://kion546.com/news/national-world/cnn-national/2023/07/31/lori-vallow-daybell-sentencing-idaho-mom-found-guilty-of-murder-and-conspiracy-to-kill-faces-up-to-life-in-prison/ |
A Libyan man who says he escaped execution by the Russian mercenary Wagner group is taking them to court in the U.S. — alleging torture and multiple human rights abuses.
Copyright 2023 NPR
A Libyan man who says he escaped execution by the Russian mercenary Wagner group is taking them to court in the U.S. — alleging torture and multiple human rights abuses.
Copyright 2023 NPR | https://www.apr.org/2023-07-31/libyan-man-who-says-he-was-tortured-wants-to-hold-wagner-group-accountable | 2023-07-31T11:54:43 | 0 | https://www.apr.org/2023-07-31/libyan-man-who-says-he-was-tortured-wants-to-hold-wagner-group-accountable |
New Jersey school district reaches $9.1 million settlement with family of teen who died by suicide
By Celina Tebor and Jessica Xing, CNN
(CNN) — A New Jersey school district has agreed to pay $9.1 million to the family of a girl who died by suicide after she was bullied at school, the family’s attorney said.
The settlement comes after Diane and Seth Grossman sued Rockaway Township School District in 2018, claiming that, despite repeated complaints, Copeland Middle School administrators did not do enough to prevent their daughter’s death.
Twelve-year-old Mallory Grossman took her own life in June 2017 after being bullied in school and cyberbullied by classmates throughout the school year through text and Snapchat messages, according to the lawsuit filed in New Jersey superior court.
CNN has reached out to the Rockaway Township School District for comment on the settlement, which was reached in court Wednesday.
It is the largest bullying settlement in New Jersey history, an attorney for the Grossman family, Bruce Nagel, told CNN.
“This settlement should send a strong signal to schools around the country that bullying is an epidemic and schools have a responsibility to protect our children,” Nagel said.
“Seth and I are satisfied with the settlement, ready to put this part behind us and move forward, continuing to lend our voice to the epidemic that is stealing our children’s future,” Dianne Grossman said in a statement. “We hope all schools, (Boards of Education) and administrators will take a look at their current policies & make the necessary changes to protect all students, as it pertains to bullying and cyberbullying.”
The issue of bullying in schools has taken on a new dynamic since the rise of social media, experts say.
“Before social media, there might have been an unpleasant interaction at school and that’s mostly where it stops,” Nikki Pagano, a licensed clinical social worker in Charlotte, North Carolina, previously told CNN. “Now, that interaction carries over to home and is inescapable. Instead of one person making you feel bad, there may be something posted online and peers may be seeing or even ‘liking’ this post.”
New Jersey Gov. Phil Murphy has taken measures to address bullying concerns in schools. In January 2022 he signed a measure, dubbed “Mallory’s Law,” requiring school districts to provide specific consequences in anti-bullying policies for students harassing or bullying a classmate, according to the New Jersey state legislature.
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
CNN’s Michelle Icard contributed to this report. | https://kion546.com/news/national-world/cnn-national/2023/07/31/new-jersey-school-district-reaches-9-1-million-settlement-with-family-of-teen-who-died-by-suicide/ | 2023-07-31T11:54:44 | 0 | https://kion546.com/news/national-world/cnn-national/2023/07/31/new-jersey-school-district-reaches-9-1-million-settlement-with-family-of-teen-who-died-by-suicide/ |
LA ROMANA, Dominican Republic, July 31, 2023 /PRNewswire/ -- The international known company Hilton Hotels & Resorts opens its doors to its Hilton Garden Inn La Romana hotel project in the Dominican Republic, in collaboration with a group of important investors under the company Riverhome Capital S.A.S., whose main shareholder is the prominent Dominican former major league player, Edwin Encarnación; together with the vision of the lawyer Guillermo Estrella Ramia and the Minister of Tourism, David Collado.
The inauguration was led by Luis Abinader Corona, president of the Dominican Republic and who expressed that "This hotel has something very special, opening up the beach and the sector of La Caleta of La Romana, which for a long time was closed to the province and its visitors. Since private investment must always be accompanied by public infrastructure, we are working on creating them, so we are all part of this development of La Romana."
With an investment of 25 million united states dollars and the creation of more than 300 direct jobs, it is considered as a hotel option for the growing flows of tourists that the area is currently receiving. Located a short distance from other points of relevance, such as La Romana Airport 18 minutes away, Casa de Campo 12 minutes away and Central Romana just a few blocks away.
The new hotel facility has a privileged location on a 5,000 square meters property, located on the coast of the municipal district of La Caleta, La Romana province. With a capacity of 130 rooms, distributed in five of the seven floors of the building, it also counts with swimming pools, two bars, a restaurant, gym, event, meeting and multipurpose rooms, and outdoor areas, ideal for social and corporate celebrations.
The hotel responds to the interest of Edwin Encarnación to invest in the development of his province of origin, who expressed that "from the moment this project was presented to me, I knew that I had to be part and be the one to assume this. I joined the development of this hotel, with the only requirement that most of the workers came from here, from my town La Romana, and we achieved this."
View original content to download multimedia:
SOURCE Grupo De Valle | https://www.mysuncoast.com/prnewswire/2023/07/31/hilton-garden-inn-la-romana-dominican-republic-celebrates-its-opening/ | 2023-07-31T11:54:44 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/hilton-garden-inn-la-romana-dominican-republic-celebrates-its-opening/ |
You can get a specific read on just how crazed the power struggle within the Idaho Republican Party has gotten by mentioning just one name: Damond Watkins.
The idea that he would be on the losing end of a bitter power struggle in the party’s upper reaches — for that matter, that he would have been involved in a party squabble at all — shows how much things have changed in the last few years.
He comes from one of the best-known and most solidly-established of eastern Idaho Republican families. His father, Dane, was a state senator and a Republican nominee for Congress who I covered for years, and one of the most even-tempered politicians I ever saw. (His father was a key Idaho Falls establishment figure for years before.) Damond’s brother, Dane Jr., was an elected (Republican) Bonneville County prosecutor for years, and now a judge
Damond worked for years (he has since moved on) at Melaleuca, a top executive close to its leader, Frank Vander Sloot; both Melaleuca and Vander Sloot have been well known regionally for many years as a top institutional private-sector centerpoint for the region’s Republican Party.
People are also reading…
Damond Watkins also put in many years of work for the regional and state Republican Party, chaired the county organization, and for the last decade he has been the Idaho state committee man — one of two state representatives — to the national committee, and has often paid for the travel out of his own pocket.
When last month Watkins abruptly announced his resignation from the position, the party released a statement that he “played a pivotal role in shaping our party’s vision and driving positive change … [and deserved] gratitude for his service and contributions over the years.”
What the party didn’t say then was that the same leadership making that statement had pressured Watkins to quit.
A remarkable story from the Idaho Falls Post Register put together the pieces.
The party’s state leadership — its top officials and its governing bodies — have been changing over the last decade or so, moving away from more establishment leaders like Trent Clark and Rom Luna (both former chairs) to people more aligned with the extremist groups centered in party organizations like Kootenai County. It’s become a much more hardcore group.
The immediate excuse was that he wasn’t spending enough time in Idaho (he also has a house in North Carolina), but that was a pretext only: He’d been attending meetings and doing the work. Behind the scenes several months ago someone tried a challenge to his voting qualifications in Idaho, but the county clerk said he was a properly registered voter. After that, the party brought in an “investigative committee,” which the newspaper indicated collected whatever it could find as evidence against him, including a recording of him speaking in church.
At the June party meeting in Challis, party chair Dorothy Moon confronted him with the report, saying (he recalled), that “Everybody, when they see the truth, what’s in this report, they’re going to drop you like flies.” That included, she said, his friend Vander Sloot.
Not so. Vander Sloot rebutted: “I have the highest regard for him. I think what Dorothy Moon and her team did to Damond was abhorrently wrong, immoral, and dishonest. It’s extremely sad to me to see any leader stoop to these levels. It’s especially sad to me to see this happening in the Idaho Republican Party. We are better than this.”
He wasn’t alone in support for Watkins. Clark and Luna (who had been ousted as chair by Moon) also released a statement (including one sent to the national party) saying much the same.
Moon was quoted by the Post Register about all this: “Some of this isn’t anybody’s business. It’s a private club.” This tells you what the leaders of the party running Idaho thinks of its relationship to the people of the state.
All of this was about one person and one party structural position. Here’s your sign of how far the current leadership of the party is willing to go to eliminate opposition.
Randy Stapilus is a former Idaho newspaper reporter and editor who blogs at ridenbaugh.com. Reach him at stapilus@ridenbaugh.com. | https://magicvalley.com/print-specific/twn-column/idaho-republican-party-damond-watkins-dorothy-moon-stapilus/article_abe3e37c-2e42-11ee-818b-0f5ce0d64255.html | 2023-07-31T11:54:46 | 1 | https://magicvalley.com/print-specific/twn-column/idaho-republican-party-damond-watkins-dorothy-moon-stapilus/article_abe3e37c-2e42-11ee-818b-0f5ce0d64255.html |
Georgia man electrocuted after jumping into lake
ATLANTA (WANF/Gray News) - A Georgia man is dead after jumping into Lake Lanier Thursday evening, WANF reports.
The Forsyth County Sheriff’s Office said 24-year-old Thomas Shepard Milner jumped into the lake from his family’s dock near Dove Trail and was electrocuted when he entered the water.
A family friend told investigators they heard Milner scream for help and tried to get him out of the water using a ladder.
When that didn’t work, neighbors stepped in to help and took a boat out to Milner, the sheriff’s office said. The person in the boat jumped in the water to pull Milner out but reported feeling a burning sensation, which they immediately recognized as an electric shock.
After swimming to shore and turning off the power box near the dock, the person returned to the water to pull Milner back to shore, according to investigators.
Witnesses told authorities Milner’s uncle administered CPR until emergency medical crews got to the scene. The 24-year-old was rushed to Northside Forsyth Hospital. He died from his injuries the next day.
Milner’s mother, Martha Milner, told WANF her son was gentle and kind and loved the lake.
“Shepard was known for his quirkiness, his humor and his dedication,” she said.
According to Martha Milner, the dock at their lake property was less than three years old and outfitted with electricity by a licensed electrician.
Boaters like Chris Morris were saddened to hear about the death on Sunday.
“It’s a freak accident,” he said.
It is unclear why the water was electrified.
The investigation remains ongoing.
Copyright 2023 WANF via Gray Media Group, Inc. All rights reserved. | https://www.kold.com/2023/07/31/georgia-man-electrocuted-after-jumping-into-lake/ | 2023-07-31T11:54:45 | 0 | https://www.kold.com/2023/07/31/georgia-man-electrocuted-after-jumping-into-lake/ |
Lawsuit alleges flight attendants served too much alcohol to passenger that groped woman, her daughter
(CNN) - A passenger is suing Delta Airlines, claiming flight attendants overserved alcohol to a man who became drunk while on board and groped a mother and her teenage daughter.
The alleged incident happened during an international flight last summer.
The suit claims the flight attendants ignored the mother’s pleas for them to stop serving alcohol to the man and that the passenger was making them feel unsafe.
The plaintiffs in the case said during the nine-hour flight from New York to Greece, the man made obscene gestures and sexually assaulted the 16-year-old girl sitting next to him.
When the plane landed in Greece, the man was allowed to walk free despite the mother’s request that authorities arrest him in Athens.
Delta has not commented on the suit but says the airline has zero tolerance for passengers who engage in inappropriate or unlawful behavior.
Copyright 2023 CNN Newsource. All rights reserved. | https://www.kold.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ | 2023-07-31T11:54:48 | 0 | https://www.kold.com/2023/07/31/lawsuit-alleges-flight-attendants-served-too-much-alcohol-passenger-that-groped-woman-her-daughter/ |
"I don't think it's caught up to me yet — how much my life has changed," says Emma Hardyman, singer of the 2023 Tiny Desk Contest-winning band Little Moon. The Utah-based band recently wrapped up the Tiny Desk Contest On The Road tour, headlining eight sold-out shows across the country. While on the road, Hardyman caught up with NPR to reflect on the life-changing win and also share the story behind Little Moon's winning song, "Wonder Eye."
Hardyman tells NPR the song was written during the time her mother-in-law was in hospice care. The melody came to Hardyman as she and her husband Nathan Hardyman, who is also part of Little Moon, drove from Utah to Idaho to visit his mother.
During this difficult time, Emma and Nathan Hardyman were also in the process of leaving the Mormon church in which they had grown up.
"And pretty quickly, just because of the circumstances, I realized that this song, this melody, was about death," says Emma Hardyman, who wrote the structure of the song before asking Nathan Hardyman to write the lyrics.
The couple were also observing the disintegration of many of the building blocks their Mormon belief systems were built on. "I've grieved past versions of myself throughout my whole life," Emma Hardyman shares.
"I really love where Mormonism brought me," Emma Hardyman says. "It introduced me to teachings that are supposed to love everybody, that are supposed to incorporate everybody. [But] it couldn't follow me to how much I wanted to take [those teachings] seriously," she adds, noting that many of the Little Moon band members are queer. She says Mormonism didn't align with how she wants to treat people 'without conditions.'
Emma Hardyman also shares that she had many self-doubts about herself as an artist when she and Nathan Hardman met — but that he believed in her from their very first date. And in "Wonder Eye," the two even find peace in not having all the answers. Emma sings: "Is there a knowledge that is found not in knowing?" as she's met with the warm hums of the band.
Copyright 2023 NPR. To see more, visit https://www.npr.org. | https://www.apr.org/2023-07-31/the-power-and-heartbreak-behind-the-song-that-won-the-tiny-desk-contest | 2023-07-31T11:54:49 | 0 | https://www.apr.org/2023-07-31/the-power-and-heartbreak-behind-the-song-that-won-the-tiny-desk-contest |
WATCH: Concertgoer throws drink at Cardi B; she hurls microphone at them
Published: Jul. 31, 2023 at 3:58 AM MST|Updated: 56 minutes ago
LAS VEGAS (CNN) - Cardi B hurled her microphone at a fan during a concert in Las Vegas on Saturday.
The rapper was performing her song “Bodak Yellow” when a concertgoer threw a drink at her.
In seconds, Cardi B threw her microphone into the crowd as the song continued to play.
Security guards rushed to the stage.
More security guards are then seen flocking to the person in the crowd as she watched from the stage before continuing with her set.
There’s no word on what happened to the fan or if any charges will be filed.
Copyright 2023 CNN Newsource. All rights reserved. | https://www.kold.com/2023/07/31/watch-concertgoer-throws-drink-cardi-b-she-hurls-microphone-them/ | 2023-07-31T11:54:50 | 1 | https://www.kold.com/2023/07/31/watch-concertgoer-throws-drink-cardi-b-she-hurls-microphone-them/ |
American nurse and her child kidnapped from their community ministry in Haiti
By Heather Law and Aaron Pellish, CNN
(CNN) — An American nurse and her child have been kidnapped in Haiti, according to El Roi Haiti, the Christian humanitarian aid organization she works for.
Alix Dorsainvil, wife of El Roi Haiti Director Sandro Dorsainvil, and their child were reportedly abducted Thursday morning, according to a statement on El Roi Haiti’s website.
The two were taken while serving in their community ministry on El Roi Haiti’s campus near capital city Port-au-Prince, the post read.
“Alix is a deeply compassionate and loving person who considers Haiti her home and the Haitian people her friends and family. Alix has worked tirelessly as our school and community nurse to bring relief to those who are suffering as she loves and serves the people of Haiti in the name of Jesus,” the statement said.
Dorsainvil, originally a nurse from New Hampshire, moved to Haiti after her husband invited her to a Haitian school to provide nursing care for the children, Dorsainvil said in a video on the organization’s website.
US authorities are aware of the abductions and are working with Haitian authorities and US government interagency partners, according to a statement given to CNN by a State Department spokesperson.
“The U.S. Department of State and our embassies and consulates abroad have no higher priority than the safety and security of U.S. citizens overseas,” the spokesperson said.
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/news/national-world/cnn-world/2023/07/31/american-nurse-and-child-kidnapped-in-haiti/ | 2023-07-31T11:54:51 | 0 | https://kion546.com/news/national-world/cnn-world/2023/07/31/american-nurse-and-child-kidnapped-in-haiti/ |
- CARDIO-TTRansform is the largest, most comprehensive ATTR-CM study with more than 1,400 patients enrolled
- Eplontersen is currently under U.S. FDA review for ATTRv-polyneuropathy, with ATTR-CM representing a second, larger potential patient population
CARLSBAD, Calif., July 31, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the completion of enrollment in the Phase 3 CARDIO-TTRansform cardiovascular outcomes study of eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), a large and growing patient population at risk of life-threatening cardiovascular (CV) events. The study enrolled more than 1,400 patients.
Eplontersen is an investigational antisense medicine designed to inhibit the production of transthyretin and slow the progression of cardiomyopathy for people living with hereditary or wild-type ATTR-CM.
"CARDIO-TTRansform is the largest and most comprehensive ATTR-CM study ever conducted. The evaluation of eplontersen in this broad, diverse patient population will enable robust and clinically meaningful analysis of the composite endpoint of CV mortality and recurrent CV events," said Eugene Schneider, M.D., executive vice president and chief clinical development officer for Ionis. "It will also allow us to gather data from important patient subsets, including patients with or without stabilizer therapy and those with or without hereditary disease within the evolving ATTR-CM landscape. We look forward to reporting results as early as the first half of 2025."
As part of a global development and commercialization agreement, Ionis and AstraZeneca are seeking regulatory approval for eplontersen for the treatment of transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) in the U.S. and plan to seek regulatory approval in Europe and other parts of the world. The U.S. Food and Drug Administration accepted the New Drug Application for eplontersen for the treatment of ATTRv-PN with a PDUFA action date of Dec. 22, 2023. Eplontersen was granted Orphan Drug Designation in the U.S.
For more information on the CARDIO-TTRansform study, please visit www.clinicaltrials.gov (NCT04136171).
About the CARDIO-TTRansform Study
CARDIO-TTRansform is a global, double-blind, randomized, placebo-controlled Phase 3 cardiovascular outcome study in more than 1,400 patients with ATTR cardiomyopathy (ATTR-CM). It is designed to compare eplontersen to placebo in patients with both wild-type ATTRwt-CM and hereditary ATTRv-CM who are either naïve to treatment or on a currently available standard of care. The primary composite endpoint is cardiovascular (CV) mortality and recurrent CV clinical events comparing the two study arms up to week 140. Secondary endpoints include the change from baseline in the 6-minute walk test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ) scores at week 121, as well as the rates of CV mortality, CV clinical events and all-cause mortality at week 140.
About Eplontersen
Eplontersen is an investigational LIgand-Conjugated Antisense (LICA) medicine designed to inhibit the production of TTR protein. Eplontersen is being developed as a monthly self-administered subcutaneous injection to treat all types of ATTR. ATTR amyloidosis is a systemic, progressive and fatal disease in which patients experience multiple overlapping clinical manifestations caused by the inappropriate formation and aggregation of TTR amyloid deposits in various tissues and organs, including peripheral nerves, heart, intestinal tract, eyes, kidneys, central nervous system, thyroid and bone marrow. The progressive accumulation of TTR amyloid deposits in these tissues and organs leads to organ failure and eventually death.
About Transthyretin-mediated Amyloid Cardiomyopathy (ATTR-CM)
Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease. It is caused by the accumulation of misfolded TTR protein in the cardiac muscle. Patients experience ongoing debilitating heart damage resulting in progressive heart failure, which results in death within three to five years from disease onset. ATTR-CM includes both the genetic and wild-type form of the disease. Worldwide, there are an estimated 300,000 – 500,0001,2 patients with ATTR-CM.
About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
Ionis' Forward-looking Statements
This press release includes forward-looking statements regarding Ionis' business and the therapeutic and commercial potential of eplontersen, Ionis' technologies and other products in development. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties including those related to our commercial products and the medicines in our pipeline, and particularly those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended Dec. 31, 2022, and the most recent Form 10-Q quarterly filing, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.
In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" all refer to Ionis Pharmaceuticals and its subsidiaries.
Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc.
1 Mohamed-Salem L, et al. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol. 2018 Nov 1;270:192-196. doi: 10.1016/j.ijcard.2018.06.006.
2 Cuscaden C, et al. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2020 May 8. doi: 10.1007/s12350-020-02152-x.
View original content to download multimedia:
SOURCE Ionis Pharmaceuticals, Inc. | https://www.mysuncoast.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ | 2023-07-31T11:54:51 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ |
BEIJING, July 31, 2023 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants in China, today announced the launch of its 36Kr Media Lab in Silicon Valley, an initiative to embrace the large language models (LLM) revolution taking place in the content creation industry and optimize the application of artificial intelligence (AI) for the new economy sector.
36Kr Silicon Valley Media Lab's first project leveraging LLM, "Empty Office," will experimentally explore scenarios where AI can think and work as humans, enhancing content production efficiency and reducing costs. Through "Empty Office," 36Kr is also building innovative media solutions that will transform traditional video, graphic and text communications into avant-garde dialogues between customized AI characters and audiences. These network-based dialogues will be naturally and seamlessly driven by real-time data generation, and available anytime, anywhere.
At the same time, 36Kr Silicon Valley Media Lab continues to focus on tailoring its LLM to the new economy sector. By utilizing dedicated financial and business datasets, including enterprises' financial results, news, market dynamics and knowledge repositories, among other resources, to train its LLM to thoroughly understand and analyze business information, 36Kr has developed a model that keenly grasps the business nuances to generate accurate analysis and interpretation. 36Kr Silicon Valley Media Lab constantly maintains its database, serving as the reference foundation to ensure that its fact-based model produces rigorous and up-to-date business and financial analysis.
Furthermore, 36Kr's professionally-training, fine-tuning capability enables its LLM-empowered "Empty Office" to quickly and efficiently create informative content for the new economy sector. For instance, in the case of a business event, such as a new product launch, an AI agent can instantly extract relevant data from the database, automatically perform a comprehensive analysis, and issue reports within just seconds. This top-speed response gives 36Kr's business and financial-focused media platform an unrivaled edge.
Mr. Dagang Feng, Co-chairman and CEO of 36Kr, commented, "The launch of 36Kr Silicon Valley Media Lab is a testament to our AI technology acumen and vision as well as our commitment to extending media's boundaries. By integrating pioneering AI technology into content creation, 36Kr will constantly elevate the efficiency and quality of content production alongside the rapid advancement of the LLM, fostering a superior content ecosystem encompassing business, finance and technology, further turbocharging the evolution of the New Economy. As we adopt and develop more AI tools amid the technology's rapid advancement, we are strategically positioning the Company to break new ground and ultimately drive long-term growth for our business."
About 36Kr Holdings Inc.
36Kr Holdings Inc. is a prominent brand and a pioneering platform dedicated to serving New Economy participants in China with the mission of empowering New Economy participants to achieve more. The Company started its business with high-quality New Economy-focused content offerings, covering a variety of industries in China's New Economy with diverse distribution channels. Leveraging traffic brought by high-quality content, the Company has expanded its offerings to business services, including online advertising services, enterprise value-added services, and subscription services, to address the evolving needs of New Economy companies and upgrading needs of traditional companies. The Company is supported by a comprehensive database and strong data analytics capabilities. Through diverse service offerings and significant brand influence, the Company is well-positioned to continuously capture the high growth potential of China's New Economy.
For more information, please visit: http://ir.36kr.com.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's goal and strategies; the Company's future business development, results of operations and financial condition; relevant government policies and regulations relating to our business and industry; the Company's expectations regarding the use of proceeds from this offering; the Company's expectations regarding demand for, and market acceptance of, its services; the Company's ability to maintain and enhance its brand; the Company's ability to provide high-quality content in a timely manner to attract and retain users; the Company's ability to retain and hire quality in-house writers and editors; the Company's ability to maintain cooperation with third-party professional content providers; the Company's ability to maintain relationships with third-party platforms; general economic and business conditions in China; possible disruptions in commercial activities caused by natural or human-induced disasters; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
For investor and media inquiries, please contact:
In China:
36Kr Holdings Inc.
Investor Relations
Tel: +86 (10) 8965-0708
E-mail: ir@36kr.com
The Piacente Group, Inc.
Jenny Cai
Tel: +86 (10) 6508-0677
E-mail: 36Kr@tpg-ir.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: 36Kr@tpg-ir.com
View original content:
SOURCE 36Kr Holdings Inc. | https://www.kold.com/prnewswire/2023/07/31/36kr-launches-silicon-valley-media-lab-empower-content-ecosystem-with-llm-based-ai-technology/ | 2023-07-31T11:54:52 | 0 | https://www.kold.com/prnewswire/2023/07/31/36kr-launches-silicon-valley-media-lab-empower-content-ecosystem-with-llm-based-ai-technology/ |
Juggernaut and Mr. Highman will continue as substantial shareholders of Bobbie. The acquisition positions the combined company as the third largest fully integrated infant and toddler brand in the U.S., creating a more resilient industry for American families
WASHINGTON, July 31, 2023 /PRNewswire/ -- Juggernaut Capital Partners, a leading middle market private equity investor primarily in the consumer and healthcare sectors, is pleased to announce the sale of Nature's One, the pediatric nutrition company founded by Jay Highman which set the bar for quality and innovation in formula over decades. Joining forces with Bobbie Baby, Inc., the nation's fastest growing infant formula company, the combined business will be the first of its kind in pediatric nutrition.
"Nature's One is a true pioneer in the pediatric nutrition space. Juggernaut partnered with founder, Jay Highman, to accelerate product development and vertical integration initiatives. Over the past five years, the company completed the first FDA-approved clinical feeding study of an organic infant formula and designed and constructed the first newly built infant formula facility in the U.S. in 35 years," said John Shulman, Founder and Managing Partner at Juggernaut. "It has been a pleasure to partner with Jay and his team. We believe the combination with Bobbie cements the organization as a continued disruptor and a next-generation industry leader. We are proud to continue as a meaningful shareholder in the go-forward company."
Founded in 1997, Nature's One introduced the first organic baby formula to the U.S. market. Recognized for its dedication to purity and quality, all of the company's formulas have received the Clean Label Project's Purity Award and have tested best in class for purity and nutrition when compared to popular baby formulas sold in the U.S. Nature's One operates the only independent, FDA audited organic infant nutrition facility in the U.S.
Nature's One was advised by CG / Sawaya Partners (operating under Canaccord Genuity) and Morgan Lewis & Bockius LLP. Bobbie was advised by Perella Weinberg Partners LP and Goodwin Procter LLP.
About Juggernaut Capital Partners:
Juggernaut Capital Partners is a leading private equity firm focusing on lower middle market companies, primarily in the consumer and healthcare sectors. Juggernaut is currently investing out of Juggernaut Capital Partners V, L.P. For more information on Juggernaut Capital Partners, please visit www.juggernautcap.com.
About Nature's One:
Founded in 1997, Nature's One introduced the first organic formula, Baby's Only® Organic in the United States. Nature's One has dedicated 25 years to the research, development, and sourcing of pure ingredients. Recognized as the first and highest-ranked formulas for purity and nutritional superiority by the Clean Label Project, Baby's Only Formulas are preferred by parents who want to offer their child a "Better Start…for Life™." Baby's Only Formulas are sold nationally at Whole Foods, Target, Walmart, Sam's Club, and many fine natural food retailers, as well online at www.naturesone.com.
About Bobbie:
Bobbie is the mission-driven organic pediatric nutrition company that exists to build a parenting culture of confidence, not comparison. Founded in 2018, Bobbie hit the market with its flagship European-inspired formula in 2021 as the first direct-to-consumer, subscription-based infant formula in the U.S. Today, it's proud to be the only mom-founded and led infant formula brand in the world, and the fastest-growing in the U.S. since the 1980's. Bobbie is focused on providing purposefully sourced, USDA Organic products made with simple ingredients – crafted right here in America, for American families. For more information, visit www.hibobbie.com.
View original content:
SOURCE Juggernaut Capital Partners | https://www.mysuncoast.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ | 2023-07-31T11:54:52 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ |
HOUSTON, July 31, 2023 /PRNewswire/ -- AutomationEdge, a leading Hyperautomation platform has announced strategic partnership with eAlliance Corp, a cutting-edge Hyperautomation solutions provider.
The partnership will enable eAlliance Corp to provide AutomationEdge solutions such as CogniBot - a conversational AI platform, DocEdge - an intelligent document processing platform, Intelligent Service Desk Ticket Data Analysis, IT Process Automation (ITPA) and RPA. This collaboration will empower AutomationEdge and eAlliance Corp to help customers innovate with automation to move the needle on the top and bottom line.
AutomationEdge, along with its Hyperautomation platform, has also build the ready automation solutions across industries. It will help customers achieve faster Go-To-Market for automation projects with lower cost. It is empowering 250+ customers globally in Healthcare, Banking, Insurance, Financial Services and other industries.
For over 20 years, eAlliance Corp has been delivering technology solutions to businesses worldwide across industries. It has been a trusted advisor to its customer in innovation, strategy and execution of automation solutions. Through this partnership, eAlliance will be able to offer innovative business process automation solutions to customers focusing on key enterprise domains such as finance & accounting, customer service, procurement, human resources, cash applications and more.
About AutomationEdge
AutomationEdge is a leading Hyperautomation platform across the globe with end-to-end automation capabilities. With its platforms working together as one solution, it has enabled seamless process automation for global enterprises.
AutomationEdge has already delivered its innovative solutions to large multinational organizations like American Express, Smart Dubai Government, Wipro, AccentCare, Danone, University of Maryland Medical System, Aspen Pharmacare, Oman LNG, Mashreq Bank, HDFC Bank, and Genpact, to name a few.
For more details, contact sales or request a demo.
About eAlliance Corp
eAlliance Corp is a professional services firm with big company expertise and small company relationships, taking pride in agility and real-time responsiveness. eAlliance Corp is a trusted name in the Hyperautomation industry, offering comprehensive services and solutions to help businesses achieve their automation goals with ease. Founded in 2002 in Chicago, IL, staffed with resources in the US and India possessing vast experience and leadership in business and technology.
For more details, visit website.
For media inquiries, please contact:
Rahul Wandile
Media Relations – AutomationEdge
rahul.wandile@automationedge.com
www.automationedge.com
Follow AutomationEdge on: Twitter, Facebook, LinkedIn, and YouTube
View original content:
SOURCE AutomationEdge | https://www.kold.com/prnewswire/2023/07/31/automationedge-ealliance-corp-announced-partnership-hyperautomation-solutions/ | 2023-07-31T11:54:53 | 1 | https://www.kold.com/prnewswire/2023/07/31/automationedge-ealliance-corp-announced-partnership-hyperautomation-solutions/ |
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR | https://www.apr.org/business-education/business-education/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction | 2023-07-31T11:54:56 | 0 | https://www.apr.org/business-education/business-education/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction |
Prince William serves veggie burgers to stunned customers
By Amarachi Orie, CNN
(CNN) — Prince William has shocked unsuspecting members of the public at a food truck in London when he appeared as the server handing out veggie burgers.
The heir to the British throne teamed up with Youtube channel Sorted Food to create the meat-free burger, which was made using the environmental innovations of the 2022 winners of The Earthshot Prize.
In a video uploaded to the channel on Sunday, the Sorted Food team were shown preparing the burgers using Earthshot items handed to them by Prince William, before heading out to serve them to diners from a food truck.
When a member of the team asked the “chef” for four Earthshot burgers, Prince William turned around, revealing himself to gasping customers.
“Of all the things I was expecting, it was not that,” said one woman in the video, later asking others, “What just happened?”
“My brain took like three seconds to buffer,” added one man. “Am I dreaming? Have I had enough sleep?”
“I was lost for words,” another diner said.
William told customers that the Earthshot Prize, a 10-year project which he founded in 2020, aims to “repair and restore the planet.”
The prize recognizes those providing forward-thinking environmental solutions across five categories: “Protect and Restore Nature,” “Clean Our Air,” “Revive Our Oceans,” “Build a Waste Free World,” and “Fix Our Climate.”
“Being joined at our studio and in the food truck by Prince William was a real ‘pinch me’ moment – hearing him explain how passionate he is about helping the planet and what the Earthshot Prize is doing was incredibly inspiring, and has already given us a lot of ideas for future projects to work on with our community,” said Jamie Spafford, co-founder of Sorted Food, in the release.
The Sorted Food team made the plant-based burgers using vegetables typical of what would be grown in Kheyti’s Greenhouse-in-a-box. The Indian start-up’s innovation is designed for small-hold farmers, offering their crops shelter from unpredictable elements and destructive pests, according to the prize’s website.
The team then cooked the food using Mukuru Clean Stoves, launched by Charlot Magayi in Kenya in 2017. When burning, they create 90% less pollution than an open fire and 70% less than a traditional cookstove, according to the prize’s website.
The burgers were then served in Notpla food boxes, which are made from seaweed and plants instead of plastic.
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Sign up for CNN’s Royal News, a weekly dispatch bringing you the inside track on the royal family, what they are up to in public and what’s happening behind palace walls. | https://kion546.com/news/national-world/cnn-world/2023/07/31/prince-william-serves-veggie-burgers-to-stunned-customers/ | 2023-07-31T11:54:56 | 0 | https://kion546.com/news/national-world/cnn-world/2023/07/31/prince-william-serves-veggie-burgers-to-stunned-customers/ |
BURLINGTON, N.C., July 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 14, 2023, in New York City, beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.
This event will highlight Labcorp's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial outlook. Presentations will be followed by a Q&A session.
A live webcast of the event will be available through the Labcorp Investor Relations website beginning at 1:00 p.m. ET. A replay of the webcast and supporting materials will be available after the conclusion of the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
View original content to download multimedia:
SOURCE Labcorp | https://www.mysuncoast.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ | 2023-07-31T11:54:59 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ |
A bombing kills dozens on Pakistan's border with Afghanistan. Ukraine retakes a small village from Russia. Some 30,000 people are losing their jobs as trucking company Yellow shuts down.
News from Alabama Public Radio is a public service in association with the University of Alabama. We depend on your help to keep our programming on the air and online. Please consider supporting the news you rely on with a donation today. Every contribution, no matter the size, propels our vital coverage. Thank you. | https://www.apr.org/business-education/business-education/2023-07-31/morning-news-brief | 2023-07-31T11:55:02 | 0 | https://www.apr.org/business-education/business-education/2023-07-31/morning-news-brief |
The House and Senate left Washington for the month of August with a lengthy, time-sensitive to-do list waiting when they return, including multiple key health care priorities.
There will only be three weeks before the end of the fiscal year to get everything done, and just 11 legislative days when both chambers will be in session at the same time.
Congress faces a Sept. 30 deadline to reauthorize a sweeping pandemic preparedness bill, fund community health centers and renew opioid addiction services.
But the largest looming deadline is the appropriations bills to fund the Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS), which are tied up in the House amid disagreements over abortion and spending levels.
GOP leaders scuttled a vote planned for Friday on legislation funding the FDA and the Department of Agriculture after moderate Republicans objected to a provision that would reverse the FDA’s decision to allow the abortion pill mifepristone drug to be dispensed through the mail and in retail pharmacies.
House Freedom Caucus members have also been demanding even deeper spending cuts than agreed to in the bipartistan debt ceiling deal.
The Labor-HHS bill advanced through a House Appropriations subcommittee earlier this month, but hadn’t even made it to the full committee before recess. The Republican-led House bill would slash or eliminate funding from a range of programs that deal with everything from family planning to teen pregnancy and even HIV.
Both FDA and HHS funding bills face a major fight in the Democratic-controlled Senate, where the Appropriations Committee has already passed its own version by near unanimous margins, owing to an agreement by Democratic and Republican leaders not to insert “poison pill” amendments.
House Democratic Whip Katherine Clark (Mass.) argued in a floor speech that lawmakers should stay in Washington to strip out the “toxic, divisive, bigoted riders” in the bills, and ripped Republicans for delaying votes until September.
Pandemic preparedness
The House and Senate are taking different tracks in the reauthorization of the pandemic preparedness bill, complicating its path forward.
The Senate advanced a bipartisan version of the Pandemic All-Hazards Preparedness Act out of committee, but the House is divided. House Energy and Commerce Committee Republicans advanced a bill on party lines after Democrats introduced their own version.
The primary disagreement is over drug shortages. Democrats are clamoring to give FDA more oversight authority to address the shortages, but Republicans are insisting on keeping the issues separate.
The Senate version contains some provisions addressing drug shortages, but only one involves beefing up FDA authority.
Congress is under pressure to stem drug shortages amid reports of doctors rationing cancer drugs and other medicine. Republicans on the Energy and Commerce Committee have said they are committed to dealing with the problems, but that it shouldn’t be part of the preparedness bill.
Energy and Commerce Committee GOP leaders released a discussion draft on Friday of drug shortage legislation focusing on the economic reasons for shortages, including giving some generic drug manufacturers the ability to raise the cost of their drugs if hospitals keep prices “artificially low” to the point where there’s no economic incentive.
Health centers
Legislation to reauthorize funding for community health centers also faces partisan challenges. But in this case, the House cleared its bill on a bipartisan basis, while the Senate is still working through disagreements, highlighting the work to be done.
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, originally wanted tens of billions of dollars more for the centers. He was asking for $130 billion to fund the centers over the next five years as well as $60 billion to help grow the health care workforce.
But Sanders ended up canceling a planned markup during the last week of July. Raising some eyebrows, Sanders said he is working with Sen. Roger Marshall (R-Kan.) to craft a bipartisan bill that will be “ready by the first week of September.”
Separately, Sanders and Senate Finance Committee Chairman Ron Wyden (D-Ore.) issued a joint statement pledging to partner and work towards legislation in the fall aimed at addressing primary care and other health care workforce shortages.
Opioids
At issue are several provisions of sweeping legislation signed into law in 2018 called the Support Act, which aimed to tackle the country’s drug overdose epidemic.
The House Energy and Commerce Committee advanced a bipartisan reauthorization and expansion bill, but advocates are concerned the Senate is behind.
HELP Committee ranking member Bill Cassidy (R-La.) introduced his own version of the bill on July 20, but hearings won’t be scheduled until September. Cassidy has warned that the committee is wasting time on partisan bills instead of easy bipartisan wins, such as the Support Act.
Insulin/PBM reform
Senate Majority Leader Chuck Schumer (D-N.Y.) has said for months that he wants to move legislation that would cap the cost of insulin at $35 per month for people with private insurance.
There’s hope to combine it with legislation reforming the pharmacy benefit manager (PBM) industry into a package that could get bipartisan support.
But there’s no looming deadline and no guarantee it will get taken up in September.
Sen. Jeanne Shaheen (D-N.H.), who is a co-sponsor of one of the insulin bills with Sen. Susan Collins (R-Maine), said she still has Schumer’s support heading into the fall, but has not heard anything about timing.
Multiple committees have advanced PBM reform bills in both the House and Senate, so they will all need to be combined into one floor-friendly package. | https://who13.com/hill-politics/lawmakers-set-to-face-ticking-clock-on-health-care-priorities/ | 2023-07-31T11:55:02 | 1 | https://who13.com/hill-politics/lawmakers-set-to-face-ticking-clock-on-health-care-priorities/ |
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR | https://www.wdiy.org/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction | 2023-07-31T11:55:02 | 1 | https://www.wdiy.org/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction |
Fulton County DA says work is done in Trump probe and ‘we’re ready to go’
CNN, WXIA
By Sara Murray, CNN
(CNN) — Fulton County District Attorney Fani Willis reaffirmed in a local news interview that she will announce charging decisions by September 1 in her investigation into efforts by Donald Trump and his allies to overturn Georgia’s 2020 presidential election result, while applauding the ramped-up security measures around the local courthouse.
“The work is accomplished,” Willis told CNN affiliate WXIA at a back-to-school event over the weekend. “We’ve been working for two and half years. We’re ready to go.”
Willis has previously signaled in letters to local officials and those providing security that she would make any charging announcements between July 31 and the end of August. She laid out a variety of security provisions her team plans to take beginning Monday.
Willis’ latest commitment to that time frame comes after a judge scheduled an August 10 hearing on the Trump team’s efforts to disqualify Willis, a Democrat, from the case, toss much of the evidence she has collected and remove another judge in Fulton County from presiding over the case.
In the local news interview, Willis also praised the Fulton County sheriff after barricades recently went up around the county courthouse in anticipation of what the sheriff’s office referred to as “high profile legal proceedings.”
“I think that the sheriff is doing something smart in making sure that the courthouse stays safe,” Willis said. “I’m not willing to put any of the employees or the constituents that come to the courthouse in harm’s way.”
Willis said that people may not be happy with her upcoming announcements and “sometimes when people are unhappy, they act in a way that could create harm.”
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/politics/cnn-us-politics/2023/07/31/fulton-county-da-says-work-is-done-in-trump-probe-and-were-ready-to-go-2/ | 2023-07-31T11:55:02 | 1 | https://kion546.com/politics/cnn-us-politics/2023/07/31/fulton-county-da-says-work-is-done-in-trump-probe-and-were-ready-to-go-2/ |
Impact "much bigger than a single project"
WAYNESBORO, Ga., July 31, 2023 /PRNewswire/ -- Bechtel, the engineering, procurement, and construction company brought in to complete construction on new Units 3 and 4 at the Vogtle nuclear power plant in Georgia, today issued the following statement from Brendan Bechtel, Bechtel Chairman and CEO, marking the start of commercial operations for Unit 3:
"We are extremely proud of Bechtel's part in achieving this milestone. Our team has been 100 percent committed to Vogtle's completion since being brought in to finish the project.
"Today's start of commercial operations for Vogtle Unit 3 gives the Southeast a major new source of clean, reliable, carbon-free baseload energy. And, as the first new nuclear unit built in the U.S. in more than 30 years, it helps put America back on the map as a leader in the global nuclear industry.
"Bechtel has supported the design and construction of 150 nuclear plants worldwide. We know firsthand how Vogtle Units 3 and 4 go a long way in restoring America's muscle memory in nuclear construction, including the workforce and domestic supply chains required to build America's largest nuclear power plant. Vogtle Unit 3 comes online at a pivotal time when energy security concerns and the need to cut carbon emissions are driving growth in the world's nuclear fleet.
"Plant Vogtle will generate more carbon-free electricity yearly than any other energy facility currently operating in the country. Its completion reinforces that the United States is the responsible partner of choice for new nuclear energy around the world, and maintains U.S. interests in ensuring strong safety, security, and non-proliferation standards. This is why Vogtle's impact is much bigger than a single project.
"Thank you to the thousands of skilled craft professionals, union partners, engineers, project managers, procurement experts, suppliers, subcontractors, and everyone who made this day possible. And thank you to Georgia Power and Southern Nuclear for the opportunity to bring this project over the finish line. We look forward to doing the same with Unit 4 in the coming months."
Background
In 2017, Bechtel was brought in by Georgia Power and Southern Nuclear to take over construction of Vogtle Units 3 and 4, bringing extensive experience supporting the design and construction of 150 nuclear plants worldwide. Vogtle Units 3 and 4 are the first Westinghouse AP1000 units to ever be built in the U.S.
Bechtel has completed more than 76,000 megawatts of new nuclear generation capacity and has designed, built, or performed engineering and/or construction services on more than 80% of nuclear plants in the United States. Today, the company leads efforts in designing and constructing advanced nuclear plants, critical to global efforts to achieve net zero carbon emissions.
Bechtel partnered with North America's Building Trades Unions (NABTU) to build Plant Vogtle Units 3 and 4. At peak, Bechtel and NABTU had a combined 9,000 workers on site.
About Bechtel
Bechtel is a trusted engineering, construction, and project management partner to industry and government. Differentiated by the quality of our people and our relentless drive to deliver the most successful outcomes, we align our capabilities to our customers' objectives to create a lasting positive impact. Since 1898, we have helped customers complete more than 25,000 projects in 160 countries on all seven continents that have created jobs, grown economies, improved the resiliency of the world's infrastructure, increased access to energy, resources, and vital services, and made the world a safer, cleaner place.
Bechtel serves the Energy; Infrastructure; Manufacturing & Technology; Mining & Metals; and Nuclear, Security & Environmental markets. Our services span from initial planning and investment through start-up and operations. www.bechtel.com
Contact:
Amanda Meixel
ammeixel@bechtel.com
M: 1-706-360-5526
P: 1-703-429-6313
View original content to download multimedia:
SOURCE Bechtel | https://www.kold.com/prnewswire/2023/07/31/bechtel-commercial-operations-vogtle-unit-3-is-an-important-milestone-us-nuclear-industry/ | 2023-07-31T11:55:05 | 0 | https://www.kold.com/prnewswire/2023/07/31/bechtel-commercial-operations-vogtle-unit-3-is-an-important-milestone-us-nuclear-industry/ |
Adult Males are Slightly More Likely to Live with Parents Than Their Female Counterparts
58% of Gen Z Consumers Live with Family Members
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- LendingClub Corporation (NYSE: LC), the parent company of LendingClub Bank, America's leading digital marketplace bank, today released findings from the 24th edition of the Reality Check: Paycheck-To-Paycheck research series, conducted in partnership with PYMNTS. The Household Finances Deep Dive Edition examines the impact of household composition on consumers' ability to manage expenses and put aside savings. The series draws on insights from a survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data.
The Paycheck-to-Paycheck Landscape
In June 2023, 61% of U.S. consumers lived paycheck to paycheck, unchanged from June 2022 — as is the share of those struggling to pay bills (at 21%) — even though more middle-income consumers cited living paycheck to paycheck in June 2023 than last year. Among consumers earning $50,000 to $100,000, 65% lived paycheck to paycheck as of June 2023, compared to 60% in June 2022. Meanwhile, the shares of high-income consumers — those earning more than $100,000 annually — and low-income consumers — those earning less than $50,000 annually — living paycheck to paycheck in June 2023 sit at 45% and 77%, respectively, relatively unchanged from June 2022.
This stability in the financial situation of U.S. households indicates that consumers continue to adapt to inflationary pressures, finding ways to manage their spending and live within their means.
Household Composition Determines Financial Lifestyle
Consumers living with only a partner or spouse are likely to face less financial hardship, while those with dependents and those living with friends or housemates are more likely to live paycheck to paycheck.
The research finds that 86% of consumers live with one or more people, and one-third of paycheck-to-paycheck consumers live in households of four or more people. Consumers not living paycheck to paycheck are most likely to reside in two-person households, at 41%. Meanwhile, 49% of millennials and 55% of bridge millennials live in households of four or more people, making them the age groups most likely to reside in the largest households.
There is also a direct correlation among household size, stage of life and financial lifestyle. As household size increases, the ratio of income earners to non-earners typically falls, attributable to households with dependent children. When looking at the share of paycheck-to-paycheck consumers who live in a two-member household, the data finds that 54% do so — 7 percentage points below the sample average. Meanwhile, at 66%, consumers with children under the age of 18 are 12% more likely to live paycheck to paycheck than those without children, at 59%. Among consumers living with friends or housemates, 77% live paycheck to paycheck — the most likely to do so. This suggests that those sharing expenses with a partner or spouse fare better, that is until they have children or even parents to support.
"As household size increases, the ratio of income earners to household members typically falls, creating a higher likelihood of financial distress," said Alia Dudum, LendingClub's Money Expert. "The relationship between household income and household composition explains why many families tend to struggle financially and why millennials and bridge millennials, many of whom are in their peak child-rearing years, tend to remain financially vulnerable."
Economic Considerations Top Reason to Stay in the Family Household
Economics are the main driver for consumers to live with family longer, with 43% wanting to save money and 30% unable to afford housing independently. Besides economic reasons, consumers remain at home to maintain family ties (24%), for transitional reasons (23%), and to provide care (22%).
At one-fifth (20%), adult males are slightly more likely to live with parents than their female counterparts (18%), a phenomenon that grows significantly among those financially struggling (26% of males compared to 18% of females). At 58%, Gen Z is the generation most likely to stay with family members, with 50% citing economic reasons. Members of Gen Z living with three or more people — often familial settings — spent 22% of their income on housing, compared to 30% of those living alone or with a partner.
That said, consumers living with family members to offset expenses are not planning extended stays. For example, one-third of those consumers expect to move out in the coming year, particularly millennials and bridge millennials.
Financial Transparency Determined by Relationship Status
Financial transparency within shared households is paramount to ensure bills are paid and expenses are covered, but the transparency level depends on who consumers live with. Couples living together share financial information 87% of the time and have a joint bank account 76% of the time. Parents are also likely to discuss finances with the children residing in their household, with 45% of parents sharing financial information with their children and 34% granting them access to a shared account. Bill splitting is the most common financial interaction for consumers living with friends or housemates, at 74%. Additionally, borrowing money from other household members is a financial option many use to make ends meet, with consumers mostly engaging in this practice with parents or siblings, at 47%, and friends and housemates, at 44%.
Families and couples maintain outstanding credit card balances that are significantly higher, on average, than those of consumers who live alone. Consumers with children under the age of 18 average 50% more credit card debt than those who live alone. Families represent the lion's share of credit card spending, holding average balances of $6,300 for consumers living with a partner and $7,200 for those living with children under 18. Living with a partner or children also significantly increases a consumer's likelihood of having an auto loan or mortgage.
"With today's inflationary pressures, sharing household finances has become not only common but crucial," continued Dudum. "The increasing complexity of modern lifestyles and the rising cost of living have necessitated a shift in the way consumers approach household finances. One person solely bearing the burden of managing all financial matters has become a minority practice. Instead, couples, families, and even roommates increasingly jointly navigate their economic realities, and it's a trend that is here to stay."
To view the full report, visit: https://www.pymnts.com/study/reality-check-paycheck-to-paycheck-inflation-household-spending-shared-expenses/
Methodology
New Reality Check: The Paycheck-to-Paycheck Report — The Household Finances Deep Dive Edition is based on a census-balanced survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data. The data in this report is not intended to be a representation of LendingClub's core member base. The Paycheck-to-Paycheck series expands on existing data published by government agencies, such as the Federal Reserve System and the Bureau of Labor Statistics, to provide a deep look into the core elements of American consumers' financial wellness: income, savings, debt and spending choices. Our sample was balanced to match the U.S. adult population in a set of key demographic variables: 51% of respondents identified as female, 33% were college-educated and 38% declared incomes of more than $100,000 per year.
About LendingClub
LendingClub Corporation (NYSE: LC) is the parent company of LendingClub Bank, National Association, Member FDIC. LendingClub Bank is the leading digital marketplace bank in the U.S., where members can access a broad range of financial products and services designed to help them pay less when borrowing and earn more when saving. Based on more than 150 billion cells of data and over $85 billion in loans, our advanced credit decisioning and machine-learning models are used across the customer lifecycle to expand seamless access to credit for our members while generating compelling risk-adjusted returns for our loan investors. Since 2007, more than 4.7 million members have joined the Club to help reach their financial goals. For more information about LendingClub, visit https://www.lendingclub.com.
Contact:
For Investors: IR@lendingclub.com
Media Contact: Press@lendingclub.com
PYMNTS Contact: information@PYMNTS.com
View original content to download multimedia:
SOURCE LendingClub Corporation | https://www.mysuncoast.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ | 2023-07-31T11:55:06 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ |
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR | https://www.apr.org/politics-government/politics-government/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon | 2023-07-31T11:55:08 | 0 | https://www.apr.org/politics-government/politics-government/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon |
NEW YORK (AP) — Six straight days of 12-hour driving. Single digit paychecks. The complaints come from workers in vastly different industries: UPS delivery drivers and Hollywood actors and writers.
But they point to an underlying factor driving a surge of labor unrest: The cost to workers whose jobs have changed drastically as companies scramble to meet customer expectations for speed and convenience in industries transformed by technology.
The COVID-19 pandemic accelerated those changes, pushing retailers to shift online and intensifying the streaming competition among entertainment companies. Now, from the picket lines, workers are trying to give consumers a behind-the-scenes look at what it takes to produce a show that can be binged any time or get dog food delivered to their doorstep with a phone swipe.
Overworked and underpaid employees is an enduring complaint across industries — from delivery drivers to Starbucks baristas and airline pilots — where surges in consumer demand have collided with persistent labor shortages. Workers are pushing back against forced overtime, punishing schedules or company reliance on lower-paid, part-time or contract forces.
At issue for Hollywood screenwriters and actors staging their first simultaneous strikes in 40 years is the way streaming has upended entertainment economics, slashing pay and forcing showrunners to produce content faster with smaller teams.
“This seems to happen to many places when the tech companies come in. Who are we crushing? It doesn’t matter,” said Danielle Sanchez-Witzel, a screenwriter and showrunner on the negotiating team for the Writers Guild of America, whose members have been on strike since May. Earlier this month, the Screen Actors Guild–American Federation of Television and Radio Artists joined the writers’ union on the picket line.
Actors and writers have long relied on residuals, or long-term payments, for reruns and other airings of films and televisions shows. But reruns aren’t a thing on streaming services, where series and films simply land and stay with no easy way, such as box office returns or ratings, to determine their popularity.
Consequently, whatever residuals streaming companies do pay often amount to a pittance, and screenwriters have been sharing tales of receiving single digit checks.
Adam Shapiro, an actor known for the Netflix hit “Never Have I Ever,” said many actors were initially content to accept lower pay for the plethora of roles that streaming suddenly offered. But the need for a more sustainable compensation model gained urgency when it became clear streaming is not a sideshow, but rather the future of the business, he said.
“Over the past 10 years, we realized: ‘Oh, that’s now how Hollywood works. Everything is streaming,’” Shapiro said during a recent union event.
Shapiro, who has been acting for 25 years, said he agreed to a contract offering 20% of his normal rate for “Never Have I Ever” because it seemed like “a great opportunity, and it’s going to be all over the world. And it was. It really was. Unfortunately, we’re all starting to realize that if we keep doing this we’re not going to be able to pay our bills.”
Then there’s the rising use of “mini rooms,” in which a handful of writers are hired to work only during pre-production, sometimes for a series that may take a year to be greenlit, or never get picked up at all.
Sanchez-Witzel, co-creator of the recently released Netflix series “Survival of the Thickest,” said television shows traditionally hire robust writing teams for the duration of production. But Netflix refused to allow her to keep her team of five writers past pre-production, forcing round-the-clock work on rewrites with just one other writer.
“It’s not sustainable and I’ll never do that again,” she said.
Sanchez-Witzel said she was struck by the similarities between her experience and those of UPS drivers, some of whom joined the WGA for protests as they threatened their own potentially crippling strike. UPS and the Teamsters last week reached a tentative contract staving off the strike.
Jeffrey Palmerino, a full-time UPS driver near Albany, New York, said forced overtime emerged as a top issue during the pandemic as drivers coped with a crush of orders on par with the holiday season. Drivers never knew what time they would get home or if they could count on two days off each week, while 14-hour days in trucks without air conditioning became the norm.
“It was basically like Christmas on steroids for two straight years. A lot of us were forced to work six days a week, and that is not any way to live your life,” said Palmerino, a Teamsters shop steward.
Along with pay raises and air conditioning, the Teamsters won concessions that Palmerino hopes will ease overwork. UPS agreed to end forced overtime on days off and eliminate a lower-paid category of drivers who work shifts that include weekends, converting them to full-time drivers. Union members have yet to ratify the deal.
The Teamsters and labor activists hailed the tentative deal as a game-changer that would pressure other companies facing labor unrest to raise their standards. But similar outcomes are far from certain in industries lacking the sheer economic indispensability of UPS or the clout of its 340,000-member union.
Efforts to organize at Starbucks and Amazon stalled as both companies aggressively fought against unionization.
Still, labor protests will likely gain momentum following the UPS contract, said Patricia Campos-Medina, executive director of the Worker Institute at the School of Industrial and Labor Relations at Cornell University, which released a report this year that found the number of labor strikes rose 52% in 2022.
“The whole idea that consumer convenience is above everything broke down during the pandemic. We started to think, ‘I’m at home ordering, but there is actually a worker who has to go the grocery store, who has to cook this for me so that I can be comfortable,’” Campos-Medina said. | https://who13.com/news/national-news/customers-want-instant-gratification-workers-say-theyre-on-the-brink/ | 2023-07-31T11:55:08 | 0 | https://who13.com/news/national-news/customers-want-instant-gratification-workers-say-theyre-on-the-brink/ |
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR | https://www.wdiy.org/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon | 2023-07-31T11:55:08 | 1 | https://www.wdiy.org/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon |
Fulton County DA says work is done in Trump probe and ‘we’re ready to go’
By Sara Murray, CNN
(CNN) — Fulton County District Attorney Fani Willis reaffirmed in a local news interview that she will announce charging decisions by September 1 in her investigation into efforts by Donald Trump and his allies to overturn Georgia’s 2020 presidential election result, while applauding the ramped-up security measures around the local courthouse.
“The work is accomplished,” Willis told CNN affiliate WXIA at a back-to-school event over the weekend. “We’ve been working for two and half years. We’re ready to go.”
Willis has previously signaled in letters to local officials and those providing security that she would make any charging announcements between July 31 and the end of August. She laid out a variety of security provisions her team plans to take beginning Monday.
Willis’ latest commitment to that time frame comes after a judge scheduled an August 10 hearing on the Trump team’s efforts to disqualify Willis, a Democrat, from the case, toss much of the evidence she has collected and remove another judge in Fulton County from presiding over the case.
In the local news interview, Willis also praised the Fulton County sheriff after barricades recently went up around the county courthouse in anticipation of what the sheriff’s office referred to as “high profile legal proceedings.”
“I think that the sheriff is doing something smart in making sure that the courthouse stays safe,” Willis said. “I’m not willing to put any of the employees or the constituents that come to the courthouse in harm’s way.”
Willis said that people may not be happy with her upcoming announcements and “sometimes when people are unhappy, they act in a way that could create harm.”
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/politics/cnn-us-politics/2023/07/31/fulton-county-da-says-work-is-done-in-trump-probe-and-were-ready-to-go/ | 2023-07-31T11:55:08 | 0 | https://kion546.com/politics/cnn-us-politics/2023/07/31/fulton-county-da-says-work-is-done-in-trump-probe-and-were-ready-to-go/ |
HOUSTON, July 31, 2023 /PRNewswire/ -- McDermott has been awarded a project management consultancy (PMC) and engineering, procurement, and construction management (EPCM) contract for the Naphtha Cracker Expansion (Phase II) polypropylene expansion and new ethylene derivative unit project from Indian Oil Corporation Limited (IOCL). The project is located at the Panipat Refinery and Petrochemical Complex, located 62 miles (100 kilometers) from New Delhi, India.
The project will increase the ethylene production capacity of the naphtha cracker unit (NCU) by approximately 20 percent. The additional ethylene and propylene production will act as feed for downstream polymer units. The polymer products will be used for the manufacture of household and industrial items, including containers, automobile parts, furniture, and heavy-duty films.
"McDermott is currently executing four other projects for IOCL, including the maleic anhydride (MAH) unit at the same site, allowing us to leverage our local resources and expertise while realizing synergies," said Vaseem Khan, Senior Vice President, Global Operations. "Furthermore, the project supports the growing demand for ethylene and propylene which will reduce imports and accelerate economic development in the area."
McDermott will provide comprehensive EPCM services and overall project management for the duration of the project, which will be executed from its Center of Excellence in Gurugram, India.
About McDermott
McDermott is a premier, fully-integrated provider of engineering and construction solutions to the energy industry. Our customers trust our technology-driven approach engineered to responsibly harness and transform global energy resources into the products the world needs. From concept to commissioning, McDermott's innovative expertise and capabilities advance the next generation of global energy infrastructure—empowering a brighter, more sustainable future for us all. Operating in over 54 countries, McDermott's locally-focused and globally-integrated resources include more than 30,000 employees, a diversified fleet of specialty marine construction vessels and fabrication facilities around the world. To learn more, visit www.mcdermott.com.
Forward-Looking Statements
McDermott cautions that statements in this press release which are forward-looking, and provide other than historical information, involve risks, contingencies and uncertainties. These forward-looking statements include, among other things, statements about the expected scope and execution of the project discussed in this press release. Although we believe that the expectations reflected in those forward-looking statements are reasonable, we can give no assurance that those expectations will prove to have been correct. Those statements are made by using various underlying assumptions and are subject to numerous risks, contingencies and uncertainties, including, among others: adverse changes in the markets in which we operate or credit or capital markets; our inability to successfully execute on contracts in backlog; changes in project design or schedules; the availability of qualified personnel; changes in the terms, scope or timing of contracts, contract cancellations, change orders and other modifications and actions by our customers and other business counterparties; changes in industry norms; actions by lenders, other creditors, customers and other business counterparties of McDermott; and adverse outcomes in legal or other dispute resolution proceedings. If one or more of these risks materialize, or if underlying assumptions prove incorrect, actual results may vary materially from those expected. You should not place undue reliance on forward-looking statements. This communication reflects the views of McDermott's management as of the date hereof. Except to the extent required by applicable law, McDermott undertakes no obligation to update or revise any forward-looking statement.
Contacts:
Global Media Relations
Reba Reid
Senior Director, Global Communications and Marketing
+1 281 588 5636
RReid@McDermott.com
Business Line Media Relations
Barbara Knight
Senior Director, Business Line Communications and Marketing
+971 56 403 2903
BBKnight@McDermott.com
View original content to download multimedia:
SOURCE McDermott International, Ltd | https://www.mysuncoast.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ | 2023-07-31T11:55:12 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ |
(The Hill) – Dozens of former Cabinet officials under former President Trump’s administration declined to publicly support the former president’s third bid for the White House, NBC News reported.
NBC News reached out to 44 people who previously served in Trump’s Cabinet during his four years in office to gauge whether they would support the former president during the 2024 presidential election. The outlet reported that most of the people declined to comment or ignored the requests and that only four said publicly they would support Trump for the presidency.
Trump’s Cabinet saw a higher rate of turnover compared with many of his predecessors, with many new officials rotating in and out of his administration over the four years. The only four former Cabinet members who NBC News reached out to who said they would support Trump are former acting Attorney General Matthew Whitaker, former chief of staff Mark Meadows, former Office of Management and Budget (OMB) director Russell Vought and former acting director of national intelligence Richard Grenell.
A spokesperson for Meadows told NBC News that he “fully” supports Trump. In May, Vought posted on X, the site formerly known as Twitter, that the former president is “the only person I trust to take a wrecking ball to the Deep State.”
Other former administration officials were reluctant to support Trump or have publicly said they will not support him. Former Attorney General Bill Barr told NBC News that he opposes Trump getting the 2024 GOP nomination but declined whether to say he would support him in the general election if pitted against President Biden.
Top Stories from The Hill
- White House takes the gloves off ahead of 2024
- Trump attorney calls him ‘the most ethical American I know’ in wake of superseding indictment
- Murphy says Alito’s Supreme Court seat ‘exists only because of an act passed by Congress’
- Trump attorney calls him ‘the most ethical American I know’ in wake of superseding indictment
Former chief of staff Mick Mulvaney also said that he does not want Trump to get the Republican nomination for president.
“I am working hard to make sure that someone else is the nominee,” Mulvaney told NBC News. “I think he’s the Republican who is most likely to lose in a general election, of all our leading candidates. If anyone can lose to Joe Biden, it would be him.”
Other former officials who have not endorsed Trump yet include former Secretary of State Mike Pompeo, former Defense Secretary Patrick Shanahan, former chief of staff John Kelly and Joseph Maguire and Dan Coats, who each once served as director of national intelligence. Coats told NBC News that he would be supporting former Vice President Mike Pence for the GOP primary.
The Hill has reached out to Trump’s campaign for comment. | https://who13.com/news/national-news/dozens-of-former-trump-cabinet-officials-wont-publicly-support-his-2024-bid/ | 2023-07-31T11:55:14 | 0 | https://who13.com/news/national-news/dozens-of-former-trump-cabinet-officials-wont-publicly-support-his-2024-bid/ |
How beavers are helping restore wetlands and create buffers against wildfires Published July 31, 2023 at 7:23 AM EDT Facebook Twitter LinkedIn Email Listen • 1:43 Some experts now see beavers — nature's helpers — as their dams can mitigate the effects of drought and wildfires. Copyright 2023 NPR | https://www.wdiy.org/2023-07-31/how-beavers-are-helping-restore-wetlands-and-create-buffers-against-wildfires | 2023-07-31T11:55:15 | 0 | https://www.wdiy.org/2023-07-31/how-beavers-are-helping-restore-wetlands-and-create-buffers-against-wildfires |
House Republicans aren’t done slashing food assistance and fighting over social issues
By Tami Luhby, CNN
(CNN) — After clamping down on food stamps in the debt ceiling deal, House Republicans now want to take a whack at WIC, the food assistance program for low-income women, infants and young children.
GOP lawmakers have proposed curtailing funding for WIC in the chamber’s version of the US Department of Agriculture’s annual spending bill. The legislation could force some families to wait for aid for the first time in years, as well as limit their ability to buy fresh fruits and vegetables.
It’s among the party’s latest efforts to cut federal spending by limiting benefits, reducing enrollment and adding work requirements to the nation’s safety net.
However, some of the cuts, as well as a controversial provision related to abortion, left House Republicans unable to pass the spending bill on Thursday before members left for a six-week break. In addition to agriculture, the legislation also funds the Food and Drug Administration and other related agencies.
Even though the appropriations subcommittee that crafted the bill is led by conservative GOP Rep. Andy Harris of Maryland, some of his peers want to push the bill even more to the right. They have offered scores of amendments that would slash food assistance more deeply and further the party’s war on certain social issues.
For instance, Florida Republican Rep. Byron Donalds would greatly expand work requirements for certain adults in the food stamps program, raising the age threshold to 64, from 49, and including those with dependents over age 6, instead of those without minor children.
Other amendments would restrict exempting recipients from the work requirement and allowing states to obtain waivers if there’s a lack of sufficient jobs in the area.
Then there are amendments related to the GOP’s efforts to clamp down on issues pertaining to race and gender identity, as well as other initiatives important to Democrats. Georgia Rep. Marjorie Taylor Greene would prohibit funding for drugs that disrupt puberty or sexual development of minors, as well as for sex-altering surgical procedures for minors. Other lawmakers want to reduce funding for the USDA’s Office of Civil Rights and eliminate funding for diversity initiatives.
Other amendments would prohibit the agriculture secretary from buying electric vehicles, bar any money from going to the World Health Organization and eliminate funding for the USDA’s rental assistance program.
House GOP lawmakers will face an even bigger battle reconciling their funding measure with the Senate version, which is much more generous when it comes to WIC, formally known as the Special Supplemental Nutrition Program for Women, Infants and Children.
WIC funding
The House legislation would cut WIC – which serves about 6.6 million women, infants and young children – in two ways. It would reduce funding for fiscal 2024 to $5.5 billion, which would be $185 million less than this fiscal year’s level and $800 million less than the Senate bill would provide.
But it would also slash the program’s enhanced fruit and vegetable benefit, which was initially authorized by the Democrats’ American Rescue Plan Act in 2021 and then renewed with bipartisan support in subsequent appropriations bills. Enrollees would receive between $11 and $15 a month to purchase fresh produce in fiscal 2024, down from $25 to $49 this year.
Harris said during the subcommittee’s review of the funding bill last month that since the Covid-19 pandemic is over and the public health emergency has ended, it’s time to return the benefit to “a normal, sustainable, inflation-adjusted funding level.”
But advocates for low-income Americans argue that beefed-up benefit is in line with recommendations from the National Academies of Science, Engineering, and Medicine. Plus, the enhancement is needed because people have struggled to afford groceries amid the surge in prices in recent years.
Cutting the benefit would have consequences.
“Families may have to get less,” said Jamila Taylor, CEO of the National WIC Association, an advocacy organization. “They won’t have access to as much food with their cash value benefits with the increase in costs.”
Plus, the overall reduction in funding for WIC could mean that up to 750,000 eligible people may be turned away, and some could be put on waitlists, which haven’t been needed since 1997 because Congress has provided sufficient funding for WIC, said Katie Bergh, a senior policy analyst at the Center on Budget and Policy Priorities. Toddlers, preschoolers and postpartum women would bear the heaviest brunt.
In total, about 5.3 million pregnant and postpartum women, infants and young kids would either see their food assistance cut or taken away, Bergh said.
“These are people who are in such a critical window of development – very young children, pregnant and postpartum people – where having inadequate nutrition and being turned away from a benefit that provides not just nutritious foods, but a whole host of other services could have really significant impacts for their health long term,” Bergh said.
WIC, which in recent years reached only about half of those eligible, is growing in popularity. Federal and state policymakers have made it easier to enroll, improved the shopping experience and enhanced the benefits. These changes, along with inflation, have likely helped prompt a 4.4% jump in participation in the first seven months of this fiscal year, compared with the same period in fiscal 2022.
This means that even the $6.3 billion appropriation in the Senate bill would be inadequate, forcing states to turn away up to 800,000 people, according to Bergh, who estimates that as much as $7.3 billion could be needed to serve all eligible applicants and provide the enhanced fruit and vegetable benefit.
Washington state Sen. Patty Murray, a Democrat who chairs the Senate Appropriations Committee, said that she will keep an eye on participation and food costs.
“I am going to continue monitoring the program and pushing to ensure we provide the funding needed so millions of women, infants and kids can get the food assistance through WIC that they count on and need to thrive,” she said.
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/politics/cnn-us-politics/2023/07/31/house-republicans-arent-done-slashing-food-assistance-and-fighting-over-social-issues/ | 2023-07-31T11:55:15 | 1 | https://kion546.com/politics/cnn-us-politics/2023/07/31/house-republicans-arent-done-slashing-food-assistance-and-fighting-over-social-issues/ |
Hunter Biden’s former business partner to testify behind closed doors for GOP-led committee
By Zachary Cohen and Kara Scannell, CNN
(CNN) — Hunter Biden’s former business partner Devon Archer is scheduled to give closed-door testimony on Capitol Hill on Monday, the latest development in the Republican-led investigations into the president’s son.
The Justice Department submitted a new request over the weekend that Archer be ordered to schedule a date to surrender to prison and begin serving out his one-year sentence resulting from a conviction in an unrelated fraud case, according to court filings. The move prompted immediate speculation among some Republicans that the Biden administration was attempting to prevent Archer from answering questions about Hunter Biden before the GOP-led House Oversight Committee – a theory that Archer’s attorney is pushing back on.
In a statement, Archer’s attorney said his client does not believe the DOJ request is connected in any way to the upcoming closed-door interview, despite continuing to fight demands related to scheduling a surrender date. “We are aware of speculation that the Department of Justice’s weekend request to have Mr. Archer report to prison is an attempt by the Biden administration to intimidate him in advance of his meeting with the House Oversight Committee on Monday,” Matthew Schwartz, an attorney for Archer, said in a statement Sunday.
“To be clear, Mr. Archer does not agree with that speculation. In any case, Mr. Archer will do what he has planned to do all along, which is to show up on Monday and to honestly answer the questions that are put to him by the Congressional investigators,” Schwartz added.
While House Oversight Chairman James Comer would only go as far as to call the timing of DOJ’s letter “odd” in an interview with Fox News on Sunday, the letter prompted more bombastic reactions from other House Republicans.
Archer’s scheduled testimony comes as House Republicans appear to be shifting their focus away from trying to impeach members of President Joe Biden’s Cabinet and prioritizing efforts to impeach the President himself by linking him to controversial business dealings by his son, Hunter.
And they are doing so with the apparent support of Speaker Kevin McCarthy, CNN recently reported.
As a result, House investigations related to Hunter Biden are now expected to take center stage as Republicans continue to try to link the President to his son’s controversial business dealings.
But speaking to CNN in recent weeks, McCarthy signaled that Republicans have yet to verify the most salacious allegations against Biden, namely that as vice president he engaged in a bribery scheme with a foreign national in order to benefit his son’s career, an allegation the White House furiously denies.
But he said that launching an impeachment inquiry would unleash the full power of the House to turn over critical information, mirroring an argument advanced by House Democrats when they impeached then-President Donald Trump in 2019.
McCarthy – who sources said has also been consulting with former House GOP Speaker Newt Gingrich on the issue – has warmed up to an idea of going after the president rather than members of his Cabinet. In recent weeks, he delivered his most explicit threat yet to Biden, saying House Republicans’ investigations into the Biden family’s business deals appear to be rising to the level of an impeachment inquiry.
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/politics/cnn-us-politics/2023/07/31/hunter-bidens-former-business-partner-to-testify-behind-closed-doors-for-gop-led-committee/ | 2023-07-31T11:55:16 | 0 | https://kion546.com/politics/cnn-us-politics/2023/07/31/hunter-bidens-former-business-partner-to-testify-behind-closed-doors-for-gop-led-committee/ |
Forester Wilderness Ad Showcases 'A Beautiful Silence' and Partnership with the National Park Foundation
CAMDEN, N.J., July 31, 2023 /PRNewswire/ -- Subaru of America, Inc. today unveiled a new creative spot focused on the automaker's efforts to expand access to the outdoors for all. Featuring the all-new 2023 Subaru Forester Wilderness, the advertisement stars Keivonn Woodard, the Emmy-nominated, 10-year-old Deaf actor and showcases the automaker's long-standing partnership with the National Park Foundation.
In the creative, titled "A Beautiful Silence," a father and his young son, who is Deaf, drive through Yosemite National Park, with the wonders of the park's beauty surrounding them. Featuring audio elements and American Sign Language (ASL), the spot shows how the pair experience the park's natural wonders in different ways, but share the special feeling that nature brings forth.
"The outdoors are for everyone, and whether it's a trip to a national park or a walk in the woods, we believe everyone should have the opportunity to experience its beauty," said Alan Bethke, Senior Vice President, Marketing, Subaru of America, Inc. "Through our partnership with the National Park Foundation and our commitment to making safe and capable vehicles like the Forester Wilderness, we're hoping that even more people will be inspired to explore the wonders of nature, just like the father and son in our new creative."
Through the National Park Foundation's Outdoor Exploration initiative and ParkVentures program, Subaru is helping more people create life-long relationships with the outdoors. The campaign seeks to make the outdoors more accessible to communities that have been historically excluded from parks, either through a community's physical presence on public lands or through the narrative of who belongs outdoors.
Last year, with support from Subaru, ParkVentures supported the efforts of more than 55 organizations to connect more people, including those with differing abilities, to meaningful experiences in United States national parks. Subaru also developed a direct relationship with ParkVentures grantee Black People Who Hike, which aims to help address the lack of representation in parks by empowering, educating and engaging Black people in the outdoors. Subaru provided the vehicles, gear, and experiences for an enhanced retreat in Acadia National Park to help create safe, welcoming spaces and cultivate lasting relationships with the outdoors.
Subaru is the largest corporate donor to the National Park Foundation and has provided over $70 million to organizations working to conserve national parks. To learn more about the automaker's partnership with National Park Foundation and over 20 years of environmentally focused initiatives, please visit Subaru.com/earth.
The new Subaru Forester Wilderness spot, created in collaboration with agency partner Carmichael Lynch, celebrates the automaker's devotion to adventure and environmental stewardship. Beginning today, "A Beautiful Silence" will run in 30-second format on national television and be featured in 15-second format in targeted digital and social media promotions throughout August, while a 60-second version will be available on YouTube.
About Subaru of America, Inc.
Subaru of America, Inc. (SOA) is a wholly owned subsidiary of Subaru Corporation of Japan. Headquartered at a zero-landfill office in Camden, N.J., the company markets and distributes Subaru vehicles, parts and accessories through a network of more than 630 retailers across the United States. All Subaru products are manufactured in zero-landfill plants and Subaru of Indiana Automotive, Inc. is the only U.S. automobile manufacturing plant to be designated a backyard wildlife habitat by the National Wildlife Federation. SOA is guided by the Subaru Love Promise, which is the company's vision to show love and respect to everyone, and to support its communities and customers nationwide. Over the past 20 years, SOA and the SOA Foundation have donated more than $300 million to causes the Subaru family cares about, and its employees have logged nearly 88,000 volunteer hours. As a company, Subaru believes it is important to do its part in making a positive impact in the world because it is the right thing to do. For additional information visit media.subaru.com. Follow us on Facebook, Twitter, and Instagram.
Media Contacts:
Diane Anton
Corporate Communications Manager
(856) 488-5093
danton@subaru.com
Adam Leiter
Corporate Communications Specialist
(856) 488-8668
aleiter@subaru.com
View original content to download multimedia:
SOURCE Subaru of America, Inc. | https://www.mysuncoast.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ | 2023-07-31T11:55:19 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ |
DENVER (AP) — As Denver neared triple-digit temperatures, Ben Gallegos sat shirtless on his porch swatting flies off his legs and spritzing himself with a misting fan to try to get through the heat. Gallegos, like many in the nation’s poorest neighborhoods, doesn’t have air conditioning.
The 68-year-old covers his windows with mattress foam to insulate against the heat and sleeps in the concrete basement. He knows high temperatures can cause heat stroke and death, and his lung condition makes him more susceptible. But the retired brick layer, who survives on about $1,000 a month largely from Social Security, says air conditioning is out of reach.
“Take me about 12 years to save up for something like that,” he said. “If it’s hard to breathe, I’ll get down to emergency.”
As climate change fans hotter and longer heat waves, breaking record temperatures across the U.S. and leaving dozens dead, the poorest Americans suffer the hottest days with the fewest defenses. Air conditioning, once a luxury, is now a matter of survival.
As Phoenix weathered its 27th consecutive day above 110 degrees (43 Celsius) Wednesday, the nine who died indoors didn’t have functioning air conditioning, or it was turned off. Last year, all 86 heat-related deaths indoors were in uncooled environments.
“To explain it fairly simply: Heat kills,” said Kristie Ebi, a University of Washington professor who researches heat and health. “Once the heat wave starts, mortality starts in about 24 hours.”
It’s the poorest and people of color, from Kansas City to Detroit to New York City and beyond, who are far more likely to face grueling heat without air conditioning, according to a Boston University analysis of 115 U.S. metros.
“The temperature differences … between lower-income neighborhoods, neighborhoods of color and their wealthier, whiter counterparts have pretty severe consequences,” said Cate Mingoya-LaFortune of Groundwork USA, an environmental justice organization. “There are these really big consequences like death. … But there’s also ambient misery.”
Some have window units that can offer respite, but “in the dead of heat, it don’t do nothing,” said Melody Clark, who stopped Friday to get food at a nonprofit in Kansas City, Kansas, as temperatures soared to 101, and high humidity made it feel like 109. When the central air conditioning at her rental house went on the fritz, her landlord installed a window unit. But it doesn’t do much during the day.
So the 45-year-old wets her hair, cooks outside on a propane grill and keeps the lights off indoors. She’s taken the bus to the library to cool off. At night she flips the box unit on, hauling her bed into the room where it’s located to sleep.
As far as her two teenagers, she said: “They aren’t little bitty. We aren’t dying in the heat. … They don’t complain.”
While billions in federal funding have been allocated to subsidize utility costs and the installation of cooling systems, experts say they often only support a fraction of the most vulnerable families and some still require prohibitive upfront costs. Installing a centralized heat pump system for heating and cooling can easily reach $25,000.
President Joe Biden announced steps on Thursday to defend against extreme heat, highlighting the expansion of the Low Income Home Energy Assistance Program, which funnels money through states to help poorer households pay utility bills.
While the program is critical, said Michelle Graff, who studies the subsidy at Cleveland State University, only about 16% of the nation’s eligible population is actually reached. Nearly half of states don’t offer the federal dollars for summer cooling.
“So people are engaging in coping mechanisms, like they’re turning on their air conditioners later and leaving their homes hotter,” Graff said.
While frigid temperatures and high heating bills birthed the term “heat or eat,” she said, “we can now transition to AC or eat, where people are going to have to make difficult decisions.”
As temperatures rise, so does the cost of cooling. And temperatures are already hotter in America’s low-income neighborhoods like Gallegos’ Denver suburb of Globeville, where people live along stretches of asphalt and concrete that hold heat like a cast-iron skillet. Surface temperatures there can be roughly 8 degrees hotter than in Denver’s wealthier neighborhoods, where a sea of vegetation cools the area, according to the environmental advocacy group American Forests.
This disparity plays out nationwide. Researchers at the University of San Diego analyzed 1,056 counties and in over 70%, the poorest areas and those with higher Black, Hispanic and Asian populations were significantly hotter.
About one in 10 U.S. households have no air conditioning, a disparity compounded for marginalized groups, according to a study by the Brookings Institution. Less than 4% of Detroit’s white households don’t have air conditioning; it’s 15% for Black households.
At noon on Friday, Katrice Sullivan sat on the porch of her rented house on Detroit’s westside. It was hot and muggy, but even steamier inside the house. Even if she had air conditioning, Sullivan said she’d choose her moments to run it to keep her electricity bill down.
The 37-year-old factory worker pours water on her head, freezes towels to put around her neck, and sits in her car with the air conditioner on. “Some people here spend every dollar for food, so air conditioning is something they can’t afford,” she said.
Shannon Lewis, 38, lived in her Detroit home for nearly 20 years without air conditioning. Lewis’s bedroom was the only place with a window unit, so she’d squeeze her teenager, 8-year-old and 3-year-old-twins into her queen-size bed to sleep, eat meals and watch television.
“So it was like cool in one room and a heat stroke in another,” Lewis said. For the first time, Lewis now has air conditioning through a local non-profit, she said. “We don’t have to sleep or eat in the same room, we are able to come out, sit at the dining room table, eat like a family.”
After at least 54 died during a 2021 heat wave, mostly elderly people without air conditioning, in the Portland area, Oregon passed a law prohibiting landlords from placing blanket bans on air conditioning units. By and large, however, states don’t have laws requiring landlords to provide cooling.
In the federal Inflation Reduction Act, billions were set aside for tax credits and rebates to help families install energy-efficient cooling systems, but some of those are yet to be available. For people like Gallegos, who doesn’t pay taxes, the available credits are worthless.
The law also offers rebates, the kind of state and federal point-of-sale discounts that Amanda Morian has looked into for her 640-square-foot home.
Morian, who has a 13-week-old baby susceptible to hot weather, is desperate to keep her house in Denver’s Globeville suburb cool. She bought thermal curtains, ceiling fans and runs a window unit. At night she tries to do skin-to-skin touch to regulate the baby’s body temperature. When the back door opens in the afternoon, she said, the indoor temperature jumps a degree.
“All of those are just to take the edge off, it’s not enough to actually make it cool. It’s enough to keep us from dying,” she said.
She got estimates from four different companies for installing a cooling system, but every project was between $20,000 and $25,000, she said. Even with subsidies she can’t afford it.
“I’m finding that you have to afford the project in the first place and then it’s like having a bonus coupon to take $5,000 off of the sticker price,” she said.
Lucy Molina, a single mom in Commerce City, one of Denver’s poorest areas, said her home has reached 107 degrees without air conditioning. Nearby, Molina’s two teenage children slurped popsicles to cool off, lingering in front of the open freezer.
For Molina, who bustled around her kitchen on a recent day when temperatures reached 99 degrees outdoors, it’s hard to see any path to a cooling respite.
“We’re just too poor,” she said. | https://who13.com/news/national-news/were-just-too-poor-record-heat-waves-reveal-plight-of-americans-without-air-conditioning/ | 2023-07-31T11:55:20 | 0 | https://who13.com/news/national-news/were-just-too-poor-record-heat-waves-reveal-plight-of-americans-without-air-conditioning/ |
A Libyan man who says he escaped execution by the Russian mercenary Wagner group is taking them to court in the U.S. — alleging torture and multiple human rights abuses.
Copyright 2023 NPR
A Libyan man who says he escaped execution by the Russian mercenary Wagner group is taking them to court in the U.S. — alleging torture and multiple human rights abuses.
Copyright 2023 NPR | https://www.wdiy.org/2023-07-31/libyan-man-who-says-he-was-tortured-wants-to-hold-wagner-group-accountable | 2023-07-31T11:55:21 | 1 | https://www.wdiy.org/2023-07-31/libyan-man-who-says-he-was-tortured-wants-to-hold-wagner-group-accountable |
Magnus White: US cyclist and ‘rising star’ of sport dies aged 17 after being hit by a vehicle while training
By George Ramsay, CNN
(CNN) — American cyclist Magnus White, hailed as a “rising star” of the sport, has died in a training accident in Boulder, Colorado, at the age of 17, USA Cycling announced on Sunday.
The governing body said that White was preparing to compete in the cross-country discipline at the junior Mountain Bike World Championships in Glasgow, Scotland, when he was struck by a vehicle.
“We offer our heartfelt condolences to the White family, his teammates, friends, and the Boulder community during this incredibly difficult time,” USA Cycling said in a statement. “We ride for Magnus.”
White specialized in off-road cycling and competed for the US team at the Cyclocross World Championships in 2022 and 2023. He started racing at a national level at the age of 10, according to USA Cycling.
This year was the first time he had earned a place in the Mountain Bike World Championships team. He was due to compete in Glasgow on August 10.
“White fell in love with cycling at an early age through Boulder Junior Cycling,” the USA Cycling statement added.
“He was a rising star in the off-road cycling scene and his passion for cycling was evident through his racing and camaraderie with his teammates and local community.”
CNN has contacted the Colorado State Patrol for comment.
Running from August 3 to August 13, the inaugural UCI Cycling World Championships will be hosted in Glasgow and across Scotland.
The-CNN-Wire
™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved. | https://kion546.com/sports/cnn-sports/2023/07/31/american-cyclist-magnus-white-dies-aged-17/ | 2023-07-31T11:55:23 | 1 | https://kion546.com/sports/cnn-sports/2023/07/31/american-cyclist-magnus-white-dies-aged-17/ |
Introducing the industry's first-ever utility side-by-side with a 1500cc 3-cylinder engine for more power to make tough jobs easier and the industry's only STEELDRIVE transmission for greater durability
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- Polaris Off Road, the global leader in powersports and off-road innovation, is once again breaking new ground with the industry's first extreme duty utility side-by-side: the all-new RANGER XD 1500. With its unprecedented capability, brute strength and unmatched comfort, the new extreme duty class of RANGER side-by-sides are engineered with the first-ever ProStar 1500cc 3-cylinder engine that offers an industry-leading 110 horsepower, the industry-exclusive STEELDRIVE automatic transmission for greater durability and precise control, and over 70 new accessories for enhanced customization, highlighted by Polaris' exclusive Lock & Ride MAX system. The RANGER XD 1500 establishes a new benchmark for utility side-by-sides.
"We spent over five years meeting with farmers, ranchers, large acreage property owners and big game hunters to develop an extreme duty vehicle that was missing from the market. From its ProStar 1500cc engine to the industry's only STEELDRIVE transmission, RANGER XD 1500 is unlike anything else offered today and is yet another example of our relentless commitment to advancing the industry with fresh thinking and innovative solutions that meet the real-world needs of our utility customers," said Steve Menneto, President of Polaris Off Road.
"Polaris RANGER has been the No. 1 selling utility side-by-side brand for more than 15 years and with the introduction of RANGER Extreme Duty, we've taken the industry's hardest-working lineup and expanded it," said Chris Judson, Vice President of Off Road Utility. "A segment of our utility customers said they are facing exceptionally large tasks and they simply need a machine with more power, more torque, more hauling and towing capacity, and more durability. And our team set out to deliver just that, incorporating dozens of new features and the latest engineering to make the RANGER XD 1500 more capable, stronger, and more comfortable than any other utility side-by-side out there."
Unprecedented Capability
Farmers, ranchers, and large landowners routinely haul and tow heavy loads around the property, and they've been asking for a solution when it comes to their heaviest tasks. The RANGER XD 1500 delivers unprecedented capability for hard-working customers to haul more, tow more, and get more done in less time. With the industry's only 1500cc utility engine, the RANGER XD 1500 provides over 30% more power and over 50% more torque than the next closest competitor.
- ProStar 1500cc 3-Cylinder Engine – Effortless towing, hauling, and confidence in tough terrain with an industry-leading 110HP and 105 lb-ft torque.
- 1,500 lb Cargo Box Capacity – Three-quarter ton box capacity providing nearly 50% more box volume than existing models for maximum productivity with fewer trips and bigger loads.
- 3,500 lb Towing Capacity – For those routinely towing heavy loads on the property, drive better productivity with nearly 40% more towing than existing models.
- Industry-leading Ground Clearance – All RANGER XD 1500 models get 15" of ground clearance with high-clearance arched A-arms to overcome large obstacles.
Brute Strength
Utility customers asked for a more durable, longer lasting offering to maximize their uptime and drive efficiency. Designed to last longer than any model before it, RANGER XD 1500 is the industry's most durable utility side-by-side and has been engineered from the ground up to be stronger and stand up to the demands of the longest days.
- Industry-exclusive STEELDRIVE transmission – Offers a 100 percent steel constructed belt that delivers smooth, precise operation and a fully sealed, liquid-cooled design for unmatched durability.
- High-Strength Steel Heavy Duty Frame – RANGER XD 1500 has a high-strength steel one-piece chassis featuring 160 percent more torsional stiffness for a smoother ride and better cab sealing.
- Industry-leading Service Intervals – RANGER XD 1500 offers the industry's longest service intervals so customers can maximize their uptime.
Unmatched Comfort
- From the farm to remote backcountry, utility customers work from before the sun rises to after it sets, and need something that delivers all-day comfort. Beyond industry-leading capability and durability, the RANGER XD 1500 prioritizes comfort across the entire lineup to keep customers going strong on the longest days.
- Most Spacious Interior – Equipped with the most spacious and premium cab available in utility side-by-sides, the XD 1500 offers increased leg and shoulder room, making it easy to enter and exit the vehicle. Adjustable seating and a telescopic steering wheel lets drivers find the perfect fit for height and riding preferences.
- Premium Seating – Contoured seating with added bolstering provides more rider comfort along with a center seat that flips down into an armrest with additional cup holders.
- Available Heated Seats – For comfort on the coldest days, RANGER XD 1500 NorthStar Ultimate is the first utility side-by-side that comes from the factory with heated seats.
- Drive Modes – RANGER XD 1500 comes with an intuitive and easy-to-use rotary drive mode selector that lets customers choose from four different drive modes, including:
- Heating and Air Conditioning (HVAC) – Riders can stay comfortable in harsh weather conditions in the RANGER XD 1500 NorthStar Edition, featuring an all-new HVAC system and a fully-enclosed, next generation ProShield cab that's been redesigned with improved sealing to prevent dust and water intrusion, while locking in the temperature from the climate-controlled cab.
- Sun Visors – All-new integrated sun visors provide improved visibility throughout the day for added confidence while driving.
- RIDE COMMAND – Available 7" waterproof touchscreen display powered by RIDE COMMAND technology featuring a back-up camera, GPS navigation regardless of cell service, and AM/FM radio with Bluetooth® streaming capability.
- RIDE COMMAND+ – Customers can keep tabs on their vehicle directly from the Polaris App and access critical vehicle information like vehicle location, maintenance reminders, and issue diagnostics right from the palm of their hand with the industry's only connected-vehicle technology. Available from the factory on NorthStar Ultimate.
Customization
Customers have been asking for increased versatility, durability, and ease of use for the different work applications they face throughout the day. With over 70 new Polaris Engineered Accessory options designed specifically for the RANGER XD 1500, plus options from partners brands including JBL®, Rhino Rack®, Pro Armor, Kolpin, and HD Parts, customers have more opportunity than ever before to make their vehicle fit their specific needs.
- Lock & Ride MAX – Polaris' easiest to use, most versatile, and confident accessory attachment platform ever. With customizable configurations and the ability to reconfigure on the fly with no tools required, this new accessory platform allows users to prepare for their day, their way. Customers can simply choose and place their accessory, lock it in place, and ride confidently knowing their gear is secure.
- New JBL® Audio – Polaris partnered with JBL® to create the highest performing audio system ever included in a RANGER from the factory. For customers wanting to turn it up a notch, the JBL® Trail Pro 4200 audio upgrade adds rear speakers and two subwoofers for an immersive audio experience.
- Glacier Pro HD Plow – New 84" plow designed for faster, more efficient plowing during the winter months. A hydraulic plow lift and angle kit can be paired with an all-new plow controller to manage the largest plow Polaris has ever offered, all without ever leaving the comfort of the cab.
2024 RANGER XD 1500 Premium: Starting at US $29,999 / CAN $36,199
The RANGER XD 1500 Premium commands a large presence thanks to heavy-duty components and the industry's largest bumper, providing complete front-end protection. The vehicle comes equipped with one of the most comprehensive standard packages in a side-by-side to date including 29" tires, tilt steering and seat slider for customizable comfort, four drive modes, high output LED headlights for enhanced visibility, and USB ports with multiple charging capabilities. The vehicle also comes equipped with boosted brakes and heavy-duty suspension to ensure performance across a variety of off-road environments.
2024 RANGER XD 1500 NorthStar Premium: Starting at US $39,999 / CAN $48,799
The next step up is the RANGER XD 1500 NorthStar Premium. This machine features a fully enclosed cab with HVAC temperature and five different mode controls, lockable full doors with power windows and a fixed front glass windshield. Additional features include an electronically controlled power tilt bed to dump heavy loads with ease, an overhead switch panel for easy accessorization, and an overhead rear work light to illuminate the cargo box in low-light conditions. NorthStar Premium comes stock with 30" Kenda® CrossTrail tires and available 32" tires to overcome large obstacles and tough terrain.
2024 RANGER XD 1500 NorthStar Ultimate: Starting at US $44,999 / CAN $54,499
Rounding out the lineup is the RANGER XD 1500 NorthStar Ultimate, which features everything from the NorthStar Premium trim, plus the 7" infotainment display powered by RIDE COMMAND and heated seats. The NorthStar Ultimate trim also delivers an immersive sound experience, featuring full AM/FM radio with Bluetooth® streaming capability and industry-exclusive JBL® speakers for precise audio and premium sound. Finally, the vehicle comes standard with RIDE COMMAND+, allowing for vehicle health monitoring and more.
The 2024 RANGER XD 1500 lineup is expected to begin shipping to dealers in late summer. To learn more about the 2024 RANGER family, please visit https://ranger.polaris.com/en-us/ or join the conversation and follow on Facebooksm, Instagramsm, YouTubesm and Twittersm.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
Warning: vehicle rollaway can cause serious injury or death. This vehicle can roll whenever the gear selector is not in the park position. Always shift to park when stopping the engine or leaving the vehicle. When leaving the vehicle on an incline is unavoidable, use extra care. If leaving the vehicle unattended, block the rear wheels on the downhill side and keep children, pets, and others away form the gear selector. Notice: Vehicle payload and trailer weight will affect the angle of hill on which the vehicle will hold.
Kenda® is a registered trademark of Kenda Rubber Industrial Co, Ltd.
Bluetooth® is a registered trademark of Bluetooth Sig, Inc.
JBL® is a registered trademark of Harman International Industries, Incorporated
Rhino-Rack® is a registered trademark of Rhino Rack Australia Pty Limited
Unless noted, trademarks are the property of Polaris Industries Inc.
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.mysuncoast.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ | 2023-07-31T11:55:25 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ |
- Cash, cash equivalents, and marketable securities totaled $349.0 million as of June 30, 2023
- Announced positive interim data from BHV-7000 EEG biomarker study demonstrating evidence of central nervous system (CNS) target engagement, confirming previously reported preclinical and clinical data, and highlighting the paradigm-changing potential of BHV-7000 in the treatment of epilepsy and mood disorders
- Brain penetrant TYK2/JAK1 inhibitor, BHV-8000, advanced into Phase 1 with projected therapeutic concentrations achieved and well-tolerated profile observed to date
- Advanced targeted extracellular protein degradation platform with potential to support numerous clinical candidates across a broad range of high unmet need indications
- Orphan drug designation (ODD) granted by the European Commission for taldefgrobep alfa a novel anti-myostatin adnectin, for the treatment of spinal muscular atrophy (SMA)
- Type A meeting planned with FDA regarding troriluzole program in Spinocerebellar Ataxia Type 3 (SCA3) and enrollment in Phase 3 obsessive compulsive disorder (OCD) trial expected to complete at end of 2023
NEW HAVEN, Conn., July 31, 2023 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the second quarter ended June 30, 2023, and provided a review of recent accomplishments and anticipated upcoming milestones.
Vlad Coric, M.D., Chairman and Chief Executive Officer of Biohaven, commented, "In less than a year since our spin-off, the Biohaven team has driven strong and consistent progress across multiple drug development platforms. We were excited to recently report positive interim data from the ongoing EEG biomarker study of our lead Kv7 activator, BHV-7000. As expected, BHV-7000 demonstrated CNS activity consistent with what has been reported in EEG studies with other Kv7 channel activators in development that are clinically effective in treating epilepsy and with other approved anti-seizure medications. Importantly, BHV-7000 demonstrates CNS target engagement but is not associated with the typical CNS adverse events associated with other ASMs, like somnolence and fatigue. We look forward to completing the higher dose groups in this EEG study and initiating Phase 2/3 studies with our once daily, extended-release oral formulation later this year."
Dr. Coric continued, "We also shared a number of equally exciting announcements across our broader pipeline this quarter. We successfully administered the first three doses in the SAD portion of our ongoing SAD/MAD study evaluating BHV-8000, an oral, brain-penetrant, dual TYK2/JAK1 inhibitor. Potential therapeutic concentrations of BHV-8000 were achieved and BHV-8000 was well tolerated with only mild adverse events reported, reinforcing our plans to start a Phase 2 clinical trial with BHV-8000 in Parkinson's disease and potentially other neuroinflammatory diseases in 2024. In addition, we have advanced IND enabling preclinical studies and remain on track to submit an IND with our IgG degrader, BHV-1300, later this year. We also anticipate submitting an IND with our IgA degrader in 2024 as we continue to advance multiple clinical degrader candidates across a wide range of indications. We also shared key updates for our taldefgrobep alfa program (an anti-myostatin) with enrollment completion in our pivotal study in SMA and a planned Phase 2 trial initiation in obesity."
"Finally, I want to reaffirm Biohaven's commitment to the SCA3 patient community in spite of the recent disappointing regulatory decision by the FDA not to review our submitted NDA. Given the seriousness of SCA3 and consistent treatment benefits observed across multiple prespecified outcome measures, including an 80% delay in disease progression over the one-year study period with substantial risk reduction in falls, we believe that full consideration of all available data is warranted for this ultra-rare disease. Biohaven has built its foundation around our patient mission and we plan to continue to work with regulatory agencies to try to advance troriluzole for individuals suffering from SCA3."
Second Quarter 2023 and Recent Business Highlights
- Announced positive interim data from EEG biomarker study with BHV-7000 - In July 2023, the Company provided a preliminary data update from the ongoing electroencephalogram (EEG) biomarker study for the Kv7 Channel Activator platform. Preliminary Phase 1 data confirmed evidence of target engagement in the central nervous system for subjects with projected therapeutic concentrations of BHV-7000 (based on the EC50 from preclinical models), measured by changes from baseline in EEG spectral power that occurred after dosing. These pharmacodynamic (PD) effects were similar to those reported in the literature for anti-seizure medicines (ASMs), including Kv7 activators in development that are clinically effective in treating epilepsy. BHV-7000's PD effects were also differentiated from those reported for other Kv7 activators including, specifically, the absence of increases in EEG spectral power in frequency bands associated with drowsiness and somnolence. Results from the low-dose group validate the preclinical hypothesis, confirm the Phase 1 SAD/MAD clinical data, and provide strong support for Biohaven's plans to initiate pivotal studies with BHV-7000 in focal epilepsy and bipolar disorder in the second half of 2023. The preliminary data highlight BHV-7000's differentiation and potentially favorable clinical profile compared to other ASMs, and the Company expects to present the complete EEG results by the end of the year. Additionally, new pharmacokinetic data from multiple clinical formulations being studied has now confirmed a once daily extended-release oral formulation that will be used in the Phase 2/3 clinical programs.
- Successfully dosed three cohorts with single ascending doses of oral, brain penetrant, dual TYK2/JAK1 agent, BHV-8000 - In July 2023, the Company announced that it successfully dosed three cohorts in the SAD portion of an ongoing SAD/MAD Phase 1 study evaluating brain penetrant TYK2/JAK1 agent, BHV-8000 in healthy volunteers. The ongoing Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK) and PD of single and multiple ascending doses of BHV-8000 in healthy volunteers. Based on the preliminary data available, projected therapeutic concentrations of BHV-8000 were achieved, and BHV-8000 was well tolerated with only mild adverse events reported. These data provide support for further development of BHV-8000, and the Company anticipates beginning a Phase 2 clinical trial with BHV-8000 in Parkinson's disease and potentially other neuroinflammatory diseases in 2024. The Company had previously reported initiation of dosing with BHV-8000 in the Phase 1 study at Biohaven's R&D Day in May 2023.
- Reported on continued progress observed with Biohaven's first-in-class bispecific IgG degrader, BHV-1300, as compound advances to IND filing in 2H2023 - In July 2023, the Company shared an update on BHV-1300's highly competitive safety, manufacturable and PD profile. The Company is assembling a pipeline of partially de-risked, follow-on IgG degraders as well as antigen-specific degraders providing both optionality and a sustainable output of drug candidates for several years. An IND application for BHV-1300 is on track for submission in 2023 and an IND application for Biohaven's IgA degrader on track for submission in 2024
- Type A meeting planned to comprehensively address FDA's concerns in connection with Troriluzole program in SCA3 - In July 2023, the Company announced that the FDA informed Biohaven it would not review the recently submitted New Drug Application (NDA) for troriluzole for the treatment of spinocerebellar ataxia type 3 (SCA3), an ultra-rare, genetically-defined, neurodegenerative disease associated with progressive disability, frequent falls, loss of ambulation, speech and swallowing impairment, and premature death that is the most common SCA genotype worldwide. The FDA informed Biohaven it would not review the application given that the study's primary endpoint was not met and thus, would not permit a substantive review. Biohaven is committed to working closely with the FDA to bring troriluzole to people with SCA3 as quickly as possible given no therapy is currently approved for this ultra-rare genetic disorder. Biohaven plans to request a Type A meeting to comprehensively address FDA's concerns cited in the refusal to file letter.
- EMA orphan drug designation granted for taldefgrobep alfa for the treatment of SMA: - In July 2023, the Company announced that taldefgrobep alfa received orphan drug designation (ODD) from the European Commission for taldefgrobep for the treatment of SMA. Taldefgrobep previously received Fast-Track and ODD from the FDA. At Biohaven's R&D Day, the Company announced plans to complete randomization of approximately 180 patients in global SMA trial.
Upcoming Milestones:
Biohaven is progressing its product candidates through clinical programs in a number of common and rare disorders. The Company plans to reach significant pipeline milestones in the coming periods. Biohaven expects to:
- Announce Phase 1 EEG study results by year-end 2023: The Company expects to present complete results from its ongoing EEG study with BHV-7000 in healthy volunteers by the end of the year.
- Initiate Phase 2/3 studies with BHV-7000 in the second half of 2023: Biohaven expects to initiate pivotal trials in patients with focal epilepsy and bipolar disorder in the second half of 2023.
- Submit IND with BHV-1300, the Company's lead extracellular degrader: The Company expects to submit an IND with pan-IgG degrader BHV-1300 in the second half of 2023 and expects to initiate Phase 2 studies in 2024.
- Submit IND with selective Gd-IgA1 degrader: The Company expects to submit an IND with a Gd-IgA1 degrader indicated for IgA nephropathy in the first half of 2024.
- Initiate Phase 2 study with BHV-8000: The Company commenced Phase 1 studies with BHV-8000, an oral, brain-penetrant, dual TYK2/JAK1 inhibitor for neuroinflammatory disorders, in the first half of 2023 and expects to initiate a Phase 2 study in Parkinson's disease in 2024.
- Submit IND with BHV-2100 in chronic pain: The Company expects to submit an IND with BHV-2100, a selective TRPM3 antagonist in the Company's ion channel platform, in the second half of 2023.
- Complete enrollment in Phase 3 study of troriluzole in OCD in 2023: Two Phase 3 randomized, double-blind, placebo-controlled studies of troriluzole in OCD are expected to enroll up to 700 patients (in each trial) across nearly 200 global study sites. The Company anticipates completing enrollment in at least one Phase 3 trial by year-end 2023.
- Complete enrollment in Phase 3 clinical study of taldefgrobep alfa in SMA: The Company expects to complete enrollment in the study of taldefgrobep in SMA in the second half of 2023.
- Continue advancements across multiple neuroscience and immunoscience indications: The Company's preclinical pipeline includes a platform of bispecific degraders of extracellular proteins directed against IgG, IgA and other targets, TRPM3 and Kv7 family of ion channels, and other undisclosed targets, including those with disease-modifying potential.
Capital Position:
Cash, cash equivalents and marketable securities as of June 30, 2023 was $349.0 million, including $13.9 million of restricted cash, and excluding $40.4 million of cash payable to Biohaven Pharmaceutical Holding Company Ltd. (the Former Parent), compared to $467.9 million, including $2.5 million of restricted cash, and excluding $35.2 million of cash payable to the Former Parent, as of December 31, 20221.
Second Quarter 2023 Financial Highlights:
Research and Development (R&D) Expenses: R&D expenses, including non-cash share-based compensation costs, were $79.5 million for the three months ended June 30, 2023, compared to $177.1 million for the three months ended June 30, 2022. Non-cash share-based compensation expense was $2.5 million for the three months ended June 30, 2023, a decrease of $10.3 million as compared to the same period in 2022. Non-cash share-based compensation expense was higher in the second quarter of 2022 primarily because expense allocated from the Former Parent equity plan, prior to the spin-off, was based on equity awards with higher grant date fair values.
General and Administrative (G&A) Expenses: General and administrative expenses were $14.5 million for the three months ended June 30, 2023, compared to $20.0 million for the three months ended June 30, 2022. The decrease of $5.5 million was primarily due to decreased non-cash share-based compensation costs. Non-cash share-based compensation expense was $2.2 million for the three months ended June 30, 2023, a decrease of $5.8 million as compared to the same period in 2022. Non-cash share-based compensation expense was higher in the second quarter of 2022 primarily because expense allocated from the Former Parent equity plan, prior to the spin-off, was based on equity awards with higher grant date fair values.
Other Income (Expense), Net: Other income (expense), net was a net income of $5.8 million for the three months ended June 30, 2023, compared to net expense of $0.1 million for the three months ended June 30, 2022. The increase of $5.9 million was primarily due to an increase in net investment income and an increase of $1.7 million in other income related to our transition services provided to the Former Parent, which is largely non-recurring.
Net Loss: Biohaven reported a net loss for the three months ended June 30, 2023, of $90.3 million, or $1.32 per share, compared to $203.3 million, or $5.16 per share, for the same period in 2022. Non-GAAP adjusted net loss for the three months ended June 30, 2023 was $85.7 million, or $1.25 per share, compared to $182.5 million, or $4.63 per share for the same period in 2022. These non-GAAP adjusted net loss and non-GAAP adjusted net loss per share measures, more fully described below under "Non-GAAP Financial Measures," exclude non-cash share-based compensation charges. A reconciliation of the GAAP financial results to non-GAAP financial results is included in the tables below. For periods prior to Biohaven's spin-off from the Former Parent on October 3, 2022 (the "Spin-Off"), net loss per share and non-GAAP adjusted net loss per share were calculated based on the 39,375,944 common shares of Biohaven distributed to the Former Parent shareholders at the time of the distribution, including common shares issued in connection with the Former Parent share options that were settled on October 3, 2022 and common shares issued in connection with the Former Parent restricted share units that vested on October 3, 2022. The same number of shares is being utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Spin-Off.
Non-GAAP Financial Measures
This press release includes financial results prepared in accordance with accounting principles generally accepted in the United States (GAAP), and also certain non-GAAP financial measures. In particular, Biohaven has provided non-GAAP adjusted net loss and adjusted net loss per share, which are adjusted to exclude non-cash share-based compensation, which is substantially dependent on changes in the market price of common shares. Non-GAAP financial measures are not an alternative for financial measures prepared in accordance with GAAP. However, Biohaven believes the presentation of non-GAAP adjusted net loss and adjusted net loss per share, when viewed in conjunction with GAAP results, provides investors with a more meaningful understanding of ongoing operating performance and can assist investors in comparing Biohaven's performance between periods.
In addition, these non-GAAP financial measures are among those indicators Biohaven uses as a basis for evaluating performance, and planning and forecasting future periods. These non-GAAP financial measures are not intended to be considered in isolation or as a substitute for GAAP financial measures. A reconciliation between these non-GAAP measures and the most directly comparable GAAP measures is provided later in this news release.
About Biohaven
Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases. Biohaven's experienced management team brings with it a track record of delivering new drug approvals for products for diseases such as migraine, depression, bipolar and schizophrenia. The company is advancing a pipeline of therapies for diseases, many of which have limited or no treatment options, leveraging its proven drug development capabilities and proprietary platforms, including Kv7 ion channel modulation for epilepsy and neuronal hyperexcitability, glutamate modulation for obsessive-compulsive disorder and spinocerebellar ataxia, myostatin inhibition for neuromuscular diseases and metabolic disorders, and brain-penetrant TYK2/JAK1 inhibition for neuroinflammatory disorders. Biohaven's portfolio of early- and late-stage product candidates also includes discovery research programs focused on TRPM3 channel activation for neuropathic pain, CD-38 antibody recruiting, bispecific molecules for multiple myeloma, antibody drug conjugates (ADCs), and targeted extracellular protein degradation platform technology (MoDE™) with potential application in neurological disorders, cancer, and autoimmune diseases.
Forward-looking Statements
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including "continue", "plan", "will", "believe", "may", "expect", "anticipate" and similar expressions, is intended to identify forward-looking statements. Investors are cautioned that any forward-looking statements, including statements regarding the future development, timing and potential marketing approval and commercialization of development candidates, are not guarantees of future performance or results and involve substantial risks and uncertainties. Actual results, developments and events may differ materially from those in the forward-looking statements as a result of various factors including: the expected timing, commencement and outcomes of Biohaven's planned and ongoing clinical trials; the timing of planned interactions and filings with the FDA; the timing and outcome of expected regulatory filings; complying with applicable U.S. regulatory requirements; the potential commercialization of Biohaven's product candidates; the potential for Biohaven's product candidates to be first in class therapies; and the effectiveness and safety of Biohaven's product candidates. Additional important factors to be considered in connection with forward-looking statements are described in Biohaven's filings with the Securities and Exchange Commission, including within the sections titled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations". The forward-looking statements are made as of the date of this new release, and Biohaven does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
MoDEs is a trademark of Biohaven Therapeutics Ltd.
Investor Contact:
Jennifer Porcelli
Vice President, Investor Relations
jennifer.porcelli@biohavenpharma.com
+1 (201) 248-0741
Media Contact:
Mike Beyer
Sam Brown Inc.
mikebeyer@sambrown.com
+1 (312) 961-2502
View original content to download multimedia:
SOURCE Biohaven Ltd. | https://www.kold.com/prnewswire/2023/07/31/biohaven-reports-second-quarter-2023-financial-results-recent-business-developments/ | 2023-07-31T11:55:25 | 0 | https://www.kold.com/prnewswire/2023/07/31/biohaven-reports-second-quarter-2023-financial-results-recent-business-developments/ |
NEW YORK (AP) — A week later, the “Barbenheimer” boom has not abated.
Seven days after Greta Gerwig’s “Barbie” and Christopher Nolan’s “Oppenheimer” conspired to set box office records, the two films held unusually strongly in theaters. “Barbie” took in a massive $93 million in its second weekend, according to studio estimates Sunday. “Oppenheimer” stayed in second with a robust $46.2 million. Sales for the two movies dipped 43% and 44%, respectably — well shy of the usual week-two drops.
“Barbenheimer” has proven to be not a one-weekend phenomenon but an ongoing box-office bonanza. The two movies combined have already surpassed $1 billion in worldwide ticket sales. Paul Dergarabedian, senior media analyst for data firm Comscore, call it “a touchstone moment for movies, moviegoers and movie theaters.”
“Having two movies from rival studios linked in this way and both boosting each other’s fortunes — both box-office wise and it terms of their profile — I don’t know if there’s a comp for this in the annals of box-office history,” said Dergarabedian. “There’s really no comparison for this.”
Following its year-best $162 million opening, the pink-infused pop sensation of “Barbie” saw remarkably sustained business through the week and into the weekend. The film outpaced Nolan’s “The Dark Knight” to have the best first 11 days in theaters of any Warner Bros. release ever.
“Barbie” has rapidly accumulated $351.4 million in U.S. and Canadian theaters, a rate that will soon make it the biggest box-office hit of the summer. Every day it’s played, “Barbie” has made at least $20 million.
And the “Barbie” effect isn’t just in North America. The film made $122.2 million internationally over the weekend. Its global tally has reached $775 million. It’s the kind of business that astounds even veteran studio executives.
“That’s a crazy number,” said Jeff Goldstein, distribution chief for Warner Bros. “There’s just a built-in audience that wants to be part of the zeitgeist of the moment. Wherever you go, people are wearing pink. Pink is taking over the world.”
Amid the frenzy, “Barbie” is already attracting a lot of repeat moviegoers. Goldstein estimates that 12% of sales are people going back with friends or family to see it again.
For a movie industry that has been trying to regain its pre-pandemic footing — and that now finds itself largely shuttered due to actors and screenwriters strikes — the sensations of “Barbie” and “Oppenheimer” have showed what’s possible when everything lines up just right.
“Post-pandemic, there’s no ceiling and there’s no floor,” Goldstein said. “The movies that miss really miss big time, and the movies that work really work big time.”
Universal Pictures’ “Oppenheimer,” meanwhile, is performing more like a superhero movie than a three-hour film about scientists talking.
Nolan’s drama starring Cillian Murphy as atomic bomb physicist J. Robert Oppenheimer has accrued $174.1 million domestically thus far. With an additional $72.4 million in international cinemas, “Oppenheimer” has already surpassed $400 million globally.
Showings in IMAX have typically been sold out. “Oppenheimer” has made $80 million worldwide on IMAX. The large-format exhibitor said Sunday that it will extend the film’s run through Aug. 13.
The week’s top new release, Walt Disney Co.’s “Haunted Mansion,” an adaptation of the Disney theme park attraction, was easily overshadowed by the “Barbenheimer” blitz. The film, which cost about $150 million, debuted with $24 million domestically and $9 million in overseas sales. “Haunted Mansion,” directed by Justin Simien (“Dear White People,” “Bad Hair”) and starring an ensemble of LaKeith Stanfield, Tiffany Haddish, Owen Wilson, Danny DeVito and Rosario Dawson, struggled to overcome mediocre reviews.
“Talk to Me,” the A24 supernatural horror film, fared better. It debuted with $10 million. The film, directed by Australian filmmakers Danny and Michael Philippou and starring Sophie Wilde, was a midnight premiere at the Sundance Film Festival in January and received terrific reviews from critics (95% fresh on Rotten Tomatoes). It was made for a modest $4.5 million.
While theaters being flush with moviegoers has been a huge boon to the film industry, it’s been tougher sledding for Tom Cruise, the so-called savior of the movies last summer with “Top Gun: Maverick.” “Mission Impossible: Dead Reckoning Part I,” which debuted the week before the arrival of “Barbenheimer,” grossed $10.7 million in its third weekend. The film starring Cruise and directed by Christopher McQuarrie, has grossed $139.2 million domestically and $309.3 million oveseas.
Instead, the sleeper hit “Sound of Freedom” has been the best performing non-“Barbenheimer” release in theaters. The Angel Studios’ release, which is counting crowdfunding pay-it-forward sales in its box office totals, made $12.4 million in its fourth weekend, bringing its haul thus far to nearly $150 million.
Estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Comscore. Final domestic figures will be released Monday.
1. “Barbie,” $93 million.
2. “Opppenheimer,” $46.2 million.
3. “Haunted Mansion,” $24.2 million.
4. “Sound of Freedom,” $12.4 million.
5. “Mission: Impossible — Dead Reckoning Part One,” $10.7 million.
6. “Talk to Me,” $10 million.
7. “Indiana Jones and the Dial of Destiny,” $4 million.
8. “Elemental,” $3.4 million.
9. “Insidious: The Red Door,” $3.2 million.
10. “Rocky Aur Rani Ki Prem Kahani,” $1.6 million. | https://who13.com/news/while-barbie-bonanza-continues-at-the-box-office-oppenheimer-holds-no-2-spot/ | 2023-07-31T11:55:26 | 0 | https://who13.com/news/while-barbie-bonanza-continues-at-the-box-office-oppenheimer-holds-no-2-spot/ |
We know what you’re going to say: “My mom makes the best fried chicken in the world.” And how could anyone argue with that? Maybe grandma takes the blue ribbon for fried chicken in your family, or another relative is known for his or her superb frying skills.
If that’s the case, please invite us over for dinner or a picnic. Fried chicken is ideal for summer eating, and Southern folks are famous for preparing delicious plates of the stuff, to be savored by hand or maneuvered with a knife and fork.
Although homemade fried chicken is arguably the best ever, that doesn’t stop us from ordering this traditional dish when we’re dining out. Plenty of restaurants in the Birmingham area offer delectable fried chicken, and the side dishes they serve are crave-worthy, too.
Here are our picks for the top five places for fried chicken in the Magic City. For this list, we’re sticking to eateries with Alabama roots, so Publix fried chicken isn’t eligible for inclusion. Sorry, Publix fans!
Now, let’s start snacking.
READ: AL.com’s top 5 picks for barbecue, pizza, burgers, ice cream, hot dogs, doughnuts and meat-and-three in Birmingham.
5. CRAFT’S
49 Church St. in Mountain Brook; 2118 Seventh Ave. South in Birmingham. craftsbhm.com
Remember Miss Dots, a fried chicken joint that relied on the recipes used by Leola “Dot” Rogers? John Cassimus of Zoe’s Kitchen helped Miss Dots to become a reality in 2016, opening locations in Mountain Brook and Tuscaloosa. The T-Town location has closed, but Miss Dots lives on in Crestline Village, now called Craft’s and owned by the O’Neal family. (In 2023, a second location of Craft’s opened on Seventh Avenue South, as well.) Things have changed over the years, but fried chicken remains the star of the menu, and we’re extremely happy about that. You can order it here in a variety of ways, from a whole fried chicken to mini chicken bites with dipping sauces. There’s flavor and crunch aplenty, and we really like having options -- sandwiches, salads, bowls, wraps and more -- when in need of a fried chicken fix.
Order this: Bone-in fried chicken, with white or dark meat, is a good place to start at Craft’s. As a side dish, try the yummy squash casserole.
MORE: AL.com’s picks for the best eats in Birmingham, Huntsville, Mobile and across Alabama.
4. SAW’S BBQ
Six locations in Birmingham area, including Saw’s Juke Joint, 1115 Dunston Ave. sawsbbq.com
Saw’s is renowned for its barbecue, and rightly so. But there’s a wonderful fried chicken sandwich on the menu, prepared with a sweet tea brine and topped with white sauce and pickles. Goodness spills onto the plate when you order this sandwich, which boasts a hefty portion of crisp chicken and some marvelously messy toppings. It’s available at most Saw’s locations, and variations include Sweet Heat Fried Chicken (with “ranch, slaw, pickles and a little kick”) and The Colonel (”sweet tea chicken with pimento cheese and tomato”). Some folks like to pair this sandwich with fries, but as far as we’re concerned, it’s perfect as a solo act.
Order this: Sweet tea fried chicken sandwich, of course. Taylor Hicks, one of the owners of Saw’s Juke Joint, suggests extra pickles, and we’re definitely up for that.
RELATED: Where to get Birmingham’s best chicken sandwich
3. YO’ MAMA’S
2328 Second Ave. North in Birmingham. www.yomamasrestaurant.com
Yo’ Mama’s serves food with heart and soul, specializing in home-style dishes with Southern flavors. You can bet they’ve got fried chicken on the menu, and the scrumptious wings here have earned praise from ordinary folks, restaurant critics and celebrity chefs alike. Founded in 2015 by Denise Peterson and her daughter, Crystal Peterson, Yo’ Mama’s quickly became a mainstay on the Magic City restaurant scene. The downtown eatery received even more attention with a featured spot on Netflix’s “Fresh, Fried and Crispy” in 2021. Yo’ Mama’s plans to move to a new location at 2098 Fourth Ave. North, thanks to a $1.3 million investment from the City of Birmingham.
Order this: Chicken & Waffle is a mouthwatering treat at Yo’ Mama’s. The dish features Belgian waffles, six fried chicken wings, a dollop of syrup and fruit toppings. You might tempted to lick your fingers while eating wings at Yo’ Mama’s, and we won’t judge you.
READ: Randall Woodfin asked Birmingham for restaurant picks; here are 10 favorites
2. FIVE
744 29th St. South in Birmingham, other locations in Tuscaloosa, Mobile and Athens, Georgia. www.five-bar.com
Five entrees are on the menu at this casual-cool restaurant, which also offers five appetizers, five snacks, five signature cocktails ... you get the idea. If that sounds too trendy or high concept, we promise that our favorite dish at Five Birmingham (also known as 5 Bar) will make you a believer. The panéed chicken breast -- covered in bread crumbs and pan-fried -- is light, tender and juicy, served with shallot caper cream sauce and mashed potatoes, plus a house salad. (Think mixed greens, seasonal fruit, goat cheese, nuts and a creamy vinaigrette.) It’s best when served on a single plate, with various flavors mixing and mingling. We never feel guilty about eating the delicious pan-fried chicken at Five, because it almost seems healthy. Win-win!
Order this: Panéed chicken breast, naturally. The jazz brunch on weekends offers chicken and waffles, if you’re looking for something a little more decadent.
1. EUGENE’S HOT CHICKEN
2268 Ninth Ave. North in Birmingham; 3232 Galleria Circle, Suite 101, in Hoover. www.eugeneshotchicken.com
Fried chicken nirvana? Eugene’s has earned a rapturous reputation that’s pretty close to it, even if you prefer your chicken without a fiery kick. Heat levels here range from “Lemon Pepper and Southern (no heat)” to “Stupid Hot (for the bold and daring).” Other choices are Mild, Hot and Hot Damn (”not too smart, not too stupid”). We like a restaurant with a sense of humor, especially when it serves fried chicken that’s crazy-good. Zebbie Carney, the founder of Eugene’s, started with a food truck around 2015, moved to a brick-and-mortar location downtown in 2017 and expanded to Hoover in 2020. More recently, the Eater website included Eugene’s Hot Chicken in its 2022 list of “The Best Fried Chicken in America.” Take your pick among chicken tenders, wings, sandwiches, quarters, whole chickens, chicken and waffles, fried chicken salad and more.
Order this: Go for the gusto with a half or full bird, plus your choice of sauce and two sides. You can’t go wrong with Southern Slaw or creamy mac and cheese. Suggested heat level? Newbies might start with mild (”slight heat”) and work their way up the burn scale.
READ: Meet the chef who’s making hot chicken cool in Alabama
More on Alabama’s Best food:
Alabama’s best barbecue: Our Top 10
Alabama’s best burgers: Our Top 10
Alabama’s best pizza: Our Top 10
Alabama’s best ice cream: Our top 10
Alabama’s best hot dogs: Our top 10
Alabama’s best meat-and-three: Our Top 10 | https://www.al.com/life/2023/07/birminghams-best-fried-chicken-our-top-5.html | 2023-07-31T11:55:31 | 0 | https://www.al.com/life/2023/07/birminghams-best-fried-chicken-our-top-5.html |
Wanted woman arrested after disturbance near Highland Park
Published: Jul. 31, 2023 at 6:41 AM CDT|Updated: 11 minutes ago
TOPEKA, Kan. (WIBW) - A disturbance near Highland Park High School led to a woman’s arrest after she was found to have been wanted on multiple warrants.
The Topeka Police Department tells 13 NEWS that around 5 a.m. on Tuesday, July 25, officials were called to the 1900 block of SE 26th St. with reports of a disturbance.
When law enforcement arrived, they said they found a woman who was known to have two felony warrants out for her arrest. She was identified as Nicole B. Branion, 40, of Topeka.
Branion was arrested and booked into the Shawnee Co. Dept. of Corrections on:
- Theft of property or services - less than $1,500 with 2 or more convictions within 5 years
- Two counts of interference with law enforcement
- Criminal trespass
- Disorderly conduct - fighting words or noisy conduct
- Distribution of heroin or certain stimulants - between 3.5 grams and 100 grams
- Possession of paraphernalia with intent to manufacture, plant or cultivate
- Criminal use of weapons - sell, manufacture, purchase or possess a bludgeon, club or brass knuckles
- Use or possession with intent to use drug paraphernalia
- Possession of marijuana
- Operate vehicle without registration or with an expired tag
- Operate a motor vehicle without a valid license
As of Monday, Branion remains behind bars with no bond listed and a court appearance set for 1:30 p.m. on Aug. 3.
Copyright 2023 WIBW. All rights reserved. | https://www.wibw.com/2023/07/31/wanted-woman-arrested-after-disturbance-near-highland-park/ | 2023-07-31T11:55:31 | 0 | https://www.wibw.com/2023/07/31/wanted-woman-arrested-after-disturbance-near-highland-park/ |
Highlights Include the Return of Polaris Sportsman 570 and XP 1000 Hunt Editions, Along with a Host of
Aesthetic and Performance Upgrades Across the Lineup
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- On the heels of debuting its innovative Polaris XPEDITION and the all new Extreme Duty RANGER XD 1500, Polaris Off Road today unveiled updates for 2024 to the off-road industry's most expansive lineup. The 2024 lineup features a host of rider-inspired updates and refreshed styling and new colors. Additionally, the customer-favorite Polaris Sportsman 570 and XP 1000 Hunt editions make a return, and a Premium trim offering is now available on the 2024 GENERAL 1000 to provide customers with an upgrade in style and performance. RIDE COMMAND+ also received enhanced features for 2024, delivering unmatched connectivity and peace of mind to riders through all-new Location Bump Alerts and Check-In Messages.
"From the completely redesigned 2024 RZR XP and the industry's first "adventure side-by-side" Polaris XPEDITION, to our introduction of the all-new RANGER XD 1500, this year has been a powerful showcase of our ongoing commitment to lead the industry and innovate for our riders," said Steve Menneto, President of Polaris Off Road. "While those revolutionary product debuts are pivotal, our unwavering focus on refining and enhancing our current offerings based on customer needs and feedback remains essential, and that's what the 2024 updates represent."
From fresh new styles and colorways, to improved trim levels that appeal to a wide variety of riders, the Polaris Off Road 2024 model year lineup and RIDE COMMAND+ technology enhancements include the following:
RIDE COMMAND+:
Making its debut last fall, RIDE COMMAND+, the industry's first connected-vehicle technology, continues to roll out new enhancements to its service for 2024. With new features like Location Alerts, that will notify the owner if its vehicle has been bumped or moved from its last location, owners can now protect their vehicle more than ever before. RIDE COMMAND+ is now available as a factory option for 2024 RZR Pro R Ultimate, RANGER XD 1500 NorthStar, RANGER XP 1000 NorthStar, Polaris XPEDITION NorthStar and Sportsman XP 1000 RIDE COMMAND Edition. This service is also available on most 2024 RZR, RANGER, Sportsman and Polaris XPEDITION models as an accessory install.
Sportsman
Polaris Sportsman, the long-standing No. 1 selling automatic 4x4 ATV, is reintroducing the Sportsman 570 and XP 1000 Hunt Editions, while also implementing key improvements across the core 2024 lineup. A customer favorite, specifically designed to meet the unique needs of hunters, the Sportsman 570 and XP 1000 Hunt editions include accessories such as the 3,500 lb Polaris Winch, Kolpin Gun Scabbard & Mount, Kolpin Ratchet Claws and more.
Additionally, the 2024 Sportsman 450 and 570 lineup boasts several quality refinements for a better riding experience including a new rear brake pedal for reduced pedal effort and feel, improved sealing around the shifter, and enhanced seat fitment delivering a more comfortable ride. The 570 EPS trim and above will also include enhanced PVT clutch sealing with a higher intake location for better performance in wet conditions.
For added utility, the model year 2024 Sportsman 570 lineup will be equipped with new LED lights for the Premium and Utility HD for added visibility from dawn to dusk.
New color options also are available for the 570 Premium and Trail, 570 Ride Command Edition, Sportsman 850 Premium and Ultimate Trail, Sportsman XP 1000 Ultimate Trail, Sportsman XP 1000 High Lifter Edition, Scrambler XP 1000 S and Sportsman XP 1000 S.
The 2024 Sportsman lineup starts at $6,999 US MSRP and will begin shipping to dealers this early fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/sportsman/
GENERAL
Polaris GENERAL is the industry's most versatile crossover side-by-side, capable of tackling tough trails, while also knocking out tasks around the property. For 2024, the GENERAL 1000 receives a new Premium trim offering that provides both style and performance enhancements. Featuring 14" wheels with 27" Coronado tires, and FOX® Podium QS3® shocks that riders can adjust between soft, medium and firm based on terrain changes, the new Premium trim will deliver a smooth ride over rugged terrain, while LED headlights provide greater visibility at morning and night. These upgrades will help riders knock out more tasks and hit the trails confidently in the GENERAL 1000.
Additionally, new colorways on the GENERAL 1000 model include Ghost Gray and Volcanic Orange. The Premium and Ultimate trim levels for the GENERAL XP will feature new colors and graphics in Matte Silver Quartz and Polaris Blue.
The 2024 GENERAL lineup starts at $17,499 US MSRP and will begin shipping to dealers this summer. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/general/
RZR
Polaris RZR, the No. 1 sport side-by-side brand, receives fresh new colors and graphics across its lineup, helping riders make a bold statement when hitting the trails. The 2024 RZR Trail and RZR Trail S are now available in Storm Blue on the Sport trim and two-tone Storm Blue with White Lightning on the Ultimate. Both Sport and Ultimate trim levels now receive the same upgraded steering wheel offered in the fully-redesigned 2024 RZR XP that provides a sportier feel while driving on trails. New for 2024, the RZR Trail and Trail S Sport level feature electric power steering and LED headlights standard, providing riders easier steering input on tight trail corners and enhanced visibility. Additionally for 2024, the RZR Trail S Ultimate trim now features Walker Evans Racing® shocks, while the Sport trim moved to ZF Sachs shocks, both offering riders plush suspension performance against the rugged terrain.
For 2024, the RZR Pro XP Sport and Premium models feature Walker Evans Racing® shocks, while the Ultimate will continue to be equipped with FOX® Live Valve shocks with DYNAMIX active suspension. Both the Premium and Ultimate trim received a refresh with new graphics on the Super Graphite colorway.
Lastly and by consumer demand, the Wide Open lineup of RZR Pro R and RZR Turbo R receives refreshed color options for 2024. For the first time since launching, the RZR Pro R Ultimate is available in an all-new Matte Onyx Black with Lifted Lime accents or Matte Heavy Metal, while the Premium trim level is offered in Matte Heavy Metal. The 2024 RZR Turbo R also welcomes vibrant new colors like Velocity Blue with Green Burst accents and Military Tan with Orange Burst accents.
The 2024 RZR lineup starts at $15,999 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/rzr/
RANGER
In addition to the newly launched Extreme Duty RANGER XD 1500, the Polaris RANGER lineup receives a variety of rider-inspired upgrades and quality refinements for 2024. RANGER SP 570 gets new color options, while the NorthStar Edition gets exclusive tailgate badging and new 25" 8-ply Pro Armor X-Terrain tires for added durability and enhanced puncture resistance.
Additionally, Polaris expands the color options for the RANGER 1000 Premium which will now be offered in the sleek Granite Grey color and graphics, while the XP 1000 will be featured in two new options: Desert Sand and Super Graphite with orange burst accents. Furthermore, the RANGER XP 1000 NorthStar Ultimate model boasts connectivity features such as vehicle health, issue diagnostics, and maintenance reminders enabled by RIDE COMMAND+.
The 2024 RANGER lineup starts at $11,699 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/ranger/
Youth
Dedicated to inspiring the next generation of riders, Polaris Off Road delivers the industry's largest and most varied lineup of youth offerings. For 2024, the Polaris ORV Youth lineup receives a refresh with eye-catching new colors and graphics. This lineup continues to provide industry-leading safety features that give parents peace of mind and help instill confidence in growing riders, including pin code start, adjustable speed limiter, geofencing, helmet aware technology and industry-exclusive safety gear kit.
Specifically, the 2024 RZR 200 EFI is now offered in Storm Gray and a new graphic pattern with bright red accents. The Outlaw 70 EFI ATV is offered in Velocity Blue with either Lifted Lime or Fierce Fuchsia accents, while the Outlaw 110 EFI is now offered in both Bright White with Polaris Blue and Bright White with Radiant Green details.
The 2024 Polaris Youth lineup starts at $2,999 US MSRP and will begin shipping to dealers this winter. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/shop-by-use/youth/
Polaris XPEDITION
The Polaris XPEDITION, which recently launched in May 2023, is the first-of-its-kind adventure side-by-side, combining the all-terrain capabilities of traditional side-by-sides with comfort and cargo capabilities typically associated with overlanding at the highest level. With a host of standard features and optional configurations to accommodate the greatest range of outdoor pursuits and enable consumers to keep chasing the wild, the 2024 Polaris XPEDITION XP and ADV are the most adaptable, comfortable and capable adventure machine on the market.
The 2024 Polaris XPEDITION lineup starts at $28,999 US MSRP and is currently shipping to dealers. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/polaris-xpedition/
To learn more about the Polaris ORV 2024 lineup and to stay up to date on testing and demo opportunities, please visit https://offroad.polaris.com/en-us/ or join the conversation and follow on FacebookSM, InstagramSM, YouTubeSM and TwitterSM. Walker Evans Racing® is a registered trademark of Walker Evans Enterprises Incorporated; FOX® is a registered trademark of Fox Factory Inc.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.mysuncoast.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ | 2023-07-31T11:55:31 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ |
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- Today, Blitz Insurance, a specialty insurance carrier, partners with Ascend to modernize payment experiences for insurance brokers selling in specialty markets. With this partnership, Blitz Insurance will open new customer segments by offering both direct bill and premium financing into their payments workflow.
"When we looked into the market for a solution, Ascend was the right choice. Ascend meets our needs for a better payments experience for our partners while reducing everyone's operational expenses," said Brandon Murphy, Chief Distribution Officer of Blitz Insurance. "We will now have the ability to not only expand to direct bill and a premium finance option but also simplify the movement of money between us and our partners."
With Ascend, Blitz Insurance is now able to provide a direct bill in addition to their existing agency bill workflow - allowing brokers to decide what billing method works best for them. By utilizing Ascend, Blitz Insurance not only grows their footprint of appointed brokers but also gains administrative efficiency by automating what would otherwise have been a large operational undertaking.
Ascend automatically attributes incoming payments to policies in real time, speeding up the reconciliation process. By modernizing the payments experience and speeding up the reconciliation of incoming premiums, Blitz Insurance can offer a best-in-class experience to its brokers and agents.
"We find that across the insurance ecosystem - companies want to provide a seamless payment workflow for their customers and their teams," said Andrew Wynn, co-CEO of Ascend. "Ascend is built so brokers and carriers can offer this experience without shouldering the administrative resources and costs needed to support these operations."
About Ascend
Ascend is the first insurance payments platform that automates financial operations from collections and financing to carrier and commission payables. Founded by two-time insurtech entrepreneurs Andrew Wynn and Praveen Chekuri, Ascend helps insurance brokers, MGAs, and carriers improve their bottom lines by eliminating expensive and labor-intensive payment workflows. To learn more, please visit LinkedIn, Twitter or check out https://www.useascend.com/.
About Blitz Insurance
Blitz is a tech-driven insurer revolutionizing the $60B specialty market catering to SME segment. By leveraging industry knowledge and cutting-edge technology, we deliver a simpler, smarter, and faster coverage experience.
The company is led by a veteran team of insurance and technology experts and has been funded with $25M from its founder & CEO, a Forbes-listed serial entrepreneur in the real estate and insurance industries.
Contact:
Mike Nguyen
press@useascend.com
View original content to download multimedia:
SOURCE Ascend | https://www.kold.com/prnewswire/2023/07/31/blitz-insurance-partners-with-ascend-expand-payment-financing-offerings/ | 2023-07-31T11:55:32 | 0 | https://www.kold.com/prnewswire/2023/07/31/blitz-insurance-partners-with-ascend-expand-payment-financing-offerings/ |
Pitstick brings product, operations, and value-based care expertise to leading behavioral health provider
SARATOGA SPRINGS, N.Y., July 31, 2023 /PRNewswire/ -- aptihealth, the leading tech-driven behavioral healthcare provider built for higher acuity care, today announced that Regina Pitstick has joined the organization as Senior Vice President of aptihealth Medical Group.
Most recently, Pitstick was VP Advocacy Product & Innovation for the Employer and Individual segment at UnitedHealth Group, where she drove the company's product strategy and vision, focused on delivering a seamless, personalized patient experience. Responsible for product development initiatives, Pitstick's leadership and experience fueled successful long-range strategies, broader market penetration and deeper engagement for over 15M consumers.
"Regina brings more than twenty years of extremely relevant experience in the healthcare industry to aptihealth—including a deep skillset in digital health start-ups, product development, operations, process improvement and value-based care," said Tim Koehler, President and Chief Operating Officer of aptihealth. "Regina's patient-centered approach, insightful understanding of the health care landscape, innovate approach, and impeccable ability to execute strategic initiatives will greatly enhance our medical group. She's ideal for this critical role at aptihealth as we continue to pursue our mission of becoming the nation's preeminent provider of behavioral health services."
Pitstick joins aptihealth at a time of significant growth, having served nearly 15,000 patients for leading national and regional health plans. aptihealth expects to more than double its patients in 2023, with a majority covered by value-based care contracts.
"The value that aptihealth is providing to health plans, physicians groups, health systems and higher-acuity patients simply can't be underestimated," indicated Pitstick. "Whether it's the company's commitment to engaging new patients at any point of care, to their proprietary screening and assessment tools, to their proven ability to improve outcomes and decrease the overall cost of care, it's not hyperbole to state that aptihealth is changing the behavioral healthcare game. I'm thrilled to have the opportunity to help aptihealth continue to improve its care model, meet its strategic goals, and intelligently achieve its considerable opportunities for growth."
About aptihealth
aptihealth is improving higher acuity behavioral healthcare for populations who need it most—one patient at a time. The company's virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Saratoga Springs and employing over 150, aptihealth has raised over $70 million in funding from leading international private equity firms. The company's care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction. Learn more at: www.aptihealth.com.
View original content to download multimedia:
SOURCE aptihealth | https://www.mysuncoast.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ | 2023-07-31T11:55:33 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ |
Dear Annie: I’m in my late 30s. Is it rude to ignore a much older boomer friend who constantly texts me asking dumb, ridiculous questions? This person has always been out of touch, but lately they’ve been extra annoying for some reason. Every time I answer, it just extends the conversation, so when can I cut them off? And how? -- A Ghost
Dear Ghost: If you don’t want to hear from your friend, then simply stop replying to his questions.
View prior ‘Dear Annie’ columns
“How Can I Forgive My Cheating Partner?” is out now! Annie Lane’s second anthology -- featuring favorite columns on marriage, infidelity, communication and reconciliation -- is available as a paperback and e-book. Visit Creators Publishing for more information. Send your questions for Annie Lane to dearannie@creators.com.
COPYRIGHT 2023 CREATORS.COM | https://www.al.com/life/2023/07/dear-annie-is-it-ok-to-ignore-dumb-texts-from-a-friend.html | 2023-07-31T11:55:37 | 1 | https://www.al.com/life/2023/07/dear-annie-is-it-ok-to-ignore-dumb-texts-from-a-friend.html |
MIAMI, July 31, 2023 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) today announced that Carnival Corporation (the "Company") intends to commence the marketing of a new senior secured first lien term loan B facility (the "New First Lien Term Loan") with an original principal amount of $1.0 billion, expected to mature in 2027. In conjunction with the New First Lien Term Loan, and subject to market and other conditions, the Company may raise $500 million of other secured debt maturing in 2029 (together with the New First Lien Term Loan, the "Refinancing Transactions"). The Company intends to use the proceeds from the Refinancing Transactions to repay a portion of the borrowings under the Company's existing first-priority senior secured term loan facility maturing in 2025.
After the closing of the Refinancing Transactions, the Company intends to redeem all of the Company's 10.500% second-priority senior secured notes due 2026 and 10.125% second-priority senior secured notes due 2026 (collectively, the "2026 Notes"), saving over $120 million in interest expense on an annualized basis. The $1.2 billion of redemptions will be conditioned on the closing of the Refinancing Transactions. The Company expects to use cash on hand to finance the redemptions. This press release does not constitute a notice of redemption with respect to the 2026 Notes.
The Company's Chief Financial Officer David Bernstein commented: "Given the confidence we have in our business and its cash flow generation, we plan to retire $1.2 billion of our highest cost debt. In connection with this retirement, we plan to extend some of the lowest cost public debt in our portfolio. This is yet another step forward in our deleveraging journey, building on the $1.4 billion we already early retired this year. With this debt repayment, we now expect our year end debt balance to be less than $32.0 billion, an improvement over the November 30, 2023 debt balance of less than $33.0 billion provided in our June guidance."
This press release shall not constitute an offer to sell or the solicitation of an offer to purchase any security and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offering, solicitation or sale would be unlawful.
About Carnival Corporation & plc
Carnival Corporation & plc is the largest global cruise company, and among the largest leisure travel companies, with a portfolio of world-class leading cruise lines - AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, P&O Cruises (Australia), P&O Cruises (UK), Princess Cruises and Seabourn.
Cautionary Note Concerning Forward-Looking Statements
Carnival Corporation and Carnival plc and their respective subsidiaries are referred to collectively in this press release, as "Carnival Corporation & plc," "our," "us" and "we." Some of the statements, estimates or projections contained in this press release are "forward-looking statements" that involve risks, uncertainties and assumptions with respect to us, including some statements concerning the refinancing transactions described herein, future results, operations, outlooks, plans, goals, reputation, cash flows, liquidity and other events which have not yet occurred. These statements are intended to qualify for the safe harbors from liability provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are statements that could be deemed forward-looking. These statements are based on current expectations, estimates, forecasts and projections about our business and the industry in which we operate and the beliefs and assumptions of our management. We have tried, whenever possible, to identify these statements by using words like "will," "may," "could," "should," "would," "believe," "depends," "expect," "goal," "aspiration," "anticipate," "forecast," "project," "future," "intend," "plan," "estimate," "target," "indicate," "outlook," and similar expressions of future intent or the negative of such terms.
Forward-looking statements include those statements that relate to our outlook and financial position including, but not limited to, statements regarding:
Because forward-looking statements involve risks and uncertainties, there are many factors that could cause our actual results, performance or achievements to differ materially from those expressed or implied by our forward-looking statements. This note contains important cautionary statements of the known factors that we consider could materially affect the accuracy of our forward-looking statements and adversely affect our business, results of operations and financial position. Additionally, many of these risks and uncertainties are currently, and in the future may continue to be, amplified by our substantial debt balance as a result of the pause of our guest cruise operations. There may be additional risks that we consider immaterial or which are unknown. These factors include, but are not limited to, the following:
- events and conditions around the world, including war and other military actions, such as the invasion of Ukraine, inflation, higher fuel prices, higher interest rates and other general concerns impacting the ability or desire of people to travel have led, and may in the future lead, to a decline in demand for cruises, impacting our operating costs and profitability;
- pandemics have in the past and may in the future have a significant negative impact on our financial condition and operations;
- incidents concerning our ships, guests or the cruise industry have in the past and may, in the future, negatively impact the satisfaction of our guests and crew and lead to reputational damage;
- changes in and non-compliance with laws and regulations under which we operate, such as those relating to health, environment, safety and security, data privacy and protection, anti-corruption, economic sanctions, trade protection, labor and employment and tax have in the past and may, in the future, lead to litigation, enforcement actions, fines, penalties and reputational damage;
- factors associated with climate change, including evolving and increasing regulations, increasing global concern about climate change and the shift in climate conscious consumerism and stakeholder scrutiny, and increasing frequency and/or severity of adverse weather conditions could adversely affect our business;
- inability to meet or achieve our sustainability related goals, aspirations, initiatives, and our public statements and disclosures regarding them, may expose us to risks that may adversely impact our business;
- breaches in data security and lapses in data privacy as well as disruptions and other damages to our principal offices, information technology operations and system networks and failure to keep pace with developments in technology may adversely impact our business operations, the satisfaction of our guests and crew and may lead to reputational damage;
- the loss of key team members, our inability to recruit or retain qualified shoreside and shipboard team members and increased labor costs could have an adverse effect on our business and results of operations;
- increases in fuel prices, changes in the types of fuel consumed and availability of fuel supply may adversely impact our scheduled itineraries and costs;
- we rely on supply chain vendors who are integral to the operations of our businesses. These vendors and service providers may be unable to deliver on their commitments, which could negatively impact our business;
- fluctuations in foreign currency exchange rates may adversely impact our financial results;
- overcapacity and competition in the cruise and land-based vacation industry may negatively impact our cruise sales, pricing and destination options;
- inability to implement our shipbuilding programs and ship repairs, maintenance and refurbishments may adversely impact our business operations and the satisfaction of our guests;
- Failure to successfully implement our business strategy following our resumption of guest cruise operations would negatively impact the occupancy levels and pricing of our cruises and could have a material adverse effect on our business. We require a significant amount of cash to service our debt and sustain our operations. Our ability to generate cash depends on many factors, including those beyond our control, and we may not be able to generate cash required to service our debt and sustain our operations; and,
- the risk factors included in Carnival Corporation's and Carnival plc's Annual Report on Form 10-K filed with the SEC on January 27, 2023 and Carnival Corporation's and Carnival plc's Quarterly Reports on Form 10-Q filed with the SEC on March 29, 2023 and June 28, 2023.
The ordering of the risk factors set forth above is not intended to reflect our indication of priority or likelihood.
Forward-looking statements should not be relied upon as a prediction of actual results. Subject to any continuing obligations under applicable law or any relevant stock exchange rules, we expressly disclaim any obligation to disseminate, after the date of this document, any updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are based.
Forward-looking and other statements in this document may also address our sustainability progress, plans and goals (including climate change and environmental-related matters). In addition, historical, current and forward-looking sustainability- and climate-related statements may be based on standards and tools for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions and predictions that are subject to change in the future and may not be generally shared.
SOURCE Carnival Corporation & plc
View original content:
SOURCE Carnival Corporation & plc | https://www.kold.com/prnewswire/2023/07/31/carnival-corporation-amp-plc-announces-anticipated-debt-pre-payment-12b-refinancing-transaction/ | 2023-07-31T11:55:38 | 0 | https://www.kold.com/prnewswire/2023/07/31/carnival-corporation-amp-plc-announces-anticipated-debt-pre-payment-12b-refinancing-transaction/ |
BEIJING, July 31, 2023 /PRNewswire/ -- SANY Group ("SANY") has announced the 2023 employee stock ownership plan (ESOP). This is the fourth consecutive year that SANY has launched the ESOP, which gives employees an opportunity to own shares in the company through the setting up of incentive funds. The 2023 ESOP has set up a fund size of around 590 million yuan (USD 82 million) with a share repurchase price planned at 16.13 yuan per share (USD 2.24). The capital will be from the incentive funds accrued following relevant provisions of the group.
SANY has always focused on improving employee benefits and adhering to the principle of "growing together, pursuing common development, and sharing achievements." By establishing a comprehensive incentive and restraining mechanism, it aims to inspire employees' enthusiasm and creativity and align the interests of shareholders, the listed company, and individuals. This encourages all parties to join efforts to boost SANY's long-term development.
SANY's annual ESOP aims to share the fruits of the group's achievements with employees. The number of employees awarded with stock ownership incentives is growing annually, and the proportion of mid-level and key position employees is increasing year by year:
- 2020: SANY awarded 8.31 million shares to 2,264 employees, 71.52 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2021: SANY awarded 7.54 million shares to 4,205 employees, 91.33 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2022: SANY awarded 20.5 million shares to 6,996 employees, 94.26 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2023: SANY is awarding 36.62 million shares to 7,131 employees, 95.69 percent were employees in mid-level management, key positions, and core business (technical) positions.
The source of shares for the 2023 ESOP is the shares that have already been repurchased by SANY's special account. It does not exceed 36.62 million shares in total and is within one percent of SANY's current total capital stock.
In the meantime, SANY Renewable Energy (SH688349) released an announcement relating to exercising of the second exercise period of the 2020 stock option incentive plan, with 16.0368 million granted options to be exercised, with a three-year restricted period. The subsidiary is committed to becoming a global leader of clean energy equipment and services, and contributing to reaching the goals of carbon peaking and carbon neutrality.
View original content to download multimedia:
SOURCE SANY Group | https://www.mysuncoast.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ | 2023-07-31T11:55:39 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ |
Consider this a strange request but the federal government wants your dead butterflies.
People in six states – including Alabama – are being asked to submit dead butterflies and moths to help the U.S. Geological Survey establish a Lepidoptera Research Collection. The collection will include butterflies and moths from Alabama, Georgia, Kansas, Nebraska, Oklahoma and Texas.
The specimens will be used to help USGS scientists identify contaminants and other environmental factors that may be contributing to the decline of the insect population.
“There are some questions that can’t effectively be answered without help from a lot of people. It’s what makes citizen science so special and valuable,” Julie Dietze, USGS scientist-in-charge of the effort said in a statement. “Collections like this one are important because they have the potential to provide scientists now, and 20 years from now, access to specimens. Without the specimens, it will be far more difficult to answer questions related to contaminants and environmental health.”
USGS requirements
- Inspects must be already dead. In other words, don’t kill a butterfly or moth to send it in.
- Inspects must be larger than 2 inches.
- Protected species under the U.S. Fish and Wildlife Endangered Species Act aren’t accepted. In these six states, only the Mitchell’s satyr Butterfly is currently protected but it is found in Alabama.
You can go here to see a flier on what types of insects are being requested and the best ways to collect.
The deadline for submissions is Nov. 1 and they can be mailed to:
USGS LRC
1217 Biltmore Drive
Lawrence, KS 66049 | https://www.al.com/news/2023/07/federal-agency-wants-dead-butterflies-from-alabama-heres-why.html | 2023-07-31T11:55:43 | 1 | https://www.al.com/news/2023/07/federal-agency-wants-dead-butterflies-from-alabama-heres-why.html |
LA ROMANA, Dominican Republic, July 31, 2023 /PRNewswire/ -- The international known company Hilton Hotels & Resorts opens its doors to its Hilton Garden Inn La Romana hotel project in the Dominican Republic, in collaboration with a group of important investors under the company Riverhome Capital S.A.S., whose main shareholder is the prominent Dominican former major league player, Edwin Encarnación; together with the vision of the lawyer Guillermo Estrella Ramia and the Minister of Tourism, David Collado.
The inauguration was led by Luis Abinader Corona, president of the Dominican Republic and who expressed that "This hotel has something very special, opening up the beach and the sector of La Caleta of La Romana, which for a long time was closed to the province and its visitors. Since private investment must always be accompanied by public infrastructure, we are working on creating them, so we are all part of this development of La Romana."
With an investment of 25 million united states dollars and the creation of more than 300 direct jobs, it is considered as a hotel option for the growing flows of tourists that the area is currently receiving. Located a short distance from other points of relevance, such as La Romana Airport 18 minutes away, Casa de Campo 12 minutes away and Central Romana just a few blocks away.
The new hotel facility has a privileged location on a 5,000 square meters property, located on the coast of the municipal district of La Caleta, La Romana province. With a capacity of 130 rooms, distributed in five of the seven floors of the building, it also counts with swimming pools, two bars, a restaurant, gym, event, meeting and multipurpose rooms, and outdoor areas, ideal for social and corporate celebrations.
The hotel responds to the interest of Edwin Encarnación to invest in the development of his province of origin, who expressed that "from the moment this project was presented to me, I knew that I had to be part and be the one to assume this. I joined the development of this hotel, with the only requirement that most of the workers came from here, from my town La Romana, and we achieved this."
View original content to download multimedia:
SOURCE Grupo De Valle | https://www.kold.com/prnewswire/2023/07/31/hilton-garden-inn-la-romana-dominican-republic-celebrates-its-opening/ | 2023-07-31T11:55:45 | 1 | https://www.kold.com/prnewswire/2023/07/31/hilton-garden-inn-la-romana-dominican-republic-celebrates-its-opening/ |
Another round of heat advisories will be in effect for Alabama on Monday.
This time it’s southwest Alabama. The National Weather Service in Mobile has issued a heat advisory for Washington, Mobile and Baldwin counties. It’ll be in effect from 11 a.m. until 7 p.m. Monday.
The weather service said the heat index, or “feels like” temperature, could reach 105 to 110 degrees this afternoon in those areas.
The heat index measures the effects of the combination of air temperature and humidity levels.
No other counties in Alabama will be under heat advisories on Monday, but that doesn’t mean it won’t be hot.
High temperatures today will range from the low to mid-90s statewide, according to the weather service (see the forecast map at the top of this post).
More temperatures well into the 90s are expected through this week across the state. | https://www.al.com/news/2023/07/heat-advisory-for-south-alabama-on-monday.html | 2023-07-31T11:55:50 | 0 | https://www.al.com/news/2023/07/heat-advisory-for-south-alabama-on-monday.html |
- CARDIO-TTRansform is the largest, most comprehensive ATTR-CM study with more than 1,400 patients enrolled
- Eplontersen is currently under U.S. FDA review for ATTRv-polyneuropathy, with ATTR-CM representing a second, larger potential patient population
CARLSBAD, Calif., July 31, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the completion of enrollment in the Phase 3 CARDIO-TTRansform cardiovascular outcomes study of eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), a large and growing patient population at risk of life-threatening cardiovascular (CV) events. The study enrolled more than 1,400 patients.
Eplontersen is an investigational antisense medicine designed to inhibit the production of transthyretin and slow the progression of cardiomyopathy for people living with hereditary or wild-type ATTR-CM.
"CARDIO-TTRansform is the largest and most comprehensive ATTR-CM study ever conducted. The evaluation of eplontersen in this broad, diverse patient population will enable robust and clinically meaningful analysis of the composite endpoint of CV mortality and recurrent CV events," said Eugene Schneider, M.D., executive vice president and chief clinical development officer for Ionis. "It will also allow us to gather data from important patient subsets, including patients with or without stabilizer therapy and those with or without hereditary disease within the evolving ATTR-CM landscape. We look forward to reporting results as early as the first half of 2025."
As part of a global development and commercialization agreement, Ionis and AstraZeneca are seeking regulatory approval for eplontersen for the treatment of transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) in the U.S. and plan to seek regulatory approval in Europe and other parts of the world. The U.S. Food and Drug Administration accepted the New Drug Application for eplontersen for the treatment of ATTRv-PN with a PDUFA action date of Dec. 22, 2023. Eplontersen was granted Orphan Drug Designation in the U.S.
For more information on the CARDIO-TTRansform study, please visit www.clinicaltrials.gov (NCT04136171).
About the CARDIO-TTRansform Study
CARDIO-TTRansform is a global, double-blind, randomized, placebo-controlled Phase 3 cardiovascular outcome study in more than 1,400 patients with ATTR cardiomyopathy (ATTR-CM). It is designed to compare eplontersen to placebo in patients with both wild-type ATTRwt-CM and hereditary ATTRv-CM who are either naïve to treatment or on a currently available standard of care. The primary composite endpoint is cardiovascular (CV) mortality and recurrent CV clinical events comparing the two study arms up to week 140. Secondary endpoints include the change from baseline in the 6-minute walk test (6MWT) and the Kansas City Cardiomyopathy Questionnaire (KCCQ) scores at week 121, as well as the rates of CV mortality, CV clinical events and all-cause mortality at week 140.
About Eplontersen
Eplontersen is an investigational LIgand-Conjugated Antisense (LICA) medicine designed to inhibit the production of TTR protein. Eplontersen is being developed as a monthly self-administered subcutaneous injection to treat all types of ATTR. ATTR amyloidosis is a systemic, progressive and fatal disease in which patients experience multiple overlapping clinical manifestations caused by the inappropriate formation and aggregation of TTR amyloid deposits in various tissues and organs, including peripheral nerves, heart, intestinal tract, eyes, kidneys, central nervous system, thyroid and bone marrow. The progressive accumulation of TTR amyloid deposits in these tissues and organs leads to organ failure and eventually death.
About Transthyretin-mediated Amyloid Cardiomyopathy (ATTR-CM)
Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease. It is caused by the accumulation of misfolded TTR protein in the cardiac muscle. Patients experience ongoing debilitating heart damage resulting in progressive heart failure, which results in death within three to five years from disease onset. ATTR-CM includes both the genetic and wild-type form of the disease. Worldwide, there are an estimated 300,000 – 500,0001,2 patients with ATTR-CM.
About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
Ionis' Forward-looking Statements
This press release includes forward-looking statements regarding Ionis' business and the therapeutic and commercial potential of eplontersen, Ionis' technologies and other products in development. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties including those related to our commercial products and the medicines in our pipeline, and particularly those inherent in the process of discovering, developing and commercializing medicines that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such medicines. Ionis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Ionis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Ionis. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Ionis' programs are described in additional detail in Ionis' annual report on Form 10-K for the year ended Dec. 31, 2022, and the most recent Form 10-Q quarterly filing, which are on file with the Securities and Exchange Commission. Copies of these and other documents are available from the Company.
In this press release, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" all refer to Ionis Pharmaceuticals and its subsidiaries.
Ionis Pharmaceuticals® is a registered trademark of Ionis Pharmaceuticals, Inc.
1 Mohamed-Salem L, et al. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol. 2018 Nov 1;270:192-196. doi: 10.1016/j.ijcard.2018.06.006.
2 Cuscaden C, et al. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. J Nucl Cardiol. 2020 May 8. doi: 10.1007/s12350-020-02152-x.
View original content to download multimedia:
SOURCE Ionis Pharmaceuticals, Inc. | https://www.kold.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ | 2023-07-31T11:55:52 | 1 | https://www.kold.com/prnewswire/2023/07/31/ionis-completes-enrollment-landmark-phase-3-cardio-ttransform-study-patients-with-ttr-mediated-amyloid-cardiomyopathy/ |
The Avocados From Mexico® Chocolate Dulce De Leche Cupcake will be available at Sprinkles bakeries nationwide for one week beginning July 31
DALLAS, July 31, 2023 /PRNewswire/ -- Talk about a perfect pairing! Avocados From Mexico®, the number one selling avocado brand in the U.S., is making National Avocado Day even better by partnering with renowned dessert bakery chain Sprinkles for a delicious collaboration – a limited-edition cupcake featuring fresh Mexican avocados.
The Avocados From Mexico® Chocolate Dulce De Leche Sprinkles cupcake is a delectable banana cupcake that's studded with pecans and generously filled with a soft dulce de leche core. And to top it all off? A zesty frosting that blends rich cream cheese and chocolate made with fresh Mexican avocados for a delightful, creamy finish.
"The new Avocados From Mexico Chocolate Dulce De Leche cupcake features the highest quality and best-tasting ingredients," said Sprinkles Vice President, Culinary, Charles Craig. "By blending fresh avocado and smooth cream cheese alongside the banana and dulce de leche cupcake, we were able to elevate all the ingredients resulting in a cupcake that is out-of-this world. We can't wait for fans to try it!"
Beginning on July 31, National Avocado Day, consumers can make their week better by enjoying Avocados From Mexico in cupcake form — available at Sprinkles nationwide through August 6.
"Avocados From Mexico make everything better, and we're so proud that our avocados will get to shine in a unique way on National Avocado Day," said Kelly Burke, Director of Brand Marketing at Avocados From Mexico. "Our brand is known for bringing the good times with great tasting avocados. We are excited to partner with a beloved brand like Sprinkles to spark good times in a new way with everyone's favorite sweet treat."
"Sprinkles Cupcakes has always taken an innovative approach to classic desserts, and this new collaboration with Avocados From Mexico is no exception," said Sprinkles CMO, Michelle Wong. "Avocados From Mexico was an obvious choice for their quality and taste, and we can't wait for our guests to discover our latest cupcake, starring this beloved fruit."
To learn more about Avocados From Mexico, visit https://avocadosfrommexico.com, Facebook (facebook.com/avocadosfrommexico), Instagram (@avocadosfrommexico) or Twitter (@AvosFromMexico). #MakeItBetter #AFMxSprinkles
About Avocados From Mexico
Avocados From Mexico is a wholly-owned subsidiary of the Mexican Hass Avocado Importers Association (MHAIA), formed for the purpose of advertising, promotion, public relations and research for all stakeholders of Avocados From Mexico. Under agreements, MHAIA and the Association of Avocado Exporting Producers & Packers of Mexico (APEAM) have combined resources to fund and manage Avocados From Mexico, with the intent to provide a focused, highly- effective and efficient marketing program in the United States. Avocados From Mexico is headquartered in Irving, Texas.
About Sprinkles
Sprinkles offers premium cupcakes, cakes and cookies that are baked fresh in small batches throughout the day and handcrafted with only the finest ingredients. Sprinkles opened its first bakery in Beverly Hills in 2005, drawing long lines of loyal cupcake fans and celebrity endorsements. Sprinkles prides themselves in being passionate innovators and since debuting the world's first Cupcake ATM, the brand has introduced layer cakes, cookies and brownies, launched a national shipping platform and has grown to over 70 bakeries and ATMs coast-to-coast. Sprinkles launched domestic and international franchising in 2022. For additional information on Sprinkles, follow @sprinklescupcakes on social and visit www.sprinkles.com.
CONTACT: Ana Ambrosi, aambrosi@avocadosfrommexico.com
View original content to download multimedia:
SOURCE Avocados From Mexico | https://www.mysuncoast.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ | 2023-07-31T11:55:53 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ |
It’s time to say goodbye to the incandescent light bulb.
A Biden administration ban on incandescent lights bulbs starts Aug. 1. On that day, Americans will only be able to purchase LED lights from retailers due to Department of Energy requirements that manufacturers only make and sell energy-efficient light emitting diode, or LED, light bulbs. LED bulbs, while more expensive, last 25-50 times longer and use less electricity.
The switch means were incandescent or halogen incandescent – which accounted for roughly 30% of light bulbs sold in the U.S. in 2020 – will soon be a thing of the past. And while retailers won’t be allowed to sell the bulbs, there are no prohibitions stopping from people using bulbs they currently own.
The DOE predicts consumers will save about $3 billion per year on utility bills once the change is complete. The rules are also projected to cut carbon emissions by 222 million metric tons - an amount equivalent to the emissions generated by 28 million homes in one year, the Biden administration said.
The initial cost of LEDs is higher, however.
The average cost of an LED light bulb ranges from $5-$7 each while incandescent light bulbs generally cost about $2 each. | https://www.al.com/news/2023/07/us-ban-on-popular-lightbulb-goes-into-effect-aug-1.html | 2023-07-31T11:55:56 | 0 | https://www.al.com/news/2023/07/us-ban-on-popular-lightbulb-goes-into-effect-aug-1.html |
Juggernaut and Mr. Highman will continue as substantial shareholders of Bobbie. The acquisition positions the combined company as the third largest fully integrated infant and toddler brand in the U.S., creating a more resilient industry for American families
WASHINGTON, July 31, 2023 /PRNewswire/ -- Juggernaut Capital Partners, a leading middle market private equity investor primarily in the consumer and healthcare sectors, is pleased to announce the sale of Nature's One, the pediatric nutrition company founded by Jay Highman which set the bar for quality and innovation in formula over decades. Joining forces with Bobbie Baby, Inc., the nation's fastest growing infant formula company, the combined business will be the first of its kind in pediatric nutrition.
"Nature's One is a true pioneer in the pediatric nutrition space. Juggernaut partnered with founder, Jay Highman, to accelerate product development and vertical integration initiatives. Over the past five years, the company completed the first FDA-approved clinical feeding study of an organic infant formula and designed and constructed the first newly built infant formula facility in the U.S. in 35 years," said John Shulman, Founder and Managing Partner at Juggernaut. "It has been a pleasure to partner with Jay and his team. We believe the combination with Bobbie cements the organization as a continued disruptor and a next-generation industry leader. We are proud to continue as a meaningful shareholder in the go-forward company."
Founded in 1997, Nature's One introduced the first organic baby formula to the U.S. market. Recognized for its dedication to purity and quality, all of the company's formulas have received the Clean Label Project's Purity Award and have tested best in class for purity and nutrition when compared to popular baby formulas sold in the U.S. Nature's One operates the only independent, FDA audited organic infant nutrition facility in the U.S.
Nature's One was advised by CG / Sawaya Partners (operating under Canaccord Genuity) and Morgan Lewis & Bockius LLP. Bobbie was advised by Perella Weinberg Partners LP and Goodwin Procter LLP.
About Juggernaut Capital Partners:
Juggernaut Capital Partners is a leading private equity firm focusing on lower middle market companies, primarily in the consumer and healthcare sectors. Juggernaut is currently investing out of Juggernaut Capital Partners V, L.P. For more information on Juggernaut Capital Partners, please visit www.juggernautcap.com.
About Nature's One:
Founded in 1997, Nature's One introduced the first organic formula, Baby's Only® Organic in the United States. Nature's One has dedicated 25 years to the research, development, and sourcing of pure ingredients. Recognized as the first and highest-ranked formulas for purity and nutritional superiority by the Clean Label Project, Baby's Only Formulas are preferred by parents who want to offer their child a "Better Start…for Life™." Baby's Only Formulas are sold nationally at Whole Foods, Target, Walmart, Sam's Club, and many fine natural food retailers, as well online at www.naturesone.com.
About Bobbie:
Bobbie is the mission-driven organic pediatric nutrition company that exists to build a parenting culture of confidence, not comparison. Founded in 2018, Bobbie hit the market with its flagship European-inspired formula in 2021 as the first direct-to-consumer, subscription-based infant formula in the U.S. Today, it's proud to be the only mom-founded and led infant formula brand in the world, and the fastest-growing in the U.S. since the 1980's. Bobbie is focused on providing purposefully sourced, USDA Organic products made with simple ingredients – crafted right here in America, for American families. For more information, visit www.hibobbie.com.
View original content:
SOURCE Juggernaut Capital Partners | https://www.kold.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ | 2023-07-31T11:55:59 | 1 | https://www.kold.com/prnewswire/2023/07/31/juggernaut-capital-partners-natures-one-founder-jay-highman-have-sold-natures-one-bobbie-baby-inc/ |
SHENZHEN, China, July 31, 2023 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "Taoping"), today announced that the board of directors of the Company approved a one-for-ten reverse stock split of the Company's issued and outstanding ordinary shares, no par value (the "Ordinary Shares"). Beginning August 1, 2023, the Company's Ordinary Shares will be trading on a split-adjusted basis under the same symbol "TAOP" but with new CUSIP number, G8675V 127.
As a result of the share consolidation, each ten Ordinary Shares outstanding will automatically combine and convert to one issued and outstanding Ordinary Share without any action on the part of shareholders who hold their shares in brokerage accounts or "street name". Shareholders holding certificates of Ordinary Shares are expected to receive instructions from the Company's transfer agent, Transhare Corporation, regarding procedures for exchanging share certificates. All outstanding options, warrants and other rights to purchase the Company's Ordinary Shares will be adjusted proportionately as a result of the reverse stock split. No fractional shares will be issued as a result of the reverse stock split, and instead, all such fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.
The reverse stock split is intended to increase the per share trading price of the Ordinary Shares to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Stock Market. Following the reverse stock split the Company will have approximately 1.86 million Ordinary Shares issued and outstanding, exclusive of shares issuable under outstanding options and warrants. The reverse stock split will not affect the number of total authorized Ordinary Shares of the Company.
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
Safe Harbor Statement
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: our potential inability to achieve or sustain profitability or reasonably predict our future results due to our limited operating history of providing smart cloud services, the effects of the global Covid-19 pandemic, the emergence of additional competing technologies, changes in domestic and foreign laws, regulations and taxes, uncertainties related to China's legal system and economic, political and social events in China, the volatility of the securities markets; and other risks including, but not limited to, those that we discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.
View original content to download multimedia:
SOURCE Taoping Inc. | https://www.mysuncoast.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ | 2023-07-31T11:55:59 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ |
A rookie defensive back from Alabama, Brian Branch appears to have made a good initial impression on Detroit Lions coach Dan Campbell.
Campbell had press conferences on Saturday and Sunday at the Lions’ training camp, and he spoke in both about Branch, who joined Detroit in the second round of the NFL Draft on April 28.
· HOW LOW IS JALEN HURTS’ BODY-FAT PERCENTAGE?
· STEELERS SIGN OXFORD’S KWON ALEXANDER
· ALABAMA ROOTS: 10 TRAINING-CAMP BATTLES
“When you turn on the tape and watch him at Bama and watch his career,” Campbell said on Saturday, “first of all, you’re playing at as talented a conference as you’re going to get in college, and he was uber productive. And it just showed up on tape against very good athletes, so you have a pretty good feeling as long as the guy is wired right and he can learn and continue to put in the work that when he gets here, he can probably take off.
“I feel like that’s a little bit of what we’re seeing out of Branch, man. He’s a football-playing dude. He’s got a feel for it. He’s got a knack. In the heat of the moment, he doesn’t panic. I mean, we had some one-on-one reps out there, we put him outside, and he’s covering and doing a pretty good job for a guy that that’s not necessarily where we see him. There’s no panic in him, and he’s a worker. He loves it. He’s not worried about anything else other than getting better, so it’s a good start for him. He’s still got a long way to go, but good start.”
RELATED: LIONS WERE ‘SWEATING BULLETS’ OVER JAHMYR GIBBS
The Lions appear to be considering Branch most strongly for roles at strong safety and slot corner.
At free safety, Detroit has Kerby Joseph, who started 14 games as a fourth-round rookie in 2022, led the Lions with four interceptions and finished fourth on the team with 82 tackles.
At strong safety, the other candidates are Tracy Walker III, a 2021 starter limited to three games in 2022 by an Achilles tendon tear, and C.J. Gardner-Johnson, a free-agent signing from the Philadelphia Eagles.
Walker has returned to the field after his injury. Gardner-Johnson tied for NFL lead with six interceptions in 12 regular-season games and started in Super Bowl LVII last season.
Gardner-Johnson also can play the slot-corner spot, where Will Harris returns after taking two-thirds of Detroit’s defensive snaps in 2021.
“It’s early, but he’s one of those guys you kind of see the light bulb,” Campbell said on Sunday about Branch. “What showed up on the tape in college is beginning to show up already up here quickly. He’s an instinctive guy. He’s got some ball-hawk ability. And look, we did one-on-ones the other day and he’s out there on (wide receiver Kalif Raymond) as an outside corner the first three plays. And I think we all know Leaf. Leaf’s got some stripes here on the wall and can run. And he did a pretty good job. And the next day, you come back and Leaf got him back, which you would expect, but he’s not out of place.
“There’s things to him. You can see him grow. And he’s another guy that is wired correctly. He’s wired right, you know? He’s got a chip on his shoulder, he goes to work and he just wants more. He wants more, he wants more, he wants more, so we’re happy with where he’s at at this point.”
RELATED: ALABAMA ROOTS: NFL DRAFT PICKS SIGN FOR $198 MILLION
The Lions are working toward their season-opening game against the Kansas City Chiefs on Sept. 7, the Thursday night contest that will kick off the NFL’s 2023 regular-season schedule. Before that, Detroit has preseason games against the New York Giants on Aug. 11, Jacksonville Jaguars on Aug. 19 and Carolina Panthers on Aug. 25.
FOR MORE OF AL.COM’S COVERAGE OF THE NFL, GO TO OUR NFL PAGE
Mark Inabinett is a sports reporter for Alabama Media Group. Follow him on Twitter at @AMarkG1. | https://www.al.com/sports/2023/07/lions-coach-on-brian-branch-a-football-playing-dude.html | 2023-07-31T11:56:02 | 1 | https://www.al.com/sports/2023/07/lions-coach-on-brian-branch-a-football-playing-dude.html |
BURLINGTON, N.C., July 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 14, 2023, in New York City, beginning at 1:00 p.m. ET and is expected to conclude by approximately 4:00 p.m. ET.
This event will highlight Labcorp's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial outlook. Presentations will be followed by a Q&A session.
A live webcast of the event will be available through the Labcorp Investor Relations website beginning at 1:00 p.m. ET. A replay of the webcast and supporting materials will be available after the conclusion of the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
View original content to download multimedia:
SOURCE Labcorp | https://www.kold.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ | 2023-07-31T11:56:06 | 1 | https://www.kold.com/prnewswire/2023/07/31/labcorp-host-investor-day-september-14-2023/ |
This Launch Marks the Latest Expansion of the Brand's Complexion Offerings as it Doubles Down on The Skincare-Meets-Makeup Hybrid Category
NEW YORK, July 31, 2023 /PRNewswire/ -- TULA Skincare, the leading clinically proven probiotic extract powered skincare brand has announced the expansion of its complexion offerings to include concealer.
After learning that TULA's customers were looking for a skin brightening eye treatment along with a concealer, the brand created a state-of-the-art clean skincare-makeup hybrid that delivers skin-boosting benefits with high-performance medium-to-full coverage.
Available in a 20-shade range, the dermatologist-tested, Radiant Skin Brightening Serum Concealer is infused with TULA's unique Rainbow Seabright™ Elixir. This clinically-proven serum-like formula instantly conceals dark circles and discoloration for longwearing, crease-proof results, while brightening the appearance of skin over time. Additional ingredients include TULA's S6Pro Complex® - a US patent pending super six blend of prebiotics and probiotic extracts to help soothe skin, improve skin smoothness and maintain skin balance, along with eye peptides and tea leaf caffeine to help improve the look of dark circles, skin texture, and eye bags. The Radiant Skin Brightening Serum Concealer can be paired with the brand's Radiant Skin Brightening Serum Skin Tint or Filter Primer Blurring & Moisturizing Primer to help build one's complexion wardrobe, or spot conceal for a no-makeup, makeup look.
"Expanding our complexion category to include a concealer was a natural next step for us, especially knowing the strong desire our customers have had for an eye treatment with brightening benefits." said TULA Skincare CEO, Savannah Sachs. " We are excited to have another offering for our glow getters that will surely be a staple in their skincare and beauty routines."
To mark the launch, TULA will be executing a multi-channel launch campaign across its digital platform, and organic social, paid media, and influencer channels. Efforts will include launching a custom "shade finder" on tula.com to help customers find their perfect match concealer shade, highlighting content speaking to the "no-makeup, makeup" and makeup-skincare hybrid trends across TikTok and Instagram, and partnering with a curated set of influencers and providing them with an early access link exclusively for their followers to purchase the concealer prior to launch. In addition to tula.com, the concealer will launch in Ulta Beauty stores nationwide and online and will be featured in an upcoming issue of the Ulta Beauty Magazine, with in-store complexion events planned in the coming months in multiple doors.
TULA's Radiant Skin Brightening Serum Concealer will be available for purchase on July 31 on tula.com, and will retail for $32.
About TULA Skincare
TULA is a doctor-founded skincare brand built on clinically proven formulas powered by probiotic extracts. We believe that the same types of ingredients which are good for your body are also great for your skin. We focus on being healthy, not perfect and on empowering everyone to feel confident in their skin.
Media Contact: Zoe Jeans at Bux + Bewl Communications: zoe@buxandbewl.com
View original content to download multimedia:
SOURCE TULA Skincare | https://www.mysuncoast.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ | 2023-07-31T11:56:06 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ |
Adult Males are Slightly More Likely to Live with Parents Than Their Female Counterparts
58% of Gen Z Consumers Live with Family Members
SAN FRANCISCO, July 31, 2023 /PRNewswire/ -- LendingClub Corporation (NYSE: LC), the parent company of LendingClub Bank, America's leading digital marketplace bank, today released findings from the 24th edition of the Reality Check: Paycheck-To-Paycheck research series, conducted in partnership with PYMNTS. The Household Finances Deep Dive Edition examines the impact of household composition on consumers' ability to manage expenses and put aside savings. The series draws on insights from a survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data.
The Paycheck-to-Paycheck Landscape
In June 2023, 61% of U.S. consumers lived paycheck to paycheck, unchanged from June 2022 — as is the share of those struggling to pay bills (at 21%) — even though more middle-income consumers cited living paycheck to paycheck in June 2023 than last year. Among consumers earning $50,000 to $100,000, 65% lived paycheck to paycheck as of June 2023, compared to 60% in June 2022. Meanwhile, the shares of high-income consumers — those earning more than $100,000 annually — and low-income consumers — those earning less than $50,000 annually — living paycheck to paycheck in June 2023 sit at 45% and 77%, respectively, relatively unchanged from June 2022.
This stability in the financial situation of U.S. households indicates that consumers continue to adapt to inflationary pressures, finding ways to manage their spending and live within their means.
Household Composition Determines Financial Lifestyle
Consumers living with only a partner or spouse are likely to face less financial hardship, while those with dependents and those living with friends or housemates are more likely to live paycheck to paycheck.
The research finds that 86% of consumers live with one or more people, and one-third of paycheck-to-paycheck consumers live in households of four or more people. Consumers not living paycheck to paycheck are most likely to reside in two-person households, at 41%. Meanwhile, 49% of millennials and 55% of bridge millennials live in households of four or more people, making them the age groups most likely to reside in the largest households.
There is also a direct correlation among household size, stage of life and financial lifestyle. As household size increases, the ratio of income earners to non-earners typically falls, attributable to households with dependent children. When looking at the share of paycheck-to-paycheck consumers who live in a two-member household, the data finds that 54% do so — 7 percentage points below the sample average. Meanwhile, at 66%, consumers with children under the age of 18 are 12% more likely to live paycheck to paycheck than those without children, at 59%. Among consumers living with friends or housemates, 77% live paycheck to paycheck — the most likely to do so. This suggests that those sharing expenses with a partner or spouse fare better, that is until they have children or even parents to support.
"As household size increases, the ratio of income earners to household members typically falls, creating a higher likelihood of financial distress," said Alia Dudum, LendingClub's Money Expert. "The relationship between household income and household composition explains why many families tend to struggle financially and why millennials and bridge millennials, many of whom are in their peak child-rearing years, tend to remain financially vulnerable."
Economic Considerations Top Reason to Stay in the Family Household
Economics are the main driver for consumers to live with family longer, with 43% wanting to save money and 30% unable to afford housing independently. Besides economic reasons, consumers remain at home to maintain family ties (24%), for transitional reasons (23%), and to provide care (22%).
At one-fifth (20%), adult males are slightly more likely to live with parents than their female counterparts (18%), a phenomenon that grows significantly among those financially struggling (26% of males compared to 18% of females). At 58%, Gen Z is the generation most likely to stay with family members, with 50% citing economic reasons. Members of Gen Z living with three or more people — often familial settings — spent 22% of their income on housing, compared to 30% of those living alone or with a partner.
That said, consumers living with family members to offset expenses are not planning extended stays. For example, one-third of those consumers expect to move out in the coming year, particularly millennials and bridge millennials.
Financial Transparency Determined by Relationship Status
Financial transparency within shared households is paramount to ensure bills are paid and expenses are covered, but the transparency level depends on who consumers live with. Couples living together share financial information 87% of the time and have a joint bank account 76% of the time. Parents are also likely to discuss finances with the children residing in their household, with 45% of parents sharing financial information with their children and 34% granting them access to a shared account. Bill splitting is the most common financial interaction for consumers living with friends or housemates, at 74%. Additionally, borrowing money from other household members is a financial option many use to make ends meet, with consumers mostly engaging in this practice with parents or siblings, at 47%, and friends and housemates, at 44%.
Families and couples maintain outstanding credit card balances that are significantly higher, on average, than those of consumers who live alone. Consumers with children under the age of 18 average 50% more credit card debt than those who live alone. Families represent the lion's share of credit card spending, holding average balances of $6,300 for consumers living with a partner and $7,200 for those living with children under 18. Living with a partner or children also significantly increases a consumer's likelihood of having an auto loan or mortgage.
"With today's inflationary pressures, sharing household finances has become not only common but crucial," continued Dudum. "The increasing complexity of modern lifestyles and the rising cost of living have necessitated a shift in the way consumers approach household finances. One person solely bearing the burden of managing all financial matters has become a minority practice. Instead, couples, families, and even roommates increasingly jointly navigate their economic realities, and it's a trend that is here to stay."
To view the full report, visit: https://www.pymnts.com/study/reality-check-paycheck-to-paycheck-inflation-household-spending-shared-expenses/
Methodology
New Reality Check: The Paycheck-to-Paycheck Report — The Household Finances Deep Dive Edition is based on a census-balanced survey of 4,602 U.S. consumers conducted from June 5 to June 16, as well as analysis of other economic data. The data in this report is not intended to be a representation of LendingClub's core member base. The Paycheck-to-Paycheck series expands on existing data published by government agencies, such as the Federal Reserve System and the Bureau of Labor Statistics, to provide a deep look into the core elements of American consumers' financial wellness: income, savings, debt and spending choices. Our sample was balanced to match the U.S. adult population in a set of key demographic variables: 51% of respondents identified as female, 33% were college-educated and 38% declared incomes of more than $100,000 per year.
About LendingClub
LendingClub Corporation (NYSE: LC) is the parent company of LendingClub Bank, National Association, Member FDIC. LendingClub Bank is the leading digital marketplace bank in the U.S., where members can access a broad range of financial products and services designed to help them pay less when borrowing and earn more when saving. Based on more than 150 billion cells of data and over $85 billion in loans, our advanced credit decisioning and machine-learning models are used across the customer lifecycle to expand seamless access to credit for our members while generating compelling risk-adjusted returns for our loan investors. Since 2007, more than 4.7 million members have joined the Club to help reach their financial goals. For more information about LendingClub, visit https://www.lendingclub.com.
Contact:
For Investors: IR@lendingclub.com
Media Contact: Press@lendingclub.com
PYMNTS Contact: information@PYMNTS.com
View original content to download multimedia:
SOURCE LendingClub Corporation | https://www.kold.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ | 2023-07-31T11:56:12 | 0 | https://www.kold.com/prnewswire/2023/07/31/lendingclub-pymnts-research-shows-86-consumers-live-with-one-or-more-people-yet-those-living-with-only-partners-or-spouses-reap-financial-benefits/ |
Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access
PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application (ANDA) approved by the U.S. Food and Drug Administration (FDA). Breyna, a drug-device combination product, is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD) and will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.
Viatris Head of North America Jose Cotarelo said: "We are excited to bring Breyna to the U.S. market for the many Americans living with asthma and COPD. This launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain. Being the first to bring an FDA-approved generic version of Symbicort to patients is a true example of how access is the cornerstone of our mission to empower people worldwide to live healthier at every stage of life."
The indications for Breyna include asthma in patients six years of age and older, and the maintenance treatment of airflow obstruction and reducing exacerbations in patients with COPD, including chronic bronchitis and/or emphysema. Breyna is not indicated for the relief of acute bronchospasm. The 160 mcg/4.5 mcg is the only strength indicated for the treatment of COPD. COPD is a term used to describe a certain kind of chronic lung disease and is characterized by breathlessness; it affects more than 16 million Americans. Asthma causes swelling of the airways resulting in difficulty breathing, and approximately 25 million Americans have the chronic condition.
Milton Boyer, CEO of Kindeva Drug Delivery, added: "The launch of Breyna represents a significant milestone as it is the first FDA-approved generic version of Symbicort in the U.S., one of the most prescribed complex drug-device combination products to treat asthma and COPD. We are pleased for Viatris as well as the many Kindeva colleagues who have worked tirelessly to leverage our complex drug-delivery expertise for this important respiratory product — supporting a persistent need to continue bringing more quality medicines for asthma and COPD to patients."
To further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply. The program offers $30/month or up to $360 per year with 12 refills annually. The program will be available in August.
About Breyna
Breyna is indicated for the treatment of asthma in patients 6 years and older not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta2-adrenergic agonists (LABA). Breyna 160 mcg/4.5 mcg dosage is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and Breyna 160 mcg/4.5 mcg is also indicated to reduce exacerbations of COPD. Breyna is NOT indicated for the relief of acute bronchospasm.
Important Safety Information
Breyna is contraindicated in the primary treatment of status asthmaticus or other acute episode of asthma or COPD where intensive measures are required, and in hypersensitivity to any of the ingredients in Breyna. Use of long-acting beta2-adrenergic agonists (LABA) as monotherapy (without inhaled corticosteroids [ICS]) for asthma is associated with an increased risk of asthma-related death. Available data from controlled clinial trials also suggest that use of LABA as monotherapy increases the risk of asthma-related hospitalization in pediatric and adolescent patients. These findings are considered a class effect of LABA. When LABA are used in fixed dose combination with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared to ICS alone. Breyna is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms. Breyna should not be initiated in patients during rapidly deteriorating episodes of asthma or COPD. Patients who are receiving Breyna should not use additional formoterol or other LABA for any reason. Localized infections of the mouth and pharynx with Candida albicans has occurred in patients treated with Breyna. Patients should rinse the mouth after inhalation of Breyna. Lower respiratory tract infections, including pneumonia, have been reported following the administration of ICS. Due to possible immunosuppression, potential worsening of infections could occur. A more serious or even fatal course of chickenpox or measles can occur in susceptible patients. It is possible that systemic corticosteroid effects such as hypercorticism and adrenal suppression may occur, particularly at higher doses. Particular care is needed for patients who are transferred from systemically active corticosteroids to ICS. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available ICS. Caution should be exercised when considering administration of Breyna in patients on long-term ketoconazole and other known potent CYP3A4 inhibitors. As with other inhaled medications, paradoxical bronchospasm may occur with Breyna. Immediate hypersensitivity reactions may occur, as demonstrated by cases of urticaria, angioedema, rash, and bronchospasm. Excessive beta-adrenergic stimulation has been associated with central nervous system and cardiovascular effects. Breyna should be used with caution in patients with cardiovascular disorders especially coronary insufficiency, cardiac arrhythmias, and hypertension. Long-term use of ICS may result in a decrease in bone mineral density (BMD Assessment of BMD is recommended prior to initiating Breyna and periodically thereafter. ICS may result in a reduction in growth velocity when administered to pediatric patients. Glaucoma, increased intracolular pressure, and cataracts have been reported following the administration of ICS, including budesonide, a component of Breyna. Close monitoring for glaucoma and cataracts is warranted in patients with a change in vision or history of increased intraocular pressure. In rare cases, patients on ICS may present with systemic eosinophilic conditions. Breyna should be used with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, and in patients who are unusually responsive to sympathomimetic amines. The most common adverse reactions ≥3% reported in asthma clinical trials included nasopharyngitis, headache, upper respiratory tract infection, pharyngolaryngeal pain, sinusitis, influenza, back pain, nasal congestion, stomach discomfort, vomiting, and oral candidiasis. The most common adverse reactions ≥3% reported in COPD clinical trials included nasopharyngitis, oral candidiasis, bronchitis, sinusitis, and upper respiratory tract infection. Breyna should be administered with caution to patients being treated with MAO inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents. Beta-blockers may not only block the pulmonary effect of beta-agonists, such as formoterol, but may produce severe bronchospasm in patients with asthma. ECG changes and/or hypokalemia associated with nonpotassium-sparing diuretics may worsen with concomitant beta-agonists. Use caution with the coadministration of Breyna.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
About Kindeva Drug Delivery
Kindeva Drug Delivery is a global contract development manufacturing organization focused on drug-device combination products. Kindeva Drug Delivery develops and manufactures products across a broad range of complex drug-delivery formats, including injectables (autoinjector, intradermal, microneedle), pulmonary & nasal, and transdermal patches. Its service offering spans early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva Drug Delivery serves a global client base from its nine manufacturing and research and development facilities located in the U.S. and U.K. For more information, please visit www.kindevadd.com.
Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements that the launch of Breyna demonstrates the companies' commitment to bringing complex generic medicines to the market to help increase patient access; Breyna will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths; this launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain; to further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply; and, the program will be available in August. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company's failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by COVID-19; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris' ability to bring new products to market, including but not limited to "at-risk" launches; Viatris' or its partners' ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris' filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this release other than as required by law.
View original content to download multimedia:
SOURCE Viatris Inc. | https://www.mysuncoast.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ | 2023-07-31T11:56:13 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ |
HOUSTON, July 31, 2023 /PRNewswire/ -- McDermott has been awarded a project management consultancy (PMC) and engineering, procurement, and construction management (EPCM) contract for the Naphtha Cracker Expansion (Phase II) polypropylene expansion and new ethylene derivative unit project from Indian Oil Corporation Limited (IOCL). The project is located at the Panipat Refinery and Petrochemical Complex, located 62 miles (100 kilometers) from New Delhi, India.
The project will increase the ethylene production capacity of the naphtha cracker unit (NCU) by approximately 20 percent. The additional ethylene and propylene production will act as feed for downstream polymer units. The polymer products will be used for the manufacture of household and industrial items, including containers, automobile parts, furniture, and heavy-duty films.
"McDermott is currently executing four other projects for IOCL, including the maleic anhydride (MAH) unit at the same site, allowing us to leverage our local resources and expertise while realizing synergies," said Vaseem Khan, Senior Vice President, Global Operations. "Furthermore, the project supports the growing demand for ethylene and propylene which will reduce imports and accelerate economic development in the area."
McDermott will provide comprehensive EPCM services and overall project management for the duration of the project, which will be executed from its Center of Excellence in Gurugram, India.
About McDermott
McDermott is a premier, fully-integrated provider of engineering and construction solutions to the energy industry. Our customers trust our technology-driven approach engineered to responsibly harness and transform global energy resources into the products the world needs. From concept to commissioning, McDermott's innovative expertise and capabilities advance the next generation of global energy infrastructure—empowering a brighter, more sustainable future for us all. Operating in over 54 countries, McDermott's locally-focused and globally-integrated resources include more than 30,000 employees, a diversified fleet of specialty marine construction vessels and fabrication facilities around the world. To learn more, visit www.mcdermott.com.
Forward-Looking Statements
McDermott cautions that statements in this press release which are forward-looking, and provide other than historical information, involve risks, contingencies and uncertainties. These forward-looking statements include, among other things, statements about the expected scope and execution of the project discussed in this press release. Although we believe that the expectations reflected in those forward-looking statements are reasonable, we can give no assurance that those expectations will prove to have been correct. Those statements are made by using various underlying assumptions and are subject to numerous risks, contingencies and uncertainties, including, among others: adverse changes in the markets in which we operate or credit or capital markets; our inability to successfully execute on contracts in backlog; changes in project design or schedules; the availability of qualified personnel; changes in the terms, scope or timing of contracts, contract cancellations, change orders and other modifications and actions by our customers and other business counterparties; changes in industry norms; actions by lenders, other creditors, customers and other business counterparties of McDermott; and adverse outcomes in legal or other dispute resolution proceedings. If one or more of these risks materialize, or if underlying assumptions prove incorrect, actual results may vary materially from those expected. You should not place undue reliance on forward-looking statements. This communication reflects the views of McDermott's management as of the date hereof. Except to the extent required by applicable law, McDermott undertakes no obligation to update or revise any forward-looking statement.
Contacts:
Global Media Relations
Reba Reid
Senior Director, Global Communications and Marketing
+1 281 588 5636
RReid@McDermott.com
Business Line Media Relations
Barbara Knight
Senior Director, Business Line Communications and Marketing
+971 56 403 2903
BBKnight@McDermott.com
View original content to download multimedia:
SOURCE McDermott International, Ltd | https://www.kold.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ | 2023-07-31T11:56:19 | 0 | https://www.kold.com/prnewswire/2023/07/31/mcdermott-selected-petrochemical-expansion-project-by-iocl/ |
New nuclear unit now serving customers with clean, reliable energy 24/7
ATLANTA, July 31, 2023 /PRNewswire/ -- Georgia Power declared today that Plant Vogtle Unit 3 has entered commercial operation and is now serving customers and the State of Georgia. The new unit represents a long-term investment in the state's clean energy future and will provide reliable, emissions-free energy to customers for decades to come.
"The Plant Vogtle 3 & 4 nuclear expansion is another incredible example of how Georgia Power is building a reliable and resilient energy future for our state," said Kim Greene, chairman, president and CEO of Georgia Power. "It is important that we make these kinds of long-term investments and see them through so we can continue providing clean, safe, reliable and affordable energy to our 2.7 million customers. Today's achievement is a testament to our commitment to doing just that, and it marks the first day of the next 60 to 80 years that Vogtle Unit 3 will serve our customers with clean, reliable energy."
Vogtle Unit 3 is the first newly-constructed nuclear unit in the U.S. in over 30 years and can power an estimated 500,000 homes and businesses. Once all four units are online, the Plant Vogtle site will be the largest generator of clean energy in the nation and support continued growth in Georgia as more industries, businesses and families come to the state.
"Today is a historic day for the State of Georgia, Southern Company, and the entire energy sector, as we continue transforming the way we power the lives of millions of Americans," said Chris Womack, president and CEO of Southern Company. "With Unit 3 completed, and Unit 4 in the final stages of construction and testing, this project shows just how new nuclear can and will play a critical role in achieving a clean energy future for the United States. Bringing this unit safely into service is a credit to the hard work and dedication of our teams at Southern Company and the thousands of additional workers who have helped build that future at this site, as well as all of the partners who have helped make this day a reality."
Nuclear energy is the only zero-emission baseload energy source available today, offering high reliability, and efficient operations around the clock. Nuclear energy currently provides approximately 25% of Georgia Power's overall energy mix, including the existing units at Plant Vogtle and Georgia's other nuclear facility at Plant Hatch in Baxley, Georgia.
"The Vogtle expansion is an American energy success story and would not be possible without the support of strong public and private partners like our partners at North America's Building Trades Unions," said Tom Fanning, chairman of the Board of Directors for Southern Company. "We continue to appreciate their support and those who have stood with us at the local, state and federal levels to complete this new clean energy source to serve electric customers. Providing leadership in our industry and a commitment to safety and quality are in Southern Company's DNA. Today's milestone at the Vogtle expansion site underscores this legacy, and I couldn't be prouder of the dedication our teams have shown in seeing Unit 3 through to completion."
The final stages of construction and testing continue at Vogtle Unit 4, with the unit projected to be placed in service during the late fourth quarter 2023 or the first quarter of 2024. The unit completed hot functional testing in May, in significantly less time than Unit 3 as the team continues leveraging best practices and learnings from the earlier unit. The Vogtle site has also received nuclear fuel for Unit 4, with a total of 157 fuel assemblies necessary for the safe and reliable startup of the unit.
Also, last week, Georgia Power announced the receipt of the 103(g) finding from the Nuclear Regulatory Commission (NRC) for Vogtle Unit 4. This finding was confirmed in an official letter received by Southern Nuclear and signifies that the new unit has been constructed and will be operated in conformance with the Combined License and NRC regulations. No further NRC findings are necessary in order for Southern Nuclear to load fuel or begin the startup sequence for the new unit.
The new Vogtle units are an essential part of Georgia Power's commitment to delivering clean, safe, reliable and affordable energy to its 2.7 million customers. Southern Nuclear will operate the new units on behalf of the co-owners: Georgia Power, Oglethorpe Power, MEAG Power and Dalton Utilities.
About Georgia Power
Georgia Power is the largest electric subsidiary of Southern Company (NYSE: SO), America's premier energy company. Value, Reliability, Customer Service and Stewardship are the cornerstones of the company's promise to 2.7 million customers in all but four of Georgia's 159 counties. Committed to delivering clean, safe, reliable and affordable energy, Georgia Power maintains a diverse, innovative generation mix that includes nuclear, coal and natural gas, as well as renewables such as solar, hydroelectric and wind. Georgia Power focuses on delivering world-class service to its customers every day and the company is recognized by J.D. Power as an industry leader in customer satisfaction. For more information, visit www.GeorgiaPower.com and connect with the company on Facebook (Facebook.com/GeorgiaPower), Twitter (Twitter.com/GeorgiaPower) and Instagram (Instagram.com/ga_power).
Cautionary Note Regarding Forward-Looking Statements
Certain information contained in this release is forward-looking information based on current expectations and plans that involve risks and uncertainties. Forward-looking information includes, among other things, statements concerning the projected in-service date for Plant Vogtle Unit 4 and the future operations of Plant Vogtle Units 3 and 4. Georgia Power cautions that there are certain factors that can cause actual results to differ materially from the forward-looking information that has been provided. The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of Georgia Power; accordingly, there can be no assurance that such suggested results will be realized. The following factors, in addition to those discussed in Georgia Power's Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent securities filings, could cause actual results to differ materially from management expectations as suggested by such forward-looking information: the ability to control costs and avoid cost and schedule overruns during the development, construction, and operation of facilities or other projects, including Plant Vogtle Unit 4, which includes components based on new technology that only within the last few years began initial operation in the global nuclear industry at this scale, due to current and/or future challenges which include, but are not limited to, changes in labor costs, availability and productivity, challenges with the management of contractors or vendors, subcontractor performance, adverse weather conditions, shortages, delays, increased costs, or inconsistent quality of equipment, materials, and labor, contractor or supplier delay, the impacts of inflation, delays due to judicial or regulatory action, nonperformance under construction, operating, or other agreements, operational readiness, including specialized operator training and required site safety programs, engineering or design problems or any remediation related thereto, design and other licensing-based compliance matters, challenges with start-up activities, including major equipment failure, or system integration, and/or operational performance, continued challenges related to the COVID-19 pandemic or future pandemic health events, continued public and policymaker support for projects, environmental and geological conditions, delays or increased costs to interconnect facilities to transmission grids, and increased financing costs as a result of changes in market interest rates or as a result of project delays; the ability to overcome or mitigate the current challenges, or challenges yet to be identified, at Plant Vogtle Unit 4, that could further impact the cost and schedule for the project; legal proceedings and regulatory approvals and actions related to construction projects, such as Plant Vogtle Unit 4, including Georgia Public Service Commission approvals and U.S. Nuclear Regulatory Commission ("NRC") actions; under certain specified circumstances, a decision by holders of more than 10% of the ownership interests of Plant Vogtle Unit 3 and 4 not to proceed with construction; the notices of tender by Oglethorpe Power Corporation and the City of Dalton of a portion of their ownership interests in Plant Vogtle Units 3 and 4 to Georgia Power, including related litigation; the ability to construct facilities in accordance with the requirements of permits and licenses (including satisfaction of NRC requirements), to satisfy any environmental performance standards and the requirements of tax credits and other incentives, and to integrate facilities into the Southern Company system upon completion of construction; the inherent risks involved in operating and constructing nuclear generating facilities; the ability of counterparties of Georgia Power to make payments as and when due and to perform as required; the direct or indirect effect on Georgia Power's business resulting from cyber intrusion or physical attack and the threat of cyber and physical attacks; catastrophic events such as fires, earthquakes, explosions, floods, tornadoes, hurricanes and other storms, droughts, pandemic health events, political unrest, wars or other similar occurrences; the potential effects of the continued COVID-19 pandemic; and the direct or indirect effects on Georgia Power's business resulting from incidents affecting the U.S. electric grid or operation of generating or storage resources. Georgia Power expressly disclaim any obligation to update any forward–looking information.
View original content to download multimedia:
SOURCE Georgia Power | https://www.mysuncoast.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ | 2023-07-31T11:56:19 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ |
Forester Wilderness Ad Showcases 'A Beautiful Silence' and Partnership with the National Park Foundation
CAMDEN, N.J., July 31, 2023 /PRNewswire/ -- Subaru of America, Inc. today unveiled a new creative spot focused on the automaker's efforts to expand access to the outdoors for all. Featuring the all-new 2023 Subaru Forester Wilderness, the advertisement stars Keivonn Woodard, the Emmy-nominated, 10-year-old Deaf actor and showcases the automaker's long-standing partnership with the National Park Foundation.
In the creative, titled "A Beautiful Silence," a father and his young son, who is Deaf, drive through Yosemite National Park, with the wonders of the park's beauty surrounding them. Featuring audio elements and American Sign Language (ASL), the spot shows how the pair experience the park's natural wonders in different ways, but share the special feeling that nature brings forth.
"The outdoors are for everyone, and whether it's a trip to a national park or a walk in the woods, we believe everyone should have the opportunity to experience its beauty," said Alan Bethke, Senior Vice President, Marketing, Subaru of America, Inc. "Through our partnership with the National Park Foundation and our commitment to making safe and capable vehicles like the Forester Wilderness, we're hoping that even more people will be inspired to explore the wonders of nature, just like the father and son in our new creative."
Through the National Park Foundation's Outdoor Exploration initiative and ParkVentures program, Subaru is helping more people create life-long relationships with the outdoors. The campaign seeks to make the outdoors more accessible to communities that have been historically excluded from parks, either through a community's physical presence on public lands or through the narrative of who belongs outdoors.
Last year, with support from Subaru, ParkVentures supported the efforts of more than 55 organizations to connect more people, including those with differing abilities, to meaningful experiences in United States national parks. Subaru also developed a direct relationship with ParkVentures grantee Black People Who Hike, which aims to help address the lack of representation in parks by empowering, educating and engaging Black people in the outdoors. Subaru provided the vehicles, gear, and experiences for an enhanced retreat in Acadia National Park to help create safe, welcoming spaces and cultivate lasting relationships with the outdoors.
Subaru is the largest corporate donor to the National Park Foundation and has provided over $70 million to organizations working to conserve national parks. To learn more about the automaker's partnership with National Park Foundation and over 20 years of environmentally focused initiatives, please visit Subaru.com/earth.
The new Subaru Forester Wilderness spot, created in collaboration with agency partner Carmichael Lynch, celebrates the automaker's devotion to adventure and environmental stewardship. Beginning today, "A Beautiful Silence" will run in 30-second format on national television and be featured in 15-second format in targeted digital and social media promotions throughout August, while a 60-second version will be available on YouTube.
About Subaru of America, Inc.
Subaru of America, Inc. (SOA) is a wholly owned subsidiary of Subaru Corporation of Japan. Headquartered at a zero-landfill office in Camden, N.J., the company markets and distributes Subaru vehicles, parts and accessories through a network of more than 630 retailers across the United States. All Subaru products are manufactured in zero-landfill plants and Subaru of Indiana Automotive, Inc. is the only U.S. automobile manufacturing plant to be designated a backyard wildlife habitat by the National Wildlife Federation. SOA is guided by the Subaru Love Promise, which is the company's vision to show love and respect to everyone, and to support its communities and customers nationwide. Over the past 20 years, SOA and the SOA Foundation have donated more than $300 million to causes the Subaru family cares about, and its employees have logged nearly 88,000 volunteer hours. As a company, Subaru believes it is important to do its part in making a positive impact in the world because it is the right thing to do. For additional information visit media.subaru.com. Follow us on Facebook, Twitter, and Instagram.
Media Contacts:
Diane Anton
Corporate Communications Manager
(856) 488-5093
danton@subaru.com
Adam Leiter
Corporate Communications Specialist
(856) 488-8668
aleiter@subaru.com
View original content to download multimedia:
SOURCE Subaru of America, Inc. | https://www.kold.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ | 2023-07-31T11:56:26 | 1 | https://www.kold.com/prnewswire/2023/07/31/new-subaru-creative-celebrates-access-outdoors-all/ |
- Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 39.5% - Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 27.9% - Net Profit Attributable to Owners of the Company for the First Half Increased 14.6% to RMB 5,313 Million
- Diluted Earnings per Share (EPS) for the First Half Increased 20.9% to RMB1.79
- Adjusted Non-IFRS Net Profit Attributable to Owners of the Company for the First Half Increased 18.5% to RMB5,095 Million
- Adjusted Non-IFRS Diluted EPS for the First Half Increased 18.5% to RMB1.73[1]
- Free Cash Flow Achieved RMB2,926 Million for the First Half, Turned Positive and Grew Strongly
SHANGHAI, July 31, 2023 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the first half ending June 30, 2023 ("Reporting Period").
This release provides a summary of the results and is not intended to be a comprehensive report. For additional information, please refer to the 2023 Interim Report and other relevant announcements published on the websites of the Shanghai Stock Exchange (www.sse.com.cn) and the Stock Exchange of Hong Kong (www.hkexnews.hk), and the designated media for dissemination of the relevant information. Investors are advised to exercise caution and be aware of the investment risks in trading Company shares.
All financial information disclosed in this press release is prepared based on International Financial Reporting Standards (IFRS), in currency of RMB.
The 2023 Interim Report of the Company has not been audited.
Second Quarter 2023 Financial Highlights
Revenue grew 6.7% year-over-year to RMB9,908 million, excluding COVID-19 commercial projects, revenue grew strongly by 39.5%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 2.6% year-over-year to RMB7,034 million, excluding COVID-19 commercial projects, revenue grew strongly by 51.6%. Adjusted non-IFRS gross profit grew 12.9% year-over-year to RMB3,216 million, with a gross profit margin of 45.7%.
- WuXi Testing revenue grew 23.6% year-over-year to RMB1,638 million and adjusted non-IFRS gross profit grew 36.2% year-over-year to RMB640 million, with a gross profit margin of 39.1%.
- WuXi Biology revenue grew 17.5% year-over-year to RMB656 million and adjusted non-IFRS gross profit grew 21.3% year-over-year to RMB 271 million, with a gross profit margin of 41.4%.
- WuXi ATU revenue grew 22.9% year-over-year to RMB389 million and adjusted non-IFRS gross profit was RMB(16) million, with a gross profit margin of (4.2)%
- WuXi DDSU revenue declined 17.9% year-over-year to RMB176 million and adjusted non-IFRS gross profit grew year-over-year 5.2% to RMB63 million, with a gross profit margin of 35.8%. Meanwhile, we received the first royalty income from customers in the second quarter, which is a breakthrough for DDSU.
Unit: RMB million
- IFRS gross profit increased 18.1% year-over-year to RMB4,030 million. Gross profit margin was 40.7%[2]
- Adjusted non-IFRS gross profit increased 16.4% year-over-year to RM4,177 million. Adjusted non-IFRS gross margin was 42.2%.
- Net profit attributable to owners of the Company increased 5.1% year-over-year to RMB3,145 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 22.4% year-over-year to RMB2,753 million.
First-Half 2023 Financial Highlights
Revenue grew 6.3% year-over-year to RMB18,871 million, excluding COVID-19 commercial projects, revenue grew strongly by 27.9%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 3.8% year-over-year to RMB13,467 million, excluding COVID-19 commercial projects, revenue grew strongly by 36.1%. Adjusted non-IFRS gross profit grew 14.9% year-over-year to RMB6,103 million, with a gross profit margin of 45.3%.
- WuXi Testing revenue grew 18.7% year-over-year to RMB3,091 million and adjusted non-IFRS gross profit grew 26.1% year-over-year to RMB1,168 million, with a gross profit margin of 37.8%.
- WuXi Biology revenue grew 13.0% year-over-year to RMB1,233 million and adjusted non-IFRS gross profit grew 15.1% year-over-year to RMB511 million, with a gross profit margin of 41.5%.
- WuXi ATU revenue grew 16.0% year-over-year to RMB714 million and adjusted non-IFRS gross profit was RMB(40) million, with a gross profit margin of (5.7)%.
- WuXi DDSU revenue declined 24.9% year-over-year to RMB342 million and adjusted non-IFRS gross profit declined 26.2% year-over-year to RMB103 million, with a gross profit margin of 30.1%. Meanwhile, DDSU achieved a breakthrough in receiving the first royalty income from customers.
Unit: RMB million
- IFRS gross profit increased 17.6% year-over-year to RMB7,556 million. Gross profit margin was 40.0%[3].
- Adjusted non-IFRS gross profit increased 15.7% year-over-year to RMB7,855 million. Adjusted non-IFRS gross margin was 41.6%.
- Net profit attributable to owners of the Company increased 14.6% year-over-year to RMB 5,313 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year to RMB5,095 million.
- Diluted EPS increased 20.9% year-over-year to RMB1.79, while adjusted diluted non-IFRS EPS increased by 18.5% year-over-year to RMB1.73.
- Free cash flow achieved RMB2,926 million, turned positive and grew strongly year-over-year.
First-Half 2023 Business Operation Highlights
- As an industry innovation enabler, we grow together with our customers. In the first half of 2023, we added over 600 new customers, and in total we served more than 6,000 active customers over the past 12 months. Backlog grew 25% year-over-year excluding COVID-19 commercial projects. We continued to optimize our cross-platform synergies to better serve our customers worldwide, strengthen our unique competitive advantage as a fully integrated Contract Research, Development and Manufacturing Organization (CRDMO) and Contract Testing, Development and Manufacturing Organization (CTDMO) platform, and provide one-stop services for our customers from discovery to development and manufacturing. The diversified revenue streams from customers across regions ensure the stability and resilience of the Company's financial performance.
- WuXi Chemistry: Integrated CRDMO Business Model Drives Steady Growth, with Continued Expansion in New Modalities (WuXi TIDES)
- In the past 12 months, we successfully synthesized and delivered more than 420,000 new compounds to customers, which grew 20% year-over-year. Through our chemistry drug discovery services, we enabled our customers to accelerate their research while generating opportunities for our downstream business units. In the past 12 months, 120 molecules have transitioned from R to D&M, representing a year-on-year growth of 21%. Through our "follow-the-customer" and "follow-the-molecule" strategies, we established trusted partnerships with our global customers, supporting the sustainable growth of our CRDMO business.
- We continued executing our "long-tail" strategy. Demand from "long-tail" customers in discovery services of small molecule and new modalities continued to grow, with the number of new customers growing 17% year-over-year.
- In the first half of 2023, D&M services revenue grew 2.1% year-over-year to RMB9.67 billion. Excluding COVID-19 commercial projects, D&M services revenue grew strongly by 54.5%.
- In the first half of 2023, we added 583 molecules to our D&M pipeline. To date, our D&M pipeline consists of 2,819 molecules, including 56 commercial projects, 59 in phase III, 301 in phase II and 2,403 in phase I and pre-clinical stages, among which, 8 commercial and phase III projects were added in the first half of 2023.
- In the first half of 2023, TIDES revenue grew 37.9% year-over-year to RMB1.33 billion. As of June 30, 2023, backlog of TIDES grew strongly by 188% year-over-year. We expect revenue growth from TIDES business to exceed 70% in 2023.
- The number of TIDES D&M customers increased 25% year-over-year to 121, and the number of TIDES molecules increased 46% year-over-year to 207.
- WuXi Testing: Lab Testing Services Drive Steady Growth, Clinical Business Fully Recovered
- The Company provides a full range of laboratory testing services for our customers, including drug metabolism and pharmacokinetics (DMPK), toxicology, and bioanalysis for drug development testing, as well as medical device testing. We provide customers with high-quality services, realize "one report for global submission," and enable customers to save time, reduce costs and increase efficiency.
- H1 2023 revenue from drug safety evaluation services grew 24% year-over-year. We maintained our industry leadership position in Asia Pacific for drug safety evaluation services that meet global regulatory requirements. In the first half of 2023, new lab testing facilities in Qidong and Suzhou began operations as scheduled, ensuring the business growth to accelerate in the second half of 2023.
- Moreover, we continued to enhance capabilities related to new modalities, with comprehensive coverage such as target protein degradation, nucleic acids, conjugates, and cell and gene therapies (CGT), etc.
- SMO revenue grew strongly by 53.9% in Q2 2023 and 34.3% in H1 2023, maintaining a leadership position in China. In the first half of 2023, SMO supported 25 new drug approvals for customers.
- In the first half of 2023, clinical CRO enabled our customers to obtain 8 IND approvals and submit 3 NDA filings.
- WuXi Biology: Strong Contribution from New Modalities; Early Discovery Screening Platform Continued to Generate Downstream Opportunities
- WuXi ATU: CTDMO Business Model Drives Growth
- WuXi DDSU: the First Year to Receive New Drug Application (NDA) Approval of New Drugs Developed for Customers; Breakthrough to Receive the First Royalty Income
Our Commitment to ESG
As an industry innovation enabler, a trusted partner and a contributor to the global healthcare industry, the Company is committed to environmental protection and sustainability, and to being a good global corporate citizenship.
Our outstanding ESG performance has been recognized by major global ESG rating agencies, including MSCI, S&P Global, Sustainalytics, CDP and EcoVadis. In June 2023, we received the fourth "Silver" medal recognition from EcoVadis for our Couvet site in Switzerland.
By the first half of 2023, our carbon emission intensity, energy consumption intensity and water use intensity reduced by 20.1%, 18.4%, and 31.6%, respectively, as compared to the baseline year 2020.
As we continue to advance our sustainability strategy, we embrace our shared responsibility to be good stewards of the environment.
Management Comment
Dr. Ge Li, Chairman and CEO of WuXi AppTec, said, "We continued to achieve steady growth of revenue, net profit, and free cash flow in the first half of 2023. Our revenue increased 6.3% year-over-year to RMB18.87 billion, or 27.9% if excluding COVID-19 commercial projects. Our adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year, outpacing the revenue growth rate, and our free cash flow achieved RMB2.93 billion, as a result of the Company's pursuit of operational excellence and productivity."
"The Company's performance in the first half of 2023 demonstrated that WuXi AppTec's unique CRDMO and CTDMO business models can effectively meet the growing demands from customers worldwide and continue to drive solid growth for the Company. In 2023, we aim to deliver a 5-7% revenue growth, increase adjusted non-IFRS gross profit by 13-14%, and expand free cash flow by 750-850%. We remain committed to prioritizing our customers' needs and enhancing our capacity and capabilities as we support our customers' efforts to bring groundbreaking therapies to patients around the world. Together, we can realize our vision that 'every drug can be made and every disease can be treated'."
About WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com
Forward-Looking Statements
This press release may contain certain "forward-looking statements" which are not historical facts, but instead are predictions about future events based on our beliefs as well as assumptions made by and information currently available to our management. Although we believe that our predictions are reasonable, future events are inherently uncertain and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks relating to, among other things, the ability of our service offerings to compete effectively, our ability to meet timelines for the expansion of our service offerings, our ability to protect our customers' intellectual property, unforeseeable international tension, competition, the impact of emergencies and other force majeure. Our forward-looking statements in this press release speak only as of the date on which they are made, and we assume no obligation to update any forward-looking statements except as required by applicable law or listing rules. Accordingly, you are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section. All information provided in this press release is as of the date of this press release and are based on assumptions that we believe to be reasonable as of this date, and we do not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Use of Non-IFRS and Adjusted Non-IFRS Financial Measures
We provide non-IFRS gross profit and non-IFRS net profit attributable to owners of the Company, which exclude share-based compensation expenses, issuance expenses of convertible bonds, fair value gain or loss from derivative component of convertible bonds, foreign exchange-related gains or losses, amortization of intangible assets acquired in business combinations, non-financial assets impairment, etc. We also provide adjusted non-IFRS net profit attributable to owners of the Company and earnings per share, which further exclude realized and unrealized gains or losses from our venture capital investments and joint ventures. Neither is required by, or presented in accordance with IFRS.
We believe that the adjusted financial measures used in this press release are useful for understanding and assessing our core business performance and operating trends, and we believe that management and investors may benefit from referring to these adjusted financial measures in assessing our financial performance by eliminating the impact of certain unusual, non-recurring, non-cash and non-operating items that we do not consider indicative of the performance of our core business. Such adjusted non-IFRS net profit attributable to owners of the Company, the management of the Company believes, is widely accepted and adopted in the industry the Company is operating in. However, the presentation of these adjusted non-IFRS financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies.
For more information, please contact:
Ms. Ruijia Tang (for investors)
IR Director
Email: tang_ruijia@wuxiapptec.com
Mr. Davy Wu (for media)
PR Director
Email: davy_wu@wuxiapptec.com
View original content:
SOURCE WuXi AppTec | https://www.mysuncoast.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ | 2023-07-31T11:56:26 | 0 | https://www.mysuncoast.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ |
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR
The tech giant made the line of sneakers as a one-time gift for its employees in the '90s. A size 10.5 pair has found its way onto the Sotheby's website, where it's on sale for $50,000.
Copyright 2023 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play. | https://www.ctpublic.org/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction | 2023-07-31T11:56:32 | 0 | https://www.ctpublic.org/2023-07-31/a-pair-of-white-sneakers-made-specifically-for-apple-employees-is-up-for-auction |
Introducing the industry's first-ever utility side-by-side with a 1500cc 3-cylinder engine for more power to make tough jobs easier and the industry's only STEELDRIVE transmission for greater durability
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- Polaris Off Road, the global leader in powersports and off-road innovation, is once again breaking new ground with the industry's first extreme duty utility side-by-side: the all-new RANGER XD 1500. With its unprecedented capability, brute strength and unmatched comfort, the new extreme duty class of RANGER side-by-sides are engineered with the first-ever ProStar 1500cc 3-cylinder engine that offers an industry-leading 110 horsepower, the industry-exclusive STEELDRIVE automatic transmission for greater durability and precise control, and over 70 new accessories for enhanced customization, highlighted by Polaris' exclusive Lock & Ride MAX system. The RANGER XD 1500 establishes a new benchmark for utility side-by-sides.
"We spent over five years meeting with farmers, ranchers, large acreage property owners and big game hunters to develop an extreme duty vehicle that was missing from the market. From its ProStar 1500cc engine to the industry's only STEELDRIVE transmission, RANGER XD 1500 is unlike anything else offered today and is yet another example of our relentless commitment to advancing the industry with fresh thinking and innovative solutions that meet the real-world needs of our utility customers," said Steve Menneto, President of Polaris Off Road.
"Polaris RANGER has been the No. 1 selling utility side-by-side brand for more than 15 years and with the introduction of RANGER Extreme Duty, we've taken the industry's hardest-working lineup and expanded it," said Chris Judson, Vice President of Off Road Utility. "A segment of our utility customers said they are facing exceptionally large tasks and they simply need a machine with more power, more torque, more hauling and towing capacity, and more durability. And our team set out to deliver just that, incorporating dozens of new features and the latest engineering to make the RANGER XD 1500 more capable, stronger, and more comfortable than any other utility side-by-side out there."
Unprecedented Capability
Farmers, ranchers, and large landowners routinely haul and tow heavy loads around the property, and they've been asking for a solution when it comes to their heaviest tasks. The RANGER XD 1500 delivers unprecedented capability for hard-working customers to haul more, tow more, and get more done in less time. With the industry's only 1500cc utility engine, the RANGER XD 1500 provides over 30% more power and over 50% more torque than the next closest competitor.
- ProStar 1500cc 3-Cylinder Engine – Effortless towing, hauling, and confidence in tough terrain with an industry-leading 110HP and 105 lb-ft torque.
- 1,500 lb Cargo Box Capacity – Three-quarter ton box capacity providing nearly 50% more box volume than existing models for maximum productivity with fewer trips and bigger loads.
- 3,500 lb Towing Capacity – For those routinely towing heavy loads on the property, drive better productivity with nearly 40% more towing than existing models.
- Industry-leading Ground Clearance – All RANGER XD 1500 models get 15" of ground clearance with high-clearance arched A-arms to overcome large obstacles.
Brute Strength
Utility customers asked for a more durable, longer lasting offering to maximize their uptime and drive efficiency. Designed to last longer than any model before it, RANGER XD 1500 is the industry's most durable utility side-by-side and has been engineered from the ground up to be stronger and stand up to the demands of the longest days.
- Industry-exclusive STEELDRIVE transmission – Offers a 100 percent steel constructed belt that delivers smooth, precise operation and a fully sealed, liquid-cooled design for unmatched durability.
- High-Strength Steel Heavy Duty Frame – RANGER XD 1500 has a high-strength steel one-piece chassis featuring 160 percent more torsional stiffness for a smoother ride and better cab sealing.
- Industry-leading Service Intervals – RANGER XD 1500 offers the industry's longest service intervals so customers can maximize their uptime.
Unmatched Comfort
- From the farm to remote backcountry, utility customers work from before the sun rises to after it sets, and need something that delivers all-day comfort. Beyond industry-leading capability and durability, the RANGER XD 1500 prioritizes comfort across the entire lineup to keep customers going strong on the longest days.
- Most Spacious Interior – Equipped with the most spacious and premium cab available in utility side-by-sides, the XD 1500 offers increased leg and shoulder room, making it easy to enter and exit the vehicle. Adjustable seating and a telescopic steering wheel lets drivers find the perfect fit for height and riding preferences.
- Premium Seating – Contoured seating with added bolstering provides more rider comfort along with a center seat that flips down into an armrest with additional cup holders.
- Available Heated Seats – For comfort on the coldest days, RANGER XD 1500 NorthStar Ultimate is the first utility side-by-side that comes from the factory with heated seats.
- Drive Modes – RANGER XD 1500 comes with an intuitive and easy-to-use rotary drive mode selector that lets customers choose from four different drive modes, including:
- Heating and Air Conditioning (HVAC) – Riders can stay comfortable in harsh weather conditions in the RANGER XD 1500 NorthStar Edition, featuring an all-new HVAC system and a fully-enclosed, next generation ProShield cab that's been redesigned with improved sealing to prevent dust and water intrusion, while locking in the temperature from the climate-controlled cab.
- Sun Visors – All-new integrated sun visors provide improved visibility throughout the day for added confidence while driving.
- RIDE COMMAND – Available 7" waterproof touchscreen display powered by RIDE COMMAND technology featuring a back-up camera, GPS navigation regardless of cell service, and AM/FM radio with Bluetooth® streaming capability.
- RIDE COMMAND+ – Customers can keep tabs on their vehicle directly from the Polaris App and access critical vehicle information like vehicle location, maintenance reminders, and issue diagnostics right from the palm of their hand with the industry's only connected-vehicle technology. Available from the factory on NorthStar Ultimate.
Customization
Customers have been asking for increased versatility, durability, and ease of use for the different work applications they face throughout the day. With over 70 new Polaris Engineered Accessory options designed specifically for the RANGER XD 1500, plus options from partners brands including JBL®, Rhino Rack®, Pro Armor, Kolpin, and HD Parts, customers have more opportunity than ever before to make their vehicle fit their specific needs.
- Lock & Ride MAX – Polaris' easiest to use, most versatile, and confident accessory attachment platform ever. With customizable configurations and the ability to reconfigure on the fly with no tools required, this new accessory platform allows users to prepare for their day, their way. Customers can simply choose and place their accessory, lock it in place, and ride confidently knowing their gear is secure.
- New JBL® Audio – Polaris partnered with JBL® to create the highest performing audio system ever included in a RANGER from the factory. For customers wanting to turn it up a notch, the JBL® Trail Pro 4200 audio upgrade adds rear speakers and two subwoofers for an immersive audio experience.
- Glacier Pro HD Plow – New 84" plow designed for faster, more efficient plowing during the winter months. A hydraulic plow lift and angle kit can be paired with an all-new plow controller to manage the largest plow Polaris has ever offered, all without ever leaving the comfort of the cab.
2024 RANGER XD 1500 Premium: Starting at US $29,999 / CAN $36,199
The RANGER XD 1500 Premium commands a large presence thanks to heavy-duty components and the industry's largest bumper, providing complete front-end protection. The vehicle comes equipped with one of the most comprehensive standard packages in a side-by-side to date including 29" tires, tilt steering and seat slider for customizable comfort, four drive modes, high output LED headlights for enhanced visibility, and USB ports with multiple charging capabilities. The vehicle also comes equipped with boosted brakes and heavy-duty suspension to ensure performance across a variety of off-road environments.
2024 RANGER XD 1500 NorthStar Premium: Starting at US $39,999 / CAN $48,799
The next step up is the RANGER XD 1500 NorthStar Premium. This machine features a fully enclosed cab with HVAC temperature and five different mode controls, lockable full doors with power windows and a fixed front glass windshield. Additional features include an electronically controlled power tilt bed to dump heavy loads with ease, an overhead switch panel for easy accessorization, and an overhead rear work light to illuminate the cargo box in low-light conditions. NorthStar Premium comes stock with 30" Kenda® CrossTrail tires and available 32" tires to overcome large obstacles and tough terrain.
2024 RANGER XD 1500 NorthStar Ultimate: Starting at US $44,999 / CAN $54,499
Rounding out the lineup is the RANGER XD 1500 NorthStar Ultimate, which features everything from the NorthStar Premium trim, plus the 7" infotainment display powered by RIDE COMMAND and heated seats. The NorthStar Ultimate trim also delivers an immersive sound experience, featuring full AM/FM radio with Bluetooth® streaming capability and industry-exclusive JBL® speakers for precise audio and premium sound. Finally, the vehicle comes standard with RIDE COMMAND+, allowing for vehicle health monitoring and more.
The 2024 RANGER XD 1500 lineup is expected to begin shipping to dealers in late summer. To learn more about the 2024 RANGER family, please visit https://ranger.polaris.com/en-us/ or join the conversation and follow on Facebooksm, Instagramsm, YouTubesm and Twittersm.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
Warning: vehicle rollaway can cause serious injury or death. This vehicle can roll whenever the gear selector is not in the park position. Always shift to park when stopping the engine or leaving the vehicle. When leaving the vehicle on an incline is unavoidable, use extra care. If leaving the vehicle unattended, block the rear wheels on the downhill side and keep children, pets, and others away form the gear selector. Notice: Vehicle payload and trailer weight will affect the angle of hill on which the vehicle will hold.
Kenda® is a registered trademark of Kenda Rubber Industrial Co, Ltd.
Bluetooth® is a registered trademark of Bluetooth Sig, Inc.
JBL® is a registered trademark of Harman International Industries, Incorporated
Rhino-Rack® is a registered trademark of Rhino Rack Australia Pty Limited
Unless noted, trademarks are the property of Polaris Industries Inc.
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.kold.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ | 2023-07-31T11:56:32 | 0 | https://www.kold.com/prnewswire/2023/07/31/polaris-expands-its-ranger-lineup-with-all-new-ranger-xd-1500-an-entirely-new-class-extreme-duty-utility-side-by-sides/ |
GUANGZHOU, China, July 31, 2023 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it has published its 2022 Environmental, Social and Governance ("ESG") report, outlining the Company's progress and performance in key ESG areas.
The report provides a comprehensive review of Yatsen's ESG initiatives and developments, including corporate governance, research and development, employee rights protection, human capital development, environmental sustainability and social responsibility, among others.
To view the report in full, please visit the ESG section on the Yatsen Investor Relations website. Alternatively, please click here for the English version and here for the Chinese version of the 2022 report.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands, including Perfect Diary, Little Ondine, Abby's Choice, Galénic, DR.WU (its mainland China business), Eve Lom, Pink Bear and EANTiM. The Company's flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly, both online and offline, with an expansive presence across all major e-commerce, social and content platforms in China.
For more information, please visit http://ir.yatsenglobal.com/.
For investor and media inquiries, please contact:
In China:
Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com
The Piacente Group, Inc
Hui Fan
Tel: +86-10-6508-0677
E-mail: yatsen@thepiacentegroup.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: yatsen@thepiacentegroup.com
View original content:
SOURCE Yatsen Holding Limited | https://www.mysuncoast.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ | 2023-07-31T11:56:32 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ |
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR
NPR's Leila Fadel talks with former Trump White House attorney Ty Cobb about the federal investigation into efforts to overturn the election, and the potential legal jeopardy for the former president.
Copyright 2023 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play. | https://www.ctpublic.org/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon | 2023-07-31T11:56:38 | 0 | https://www.ctpublic.org/2023-07-31/another-indictment-against-trumps-efforts-to-undermine-democracy-could-come-soon |
Leveraging artificial intelligence, Mumbai-based IT services firm Yodaplus is catalyzing industry transformations, from nutraceuticals to retail, by streamlining business operations and boosting decision-making capabilities.
MUMBAI, India, July 31, 2023 /PRNewswire/ -- Yodaplus, a Mumbai-based IT services firm, is at the forefront of empowering organizations worldwide with advanced technological capabilities. Today, the company sheds light on the evolving global landscape of Artificial Intelligence (AI) and its growing adoption within its service portfolio.
With its wide range of services and deep industry knowledge, Yodaplus has been a game changer – enabling organizations to focus on their core operations and achieve sustainable growth. And now, by integrating AI into services, Yodaplus helps businesses navigate the complex digital transformation landscape more efficiently, creating a competitive edge.
AI continues to transform business operations globally, powering automation, analytics, decision-making, and enhancing user experiences. This ultimately delivers safer and more effective products to meet the growing global demand.
Yodaplus is known for its expansive roster of clients - from development banks and blockchain companies to EdTech startups and HRMS providers. With such a diverse clientele, embracing AI is more necessary than a choice, and Yodaplus has promptly addressed this need.
"As we navigate the digital age, the integration of AI into our service offerings has become an undeniable necessity," commented Vishrut Srivastava, MD, Yodaplus. "AI is here to stay, poised to make our lives more efficient and free mankind from the burden of mundane tasks. At Yodaplus, we are committed to embracing AI to drive growth and innovation for our clients while we continue to explore new horizons in this transformative technological landscape."
In line with this commitment, Yodaplus has developed an AI engine transforming the global nutraceutical supply chain. Addressing the complexities of generating differentiated nutraceutical label claims necessitates a well-mapped global database and the application of AI. To solve this problem, Yodaplus developed an AI-driven smart labels function via the NutrifyGenie AI engine.
NutrifyGenie uses sophisticated algorithms that facilitate simplified and precise decision-making, authenticating label claim validation and enabling real-time regulatory compliance. This feature provides users with pre-made labels, including correct dosage values for nutraceutical products, significantly expediting product development.
Enabling companies to effortlessly commercialize their innovations in essential markets fulfills the continuously increasing demand for nutraceutical products. As the nutraceutical industry continues to grow, Yodaplus's AI engine will play a crucial role in accelerating the new product development process and helping businesses bring innovative and differentiated products to market faster than ever before.
Not just that, the company has also recently deployed advanced invoice parsing for a retail giant. This smart solution facilitates operations by accurately extracting and collating relevant information from invoices, thus automating a previously laborious task. Furthermore, Yodaplus uses sophisticated AI tools to assist an asset management client in conducting comprehensive financial records analysis, rendering them outstanding financial decision-making capabilities.
About Yodaplus
An ever-evolving, highly specialized technology solutions company, Yodaplus offers an array of services designed to address the unique needs of businesses globally, extending beyond its Mumbai base to the US, UK, UAE, and Singapore. The company's mission, steered by MD Vishrut Srivastava, is dedicated to providing top-tier IT services and aims to propel businesses toward unprecedented growth and success. With this commitment, Yodaplus becomes your duly trusted tech partner.
For more information about Yodaplus, please visit www.yodaplus.com.
Press Contact:
Amit Pareek
Senior Marketing Manager
amitp@yodaplus.com
Photo: https://mma.prnewswire.com/media/2163861/Vishrut_Srivatava_MD_Yodaplus.jpg
Logo: https://mma.prnewswire.com/media/2144978/4185052/Yodaplus_Logo.jpg
View original content:
SOURCE Yodaplus Technologies | https://www.mysuncoast.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ | 2023-07-31T11:56:39 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ |
Highlights Include the Return of Polaris Sportsman 570 and XP 1000 Hunt Editions, Along with a Host of
Aesthetic and Performance Upgrades Across the Lineup
MINNEAPOLIS, July 31, 2023 /PRNewswire/ -- On the heels of debuting its innovative Polaris XPEDITION and the all new Extreme Duty RANGER XD 1500, Polaris Off Road today unveiled updates for 2024 to the off-road industry's most expansive lineup. The 2024 lineup features a host of rider-inspired updates and refreshed styling and new colors. Additionally, the customer-favorite Polaris Sportsman 570 and XP 1000 Hunt editions make a return, and a Premium trim offering is now available on the 2024 GENERAL 1000 to provide customers with an upgrade in style and performance. RIDE COMMAND+ also received enhanced features for 2024, delivering unmatched connectivity and peace of mind to riders through all-new Location Bump Alerts and Check-In Messages.
"From the completely redesigned 2024 RZR XP and the industry's first "adventure side-by-side" Polaris XPEDITION, to our introduction of the all-new RANGER XD 1500, this year has been a powerful showcase of our ongoing commitment to lead the industry and innovate for our riders," said Steve Menneto, President of Polaris Off Road. "While those revolutionary product debuts are pivotal, our unwavering focus on refining and enhancing our current offerings based on customer needs and feedback remains essential, and that's what the 2024 updates represent."
From fresh new styles and colorways, to improved trim levels that appeal to a wide variety of riders, the Polaris Off Road 2024 model year lineup and RIDE COMMAND+ technology enhancements include the following:
RIDE COMMAND+:
Making its debut last fall, RIDE COMMAND+, the industry's first connected-vehicle technology, continues to roll out new enhancements to its service for 2024. With new features like Location Alerts, that will notify the owner if its vehicle has been bumped or moved from its last location, owners can now protect their vehicle more than ever before. RIDE COMMAND+ is now available as a factory option for 2024 RZR Pro R Ultimate, RANGER XD 1500 NorthStar, RANGER XP 1000 NorthStar, Polaris XPEDITION NorthStar and Sportsman XP 1000 RIDE COMMAND Edition. This service is also available on most 2024 RZR, RANGER, Sportsman and Polaris XPEDITION models as an accessory install.
Sportsman
Polaris Sportsman, the long-standing No. 1 selling automatic 4x4 ATV, is reintroducing the Sportsman 570 and XP 1000 Hunt Editions, while also implementing key improvements across the core 2024 lineup. A customer favorite, specifically designed to meet the unique needs of hunters, the Sportsman 570 and XP 1000 Hunt editions include accessories such as the 3,500 lb Polaris Winch, Kolpin Gun Scabbard & Mount, Kolpin Ratchet Claws and more.
Additionally, the 2024 Sportsman 450 and 570 lineup boasts several quality refinements for a better riding experience including a new rear brake pedal for reduced pedal effort and feel, improved sealing around the shifter, and enhanced seat fitment delivering a more comfortable ride. The 570 EPS trim and above will also include enhanced PVT clutch sealing with a higher intake location for better performance in wet conditions.
For added utility, the model year 2024 Sportsman 570 lineup will be equipped with new LED lights for the Premium and Utility HD for added visibility from dawn to dusk.
New color options also are available for the 570 Premium and Trail, 570 Ride Command Edition, Sportsman 850 Premium and Ultimate Trail, Sportsman XP 1000 Ultimate Trail, Sportsman XP 1000 High Lifter Edition, Scrambler XP 1000 S and Sportsman XP 1000 S.
The 2024 Sportsman lineup starts at $6,999 US MSRP and will begin shipping to dealers this early fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/sportsman/
GENERAL
Polaris GENERAL is the industry's most versatile crossover side-by-side, capable of tackling tough trails, while also knocking out tasks around the property. For 2024, the GENERAL 1000 receives a new Premium trim offering that provides both style and performance enhancements. Featuring 14" wheels with 27" Coronado tires, and FOX® Podium QS3® shocks that riders can adjust between soft, medium and firm based on terrain changes, the new Premium trim will deliver a smooth ride over rugged terrain, while LED headlights provide greater visibility at morning and night. These upgrades will help riders knock out more tasks and hit the trails confidently in the GENERAL 1000.
Additionally, new colorways on the GENERAL 1000 model include Ghost Gray and Volcanic Orange. The Premium and Ultimate trim levels for the GENERAL XP will feature new colors and graphics in Matte Silver Quartz and Polaris Blue.
The 2024 GENERAL lineup starts at $17,499 US MSRP and will begin shipping to dealers this summer. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/general/
RZR
Polaris RZR, the No. 1 sport side-by-side brand, receives fresh new colors and graphics across its lineup, helping riders make a bold statement when hitting the trails. The 2024 RZR Trail and RZR Trail S are now available in Storm Blue on the Sport trim and two-tone Storm Blue with White Lightning on the Ultimate. Both Sport and Ultimate trim levels now receive the same upgraded steering wheel offered in the fully-redesigned 2024 RZR XP that provides a sportier feel while driving on trails. New for 2024, the RZR Trail and Trail S Sport level feature electric power steering and LED headlights standard, providing riders easier steering input on tight trail corners and enhanced visibility. Additionally for 2024, the RZR Trail S Ultimate trim now features Walker Evans Racing® shocks, while the Sport trim moved to ZF Sachs shocks, both offering riders plush suspension performance against the rugged terrain.
For 2024, the RZR Pro XP Sport and Premium models feature Walker Evans Racing® shocks, while the Ultimate will continue to be equipped with FOX® Live Valve shocks with DYNAMIX active suspension. Both the Premium and Ultimate trim received a refresh with new graphics on the Super Graphite colorway.
Lastly and by consumer demand, the Wide Open lineup of RZR Pro R and RZR Turbo R receives refreshed color options for 2024. For the first time since launching, the RZR Pro R Ultimate is available in an all-new Matte Onyx Black with Lifted Lime accents or Matte Heavy Metal, while the Premium trim level is offered in Matte Heavy Metal. The 2024 RZR Turbo R also welcomes vibrant new colors like Velocity Blue with Green Burst accents and Military Tan with Orange Burst accents.
The 2024 RZR lineup starts at $15,999 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/rzr/
RANGER
In addition to the newly launched Extreme Duty RANGER XD 1500, the Polaris RANGER lineup receives a variety of rider-inspired upgrades and quality refinements for 2024. RANGER SP 570 gets new color options, while the NorthStar Edition gets exclusive tailgate badging and new 25" 8-ply Pro Armor X-Terrain tires for added durability and enhanced puncture resistance.
Additionally, Polaris expands the color options for the RANGER 1000 Premium which will now be offered in the sleek Granite Grey color and graphics, while the XP 1000 will be featured in two new options: Desert Sand and Super Graphite with orange burst accents. Furthermore, the RANGER XP 1000 NorthStar Ultimate model boasts connectivity features such as vehicle health, issue diagnostics, and maintenance reminders enabled by RIDE COMMAND+.
The 2024 RANGER lineup starts at $11,699 US MSRP and will begin shipping to dealers this fall. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/ranger/
Youth
Dedicated to inspiring the next generation of riders, Polaris Off Road delivers the industry's largest and most varied lineup of youth offerings. For 2024, the Polaris ORV Youth lineup receives a refresh with eye-catching new colors and graphics. This lineup continues to provide industry-leading safety features that give parents peace of mind and help instill confidence in growing riders, including pin code start, adjustable speed limiter, geofencing, helmet aware technology and industry-exclusive safety gear kit.
Specifically, the 2024 RZR 200 EFI is now offered in Storm Gray and a new graphic pattern with bright red accents. The Outlaw 70 EFI ATV is offered in Velocity Blue with either Lifted Lime or Fierce Fuchsia accents, while the Outlaw 110 EFI is now offered in both Bright White with Polaris Blue and Bright White with Radiant Green details.
The 2024 Polaris Youth lineup starts at $2,999 US MSRP and will begin shipping to dealers this winter. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/shop-by-use/youth/
Polaris XPEDITION
The Polaris XPEDITION, which recently launched in May 2023, is the first-of-its-kind adventure side-by-side, combining the all-terrain capabilities of traditional side-by-sides with comfort and cargo capabilities typically associated with overlanding at the highest level. With a host of standard features and optional configurations to accommodate the greatest range of outdoor pursuits and enable consumers to keep chasing the wild, the 2024 Polaris XPEDITION XP and ADV are the most adaptable, comfortable and capable adventure machine on the market.
The 2024 Polaris XPEDITION lineup starts at $28,999 US MSRP and is currently shipping to dealers. For additional pricing on the entire model lineup, visit https://www.polaris.com/en-us/off-road/polaris-xpedition/
To learn more about the Polaris ORV 2024 lineup and to stay up to date on testing and demo opportunities, please visit https://offroad.polaris.com/en-us/ or join the conversation and follow on FacebookSM, InstagramSM, YouTubeSM and TwitterSM. Walker Evans Racing® is a registered trademark of Walker Evans Enterprises Incorporated; FOX® is a registered trademark of Fox Factory Inc.
About Polaris
As the global leader in powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. Polaris' high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; military and commercial off-road vehicles; snowmobiles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; Aixam quadricycles; Goupil electric vehicles; and pontoon and deck boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with a robust portfolio of parts, garments, and accessories. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com
View original content to download multimedia:
SOURCE Polaris Inc. | https://www.kold.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ | 2023-07-31T11:56:39 | 1 | https://www.kold.com/prnewswire/2023/07/31/polaris-off-road-stays-gas-with-2024-lineup-featuring-rider-inspired-updates-amp-refreshed-styles-its-industry-leading-range-side-by-sides-atvs/ |
The bear was spotted chilling in a Burbank jacuzzi while resting its paws on the side of the backyard spa. The California homeowners says the trespasser fled the scene as soon as the police showed up.
Copyright 2023 NPR
The bear was spotted chilling in a Burbank jacuzzi while resting its paws on the side of the backyard spa. The California homeowners says the trespasser fled the scene as soon as the police showed up.
Copyright 2023 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play. | https://www.ctpublic.org/2023-07-31/as-temperatures-climbed-into-the-90s-a-black-bear-cooled-off-in-a-jacuzzi | 2023-07-31T11:56:44 | 0 | https://www.ctpublic.org/2023-07-31/as-temperatures-climbed-into-the-90s-a-black-bear-cooled-off-in-a-jacuzzi |
Pitstick brings product, operations, and value-based care expertise to leading behavioral health provider
SARATOGA SPRINGS, N.Y., July 31, 2023 /PRNewswire/ -- aptihealth, the leading tech-driven behavioral healthcare provider built for higher acuity care, today announced that Regina Pitstick has joined the organization as Senior Vice President of aptihealth Medical Group.
Most recently, Pitstick was VP Advocacy Product & Innovation for the Employer and Individual segment at UnitedHealth Group, where she drove the company's product strategy and vision, focused on delivering a seamless, personalized patient experience. Responsible for product development initiatives, Pitstick's leadership and experience fueled successful long-range strategies, broader market penetration and deeper engagement for over 15M consumers.
"Regina brings more than twenty years of extremely relevant experience in the healthcare industry to aptihealth—including a deep skillset in digital health start-ups, product development, operations, process improvement and value-based care," said Tim Koehler, President and Chief Operating Officer of aptihealth. "Regina's patient-centered approach, insightful understanding of the health care landscape, innovate approach, and impeccable ability to execute strategic initiatives will greatly enhance our medical group. She's ideal for this critical role at aptihealth as we continue to pursue our mission of becoming the nation's preeminent provider of behavioral health services."
Pitstick joins aptihealth at a time of significant growth, having served nearly 15,000 patients for leading national and regional health plans. aptihealth expects to more than double its patients in 2023, with a majority covered by value-based care contracts.
"The value that aptihealth is providing to health plans, physicians groups, health systems and higher-acuity patients simply can't be underestimated," indicated Pitstick. "Whether it's the company's commitment to engaging new patients at any point of care, to their proprietary screening and assessment tools, to their proven ability to improve outcomes and decrease the overall cost of care, it's not hyperbole to state that aptihealth is changing the behavioral healthcare game. I'm thrilled to have the opportunity to help aptihealth continue to improve its care model, meet its strategic goals, and intelligently achieve its considerable opportunities for growth."
About aptihealth
aptihealth is improving higher acuity behavioral healthcare for populations who need it most—one patient at a time. The company's virtual-first model and proprietary screening, assessment, and treatment programs give members fast, convenient access to precise, personalized care. Headquartered in Saratoga Springs and employing over 150, aptihealth has raised over $70 million in funding from leading international private equity firms. The company's care program and data insights are driving breakthroughs in mental health understanding, treatment, outcomes, and cost reduction. Learn more at: www.aptihealth.com.
View original content to download multimedia:
SOURCE aptihealth | https://www.kold.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ | 2023-07-31T11:56:45 | 0 | https://www.kold.com/prnewswire/2023/07/31/regina-pitstick-named-senior-vp-aptihealth-medical-group/ |
The cutting-edge platform empowers B2B SaaS start-ups to reduce churn, increase upsell, and boost NRR
WILMINGTON, Del., July 31, 2023 /PRNewswire/ -- ZapScale, a new-age customer success platform, is making waves in the industry by offering an unrivalled one-day onboarding experience along with the ability to track 150 customer data points for a comprehensive 360-degree view of customer health. This ground-breaking feature sets ZapScale apart from its competitors.
The secret behind ZapScale's lightning-fast onboarding lies in its comprehensive toolkit. With a robust framework of 40 pre-built KPI-based health frameworks, 60 pre-designed playbooks to automate CS ops, and seamless native integrations with all popular tools, ZapScale empowers businesses to gain complete visibility over customer data. With deep customer health insights, ZapScale's customers have seen an improvement in retention and increase in upsell opportunities.
Manasij Ganguli, Founder and CEO of ZapScale, shares his personal motivation for creating this game-changing platform: "ZapScale was born out of my passion to empower B2B SaaS start-ups with an efficient and effective CS platform. Having faced numerous customer success challenges in my previous start-up, which I successfully sold in 2019, I realized the critical need for a solution that could streamline, optimize, and accelerate CS operations.
For small to mid-sized businesses that have limited time and resources, implementing a CS platform has historically been a daunting task, taking weeks, if not months, to set up essential elements like customer health, playbooks, and integrations. ZapScale has addressed this challenge by offering a user-friendly and efficient implementation process, eliminating waste of time and resources. Now, businesses can seamlessly focus on their customers right from day 1."
ZapScale eliminates the traditional barriers and time-consuming processes associated with implementing CS platforms using key in-built features that facilitate custom mapping, support custom fields, and require no unique key to integrate applications, ensuring a tailored yet quick integration experience.
ZapScale is swiftly gaining traction in the market, with 30+ global companies already using the customer success platform. Starting at $249 per month, with a one-month free trial, ZapScale is helping businesses significantly improve their customer success initiatives.
For more information about ZapScale and to schedule a demo, visit www.zapscale.com.
Contact:
Nikita Kalra
Marketing Head, ZapScale
nikita@zapscale.com
Logo: https://mma.prnewswire.com/media/2097823/ZS_Logo.jpg
View original content:
SOURCE ZapScale | https://www.mysuncoast.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ | 2023-07-31T11:56:45 | 1 | https://www.mysuncoast.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ |
Some experts now see beavers — nature's helpers — as their dams can mitigate the effects of drought and wildfires.
Copyright 2023 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play. | https://www.ctpublic.org/2023-07-31/how-beavers-are-helping-restore-wetlands-and-create-buffers-against-wildfires | 2023-07-31T11:56:50 | 0 | https://www.ctpublic.org/2023-07-31/how-beavers-are-helping-restore-wetlands-and-create-buffers-against-wildfires |
BEIJING, July 31, 2023 /PRNewswire/ -- SANY Group ("SANY") has announced the 2023 employee stock ownership plan (ESOP). This is the fourth consecutive year that SANY has launched the ESOP, which gives employees an opportunity to own shares in the company through the setting up of incentive funds. The 2023 ESOP has set up a fund size of around 590 million yuan (USD 82 million) with a share repurchase price planned at 16.13 yuan per share (USD 2.24). The capital will be from the incentive funds accrued following relevant provisions of the group.
SANY has always focused on improving employee benefits and adhering to the principle of "growing together, pursuing common development, and sharing achievements." By establishing a comprehensive incentive and restraining mechanism, it aims to inspire employees' enthusiasm and creativity and align the interests of shareholders, the listed company, and individuals. This encourages all parties to join efforts to boost SANY's long-term development.
SANY's annual ESOP aims to share the fruits of the group's achievements with employees. The number of employees awarded with stock ownership incentives is growing annually, and the proportion of mid-level and key position employees is increasing year by year:
- 2020: SANY awarded 8.31 million shares to 2,264 employees, 71.52 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2021: SANY awarded 7.54 million shares to 4,205 employees, 91.33 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2022: SANY awarded 20.5 million shares to 6,996 employees, 94.26 percent were employees in mid-level management, key positions, and core business (technical) positions.
- 2023: SANY is awarding 36.62 million shares to 7,131 employees, 95.69 percent were employees in mid-level management, key positions, and core business (technical) positions.
The source of shares for the 2023 ESOP is the shares that have already been repurchased by SANY's special account. It does not exceed 36.62 million shares in total and is within one percent of SANY's current total capital stock.
In the meantime, SANY Renewable Energy (SH688349) released an announcement relating to exercising of the second exercise period of the 2020 stock option incentive plan, with 16.0368 million granted options to be exercised, with a three-year restricted period. The subsidiary is committed to becoming a global leader of clean energy equipment and services, and contributing to reaching the goals of carbon peaking and carbon neutrality.
View original content to download multimedia:
SOURCE SANY Group | https://www.kold.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ | 2023-07-31T11:56:51 | 1 | https://www.kold.com/prnewswire/2023/07/31/sany-announces-2023-employee-stock-ownership-plan/ |
Elvina Kalieva 2023 Livesport Prague Open 2021 Odds
Elvina Kalieva's round of 32 match in the Livesport Prague Open 2021 will be versus Linda Noskova. Kalieva is +4000 to win this tournament at Tennis Club Sparta Praha.
Find all the latest odds for the 2023 Livesport Prague Open 2021 and place your bets with a new user bonus from BetMGM.
Kalieva at the 2023 Livesport Prague Open 2021
- Next Round: Round of 32
- Tournament Dates: July 28 - August 6
- Venue: Tennis Club Sparta Praha
- Location: Prague, Czechia
- Court Surface: Hard
Watch live sports without cable! Sign up today for a free trial to Fubo!
Kalieva's Next Match
Kalieva will meet Noskova in the round of 32 on Tuesday, August 1 at 5:00 AM ET, after getting past Tayisiya Morderger 6-2, 6-3 in the qualification final.
Kalieva is listed at +375 to win her next matchup against Noskova. Check out the latest odds for the entire field at BetMGM.
Want to bet on Kalieva? Head to BetMGM using our link for a bonus bet special offer for new players!
Kalieva Stats
- Kalieva defeated Morderger 6-2, 6-3 on Sunday in the qualifying round.
- In five tournaments over the past year, Kalieva is yet to win a title, and her overall record is 3-5.
- Kalieva has a record of 2-3 on hard courts over the last 12 months.
- In her eight matches over the past year, across all court surfaces, Kalieva has averaged 18.6 games.
- On hard courts, Kalieva has played five matches over the past 12 months, and she has totaled 20.8 games per match while winning 49.0% of games.
- Over the past year, Kalieva has been victorious in 12.5% of her return games and 28.6% of her service games.
- Kalieva has claimed 50% of her service games on hard courts and 11.1% of her return games over the past 12 months.
Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER.
© 2023 Data Skrive. All rights reserved. | https://www.mysuncoast.com/sports/betting/2023/07/28/elvina-kalieva-livesport-prague-open-2021-betting-odds/ | 2023-07-31T11:56:52 | 1 | https://www.mysuncoast.com/sports/betting/2023/07/28/elvina-kalieva-livesport-prague-open-2021-betting-odds/ |
A Libyan man who says he escaped execution by the Russian mercenary Wagner group is taking them to court in the U.S. — alleging torture and multiple human rights abuses.
Copyright 2023 NPR
A Libyan man who says he escaped execution by the Russian mercenary Wagner group is taking them to court in the U.S. — alleging torture and multiple human rights abuses.
Copyright 2023 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play. | https://www.ctpublic.org/2023-07-31/libyan-man-who-says-he-was-tortured-wants-to-hold-wagner-group-accountable | 2023-07-31T11:56:57 | 1 | https://www.ctpublic.org/2023-07-31/libyan-man-who-says-he-was-tortured-wants-to-hold-wagner-group-accountable |
The Avocados From Mexico® Chocolate Dulce De Leche Cupcake will be available at Sprinkles bakeries nationwide for one week beginning July 31
DALLAS, July 31, 2023 /PRNewswire/ -- Talk about a perfect pairing! Avocados From Mexico®, the number one selling avocado brand in the U.S., is making National Avocado Day even better by partnering with renowned dessert bakery chain Sprinkles for a delicious collaboration – a limited-edition cupcake featuring fresh Mexican avocados.
The Avocados From Mexico® Chocolate Dulce De Leche Sprinkles cupcake is a delectable banana cupcake that's studded with pecans and generously filled with a soft dulce de leche core. And to top it all off? A zesty frosting that blends rich cream cheese and chocolate made with fresh Mexican avocados for a delightful, creamy finish.
"The new Avocados From Mexico Chocolate Dulce De Leche cupcake features the highest quality and best-tasting ingredients," said Sprinkles Vice President, Culinary, Charles Craig. "By blending fresh avocado and smooth cream cheese alongside the banana and dulce de leche cupcake, we were able to elevate all the ingredients resulting in a cupcake that is out-of-this world. We can't wait for fans to try it!"
Beginning on July 31, National Avocado Day, consumers can make their week better by enjoying Avocados From Mexico in cupcake form — available at Sprinkles nationwide through August 6.
"Avocados From Mexico make everything better, and we're so proud that our avocados will get to shine in a unique way on National Avocado Day," said Kelly Burke, Director of Brand Marketing at Avocados From Mexico. "Our brand is known for bringing the good times with great tasting avocados. We are excited to partner with a beloved brand like Sprinkles to spark good times in a new way with everyone's favorite sweet treat."
"Sprinkles Cupcakes has always taken an innovative approach to classic desserts, and this new collaboration with Avocados From Mexico is no exception," said Sprinkles CMO, Michelle Wong. "Avocados From Mexico was an obvious choice for their quality and taste, and we can't wait for our guests to discover our latest cupcake, starring this beloved fruit."
To learn more about Avocados From Mexico, visit https://avocadosfrommexico.com, Facebook (facebook.com/avocadosfrommexico), Instagram (@avocadosfrommexico) or Twitter (@AvosFromMexico). #MakeItBetter #AFMxSprinkles
About Avocados From Mexico
Avocados From Mexico is a wholly-owned subsidiary of the Mexican Hass Avocado Importers Association (MHAIA), formed for the purpose of advertising, promotion, public relations and research for all stakeholders of Avocados From Mexico. Under agreements, MHAIA and the Association of Avocado Exporting Producers & Packers of Mexico (APEAM) have combined resources to fund and manage Avocados From Mexico, with the intent to provide a focused, highly- effective and efficient marketing program in the United States. Avocados From Mexico is headquartered in Irving, Texas.
About Sprinkles
Sprinkles offers premium cupcakes, cakes and cookies that are baked fresh in small batches throughout the day and handcrafted with only the finest ingredients. Sprinkles opened its first bakery in Beverly Hills in 2005, drawing long lines of loyal cupcake fans and celebrity endorsements. Sprinkles prides themselves in being passionate innovators and since debuting the world's first Cupcake ATM, the brand has introduced layer cakes, cookies and brownies, launched a national shipping platform and has grown to over 70 bakeries and ATMs coast-to-coast. Sprinkles launched domestic and international franchising in 2022. For additional information on Sprinkles, follow @sprinklescupcakes on social and visit www.sprinkles.com.
CONTACT: Ana Ambrosi, aambrosi@avocadosfrommexico.com
View original content to download multimedia:
SOURCE Avocados From Mexico | https://www.kold.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ | 2023-07-31T11:56:57 | 1 | https://www.kold.com/prnewswire/2023/07/31/sweet-news-avocados-mexico-sprinkles-launch-limited-edition-cupcake-national-avocado-day/ |
"I don't think it's caught up to me yet — how much my life has changed," says Emma Hardyman, singer of the 2023 Tiny Desk Contest-winning band Little Moon. The Utah-based band recently wrapped up the Tiny Desk Contest On The Road tour, headlining eight sold-out shows across the country. While on the road, Hardyman caught up with NPR to reflect on the life-changing win and also share the story behind Little Moon's winning song, "Wonder Eye."
Hardyman tells NPR the song was written during the time her mother-in-law was in hospice care. The melody came to Hardyman as she and her husband Nathan Hardyman, who is also part of Little Moon, drove from Utah to Idaho to visit his mother.
During this difficult time, Emma and Nathan Hardyman were also in the process of leaving the Mormon church in which they had grown up.
"And pretty quickly, just because of the circumstances, I realized that this song, this melody, was about death," says Emma Hardyman, who wrote the structure of the song before asking Nathan Hardyman to write the lyrics.
The couple were also observing the disintegration of many of the building blocks their Mormon belief systems were built on. "I've grieved past versions of myself throughout my whole life," Emma Hardyman shares.
"I really love where Mormonism brought me," Emma Hardyman says. "It introduced me to teachings that are supposed to love everybody, that are supposed to incorporate everybody. [But] it couldn't follow me to how much I wanted to take [those teachings] seriously," she adds, noting that many of the Little Moon band members are queer. She says Mormonism didn't align with how she wants to treat people 'without conditions.'
Emma Hardyman also shares that she had many self-doubts about herself as an artist when she and Nathan Hardman met — but that he believed in her from their very first date. And in "Wonder Eye," the two even find peace in not having all the answers. Emma sings: "Is there a knowledge that is found not in knowing?" as she's met with the warm hums of the band.
Copyright 2023 NPR. To see more, visit https://www.npr.org. | https://www.ctpublic.org/2023-07-31/the-power-and-heartbreak-behind-the-song-that-won-the-tiny-desk-contest | 2023-07-31T11:57:03 | 0 | https://www.ctpublic.org/2023-07-31/the-power-and-heartbreak-behind-the-song-that-won-the-tiny-desk-contest |
SHENZHEN, China, July 31, 2023 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company" or "Taoping"), today announced that the board of directors of the Company approved a one-for-ten reverse stock split of the Company's issued and outstanding ordinary shares, no par value (the "Ordinary Shares"). Beginning August 1, 2023, the Company's Ordinary Shares will be trading on a split-adjusted basis under the same symbol "TAOP" but with new CUSIP number, G8675V 127.
As a result of the share consolidation, each ten Ordinary Shares outstanding will automatically combine and convert to one issued and outstanding Ordinary Share without any action on the part of shareholders who hold their shares in brokerage accounts or "street name". Shareholders holding certificates of Ordinary Shares are expected to receive instructions from the Company's transfer agent, Transhare Corporation, regarding procedures for exchanging share certificates. All outstanding options, warrants and other rights to purchase the Company's Ordinary Shares will be adjusted proportionately as a result of the reverse stock split. No fractional shares will be issued as a result of the reverse stock split, and instead, all such fractional shares resulting from the reverse stock split will be rounded up to the nearest whole share.
The reverse stock split is intended to increase the per share trading price of the Ordinary Shares to satisfy the $1.00 minimum bid price requirement for continued listing on the NASDAQ Stock Market. Following the reverse stock split the Company will have approximately 1.86 million Ordinary Shares issued and outstanding, exclusive of shares issuable under outstanding options and warrants. The reverse stock split will not affect the number of total authorized Ordinary Shares of the Company.
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
Safe Harbor Statement
This press release contains "forward-looking statements" that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, such as statements regarding our estimated future results of operations and financial position, our strategy and plans, and our objectives or goals, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Our actual results may differ materially or perhaps significantly from those discussed herein, or implied by, these forward-looking statements. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: our potential inability to achieve or sustain profitability or reasonably predict our future results due to our limited operating history of providing smart cloud services, the effects of the global Covid-19 pandemic, the emergence of additional competing technologies, changes in domestic and foreign laws, regulations and taxes, uncertainties related to China's legal system and economic, political and social events in China, the volatility of the securities markets; and other risks including, but not limited to, those that we discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the "SEC") available on the SEC's website at www.sec.gov, including the Company's most recent Annual Report on Form 20-F as well as in our other reports filed or furnished from time to time with the SEC. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law.
View original content to download multimedia:
SOURCE Taoping Inc. | https://www.kold.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ | 2023-07-31T11:57:03 | 1 | https://www.kold.com/prnewswire/2023/07/31/taoping-announces-1-for-10-reverse-stock-split/ |
Insurance companies, doctors, and even medical schools can be woefully uninformed about endometriosis. The lack of knowledge delays diagnosis for many, including endometriosis awareness advocate Arleigh Cole.
“There just weren't specialists and doctors that even knew the word, let alone understood the disease,” Cole said recently on Connecticut Public Radio's "Where We Live."
Endometriosis is a chronic, inflammatory uterine disease that causes severe pain both in the uterus and throughout the body. Despite estimates from Yale Medicine that as many as one in 10 people with uteruses have endometriosis, it can take years to diagnose — and treatment can be difficult to access.
That’s why state Rep. Jillian Gilchrest, D-West Hartford, formed an Endometriosis Working Group in the state House of Representatives in 2021.
“I had a colleague and friend reach out to share with me about her experience with endometriosis. And I'll be honest, I'd never heard about it before,” Gilchrest said. “But as she started explaining what she had gone through, I certainly knew individuals throughout my life who, I think, probably were experiencing endometriosis. And so I went back and did some research, and was just shocked to find how many individuals are impacted and how much work there is to be done.”
The working group helped pass legislation during the 2022 session that required that the University of Connecticut begin plans for additional research into endometriosis diagnosis and treatment.
The legislation also requires that endometriosis be part of the UConn School of Medicine curriculum. But Gilchrest believes endometriosis education should begin even earlier.
“We've been looking at trying to get education into the schools,” Gilchrest said, “so that young people first getting their periods, first experiencing potential pain, might be able to identify that they might be experiencing endometriosis.”
Even after diagnosis, the road to treatment can be long and arduous.
Many insurance companies do not recognize endometriosis as a condition, or will refuse to pay for treatment, Gilchrest said.
“And, unfortunately, most of the very skilled specialists are all out-of-network,” Cole said. “You're looking at an average of $20,000 to $30,000 for a surgery.”
Those that do cover the condition often lump all treatment options together and cap their payments at the price of the least expensive option, even when that may not be the appropriate procedure determined by a patient and their doctor.
“There are many providers who can’t afford to take insurance [if it only covers some of their hours],” Gilchrest said. “Financially, it is a significant barrier to be able to get that treatment.”
Gilchrest’s working group is pushing for legislation on the state and federal level to correct the way insurance companies classify endometriosis treatment. | https://www.ctpublic.org/news/2023-07-31/why-ct-lawmakers-are-tackling-endometriosis-a-uterine-disease-that-affects-1-in-10 | 2023-07-31T11:57:09 | 0 | https://www.ctpublic.org/news/2023-07-31/why-ct-lawmakers-are-tackling-endometriosis-a-uterine-disease-that-affects-1-in-10 |
This Launch Marks the Latest Expansion of the Brand's Complexion Offerings as it Doubles Down on The Skincare-Meets-Makeup Hybrid Category
NEW YORK, July 31, 2023 /PRNewswire/ -- TULA Skincare, the leading clinically proven probiotic extract powered skincare brand has announced the expansion of its complexion offerings to include concealer.
After learning that TULA's customers were looking for a skin brightening eye treatment along with a concealer, the brand created a state-of-the-art clean skincare-makeup hybrid that delivers skin-boosting benefits with high-performance medium-to-full coverage.
Available in a 20-shade range, the dermatologist-tested, Radiant Skin Brightening Serum Concealer is infused with TULA's unique Rainbow Seabright™ Elixir. This clinically-proven serum-like formula instantly conceals dark circles and discoloration for longwearing, crease-proof results, while brightening the appearance of skin over time. Additional ingredients include TULA's S6Pro Complex® - a US patent pending super six blend of prebiotics and probiotic extracts to help soothe skin, improve skin smoothness and maintain skin balance, along with eye peptides and tea leaf caffeine to help improve the look of dark circles, skin texture, and eye bags. The Radiant Skin Brightening Serum Concealer can be paired with the brand's Radiant Skin Brightening Serum Skin Tint or Filter Primer Blurring & Moisturizing Primer to help build one's complexion wardrobe, or spot conceal for a no-makeup, makeup look.
"Expanding our complexion category to include a concealer was a natural next step for us, especially knowing the strong desire our customers have had for an eye treatment with brightening benefits." said TULA Skincare CEO, Savannah Sachs. " We are excited to have another offering for our glow getters that will surely be a staple in their skincare and beauty routines."
To mark the launch, TULA will be executing a multi-channel launch campaign across its digital platform, and organic social, paid media, and influencer channels. Efforts will include launching a custom "shade finder" on tula.com to help customers find their perfect match concealer shade, highlighting content speaking to the "no-makeup, makeup" and makeup-skincare hybrid trends across TikTok and Instagram, and partnering with a curated set of influencers and providing them with an early access link exclusively for their followers to purchase the concealer prior to launch. In addition to tula.com, the concealer will launch in Ulta Beauty stores nationwide and online and will be featured in an upcoming issue of the Ulta Beauty Magazine, with in-store complexion events planned in the coming months in multiple doors.
TULA's Radiant Skin Brightening Serum Concealer will be available for purchase on July 31 on tula.com, and will retail for $32.
About TULA Skincare
TULA is a doctor-founded skincare brand built on clinically proven formulas powered by probiotic extracts. We believe that the same types of ingredients which are good for your body are also great for your skin. We focus on being healthy, not perfect and on empowering everyone to feel confident in their skin.
Media Contact: Zoe Jeans at Bux + Bewl Communications: zoe@buxandbewl.com
View original content to download multimedia:
SOURCE TULA Skincare | https://www.kold.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ | 2023-07-31T11:57:10 | 1 | https://www.kold.com/prnewswire/2023/07/31/tula-skincare-launches-new-radiant-skin-brightening-serum-concealer/ |
Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access
PITTSBURGH and WOODBURY, Minn., July 31, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application (ANDA) approved by the U.S. Food and Drug Administration (FDA). Breyna, a drug-device combination product, is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD) and will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths.
Viatris Head of North America Jose Cotarelo said: "We are excited to bring Breyna to the U.S. market for the many Americans living with asthma and COPD. This launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain. Being the first to bring an FDA-approved generic version of Symbicort to patients is a true example of how access is the cornerstone of our mission to empower people worldwide to live healthier at every stage of life."
The indications for Breyna include asthma in patients six years of age and older, and the maintenance treatment of airflow obstruction and reducing exacerbations in patients with COPD, including chronic bronchitis and/or emphysema. Breyna is not indicated for the relief of acute bronchospasm. The 160 mcg/4.5 mcg is the only strength indicated for the treatment of COPD. COPD is a term used to describe a certain kind of chronic lung disease and is characterized by breathlessness; it affects more than 16 million Americans. Asthma causes swelling of the airways resulting in difficulty breathing, and approximately 25 million Americans have the chronic condition.
Milton Boyer, CEO of Kindeva Drug Delivery, added: "The launch of Breyna represents a significant milestone as it is the first FDA-approved generic version of Symbicort in the U.S., one of the most prescribed complex drug-device combination products to treat asthma and COPD. We are pleased for Viatris as well as the many Kindeva colleagues who have worked tirelessly to leverage our complex drug-delivery expertise for this important respiratory product — supporting a persistent need to continue bringing more quality medicines for asthma and COPD to patients."
To further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply. The program offers $30/month or up to $360 per year with 12 refills annually. The program will be available in August.
About Breyna
Breyna is indicated for the treatment of asthma in patients 6 years and older not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta2-adrenergic agonists (LABA). Breyna 160 mcg/4.5 mcg dosage is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and Breyna 160 mcg/4.5 mcg is also indicated to reduce exacerbations of COPD. Breyna is NOT indicated for the relief of acute bronchospasm.
Important Safety Information
Breyna is contraindicated in the primary treatment of status asthmaticus or other acute episode of asthma or COPD where intensive measures are required, and in hypersensitivity to any of the ingredients in Breyna. Use of long-acting beta2-adrenergic agonists (LABA) as monotherapy (without inhaled corticosteroids [ICS]) for asthma is associated with an increased risk of asthma-related death. Available data from controlled clinial trials also suggest that use of LABA as monotherapy increases the risk of asthma-related hospitalization in pediatric and adolescent patients. These findings are considered a class effect of LABA. When LABA are used in fixed dose combination with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared to ICS alone. Breyna is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms. Breyna should not be initiated in patients during rapidly deteriorating episodes of asthma or COPD. Patients who are receiving Breyna should not use additional formoterol or other LABA for any reason. Localized infections of the mouth and pharynx with Candida albicans has occurred in patients treated with Breyna. Patients should rinse the mouth after inhalation of Breyna. Lower respiratory tract infections, including pneumonia, have been reported following the administration of ICS. Due to possible immunosuppression, potential worsening of infections could occur. A more serious or even fatal course of chickenpox or measles can occur in susceptible patients. It is possible that systemic corticosteroid effects such as hypercorticism and adrenal suppression may occur, particularly at higher doses. Particular care is needed for patients who are transferred from systemically active corticosteroids to ICS. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available ICS. Caution should be exercised when considering administration of Breyna in patients on long-term ketoconazole and other known potent CYP3A4 inhibitors. As with other inhaled medications, paradoxical bronchospasm may occur with Breyna. Immediate hypersensitivity reactions may occur, as demonstrated by cases of urticaria, angioedema, rash, and bronchospasm. Excessive beta-adrenergic stimulation has been associated with central nervous system and cardiovascular effects. Breyna should be used with caution in patients with cardiovascular disorders especially coronary insufficiency, cardiac arrhythmias, and hypertension. Long-term use of ICS may result in a decrease in bone mineral density (BMD Assessment of BMD is recommended prior to initiating Breyna and periodically thereafter. ICS may result in a reduction in growth velocity when administered to pediatric patients. Glaucoma, increased intracolular pressure, and cataracts have been reported following the administration of ICS, including budesonide, a component of Breyna. Close monitoring for glaucoma and cataracts is warranted in patients with a change in vision or history of increased intraocular pressure. In rare cases, patients on ICS may present with systemic eosinophilic conditions. Breyna should be used with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, and in patients who are unusually responsive to sympathomimetic amines. The most common adverse reactions ≥3% reported in asthma clinical trials included nasopharyngitis, headache, upper respiratory tract infection, pharyngolaryngeal pain, sinusitis, influenza, back pain, nasal congestion, stomach discomfort, vomiting, and oral candidiasis. The most common adverse reactions ≥3% reported in COPD clinical trials included nasopharyngitis, oral candidiasis, bronchitis, sinusitis, and upper respiratory tract infection. Breyna should be administered with caution to patients being treated with MAO inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents. Beta-blockers may not only block the pulmonary effect of beta-agonists, such as formoterol, but may produce severe bronchospasm in patients with asthma. ECG changes and/or hypokalemia associated with nonpotassium-sparing diuretics may worsen with concomitant beta-agonists. Use caution with the coadministration of Breyna.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
About Kindeva Drug Delivery
Kindeva Drug Delivery is a global contract development manufacturing organization focused on drug-device combination products. Kindeva Drug Delivery develops and manufactures products across a broad range of complex drug-delivery formats, including injectables (autoinjector, intradermal, microneedle), pulmonary & nasal, and transdermal patches. Its service offering spans early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva Drug Delivery serves a global client base from its nine manufacturing and research and development facilities located in the U.S. and U.K. For more information, please visit www.kindevadd.com.
Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements that the launch of Breyna demonstrates the companies' commitment to bringing complex generic medicines to the market to help increase patient access; Breyna will be immediately available in both 80 mcg/4.5 mcg and 160 mcg/4.5 mcg dosage strengths; this launch represents years of hard work breaking down barriers to access and builds upon our past successes of bringing other complex products to market as we continue to move up the value chain; to further expand access to Breyna, Viatris has established a copay program offered for eligible commercially-insured patients, which may help reduce out-of-pocket expenses on prescriptions to as little as $20 per 30-day supply; and, the program will be available in August. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company's failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by COVID-19; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris' ability to bring new products to market, including but not limited to "at-risk" launches; Viatris' or its partners' ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris' filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this release other than as required by law.
View original content to download multimedia:
SOURCE Viatris Inc. | https://www.kold.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ | 2023-07-31T11:57:17 | 0 | https://www.kold.com/prnewswire/2023/07/31/viatris-announces-launch-breyna-budesonide-formoterol-fumarate-dihydrate-inhalation-aerosol-first-fda-approved-generic-version-symbicort-people-with-asthma-chronic-obstructive-pulmonary-disease-partnership-with-kindeva/ |
New nuclear unit now serving customers with clean, reliable energy 24/7
ATLANTA, July 31, 2023 /PRNewswire/ -- Georgia Power declared today that Plant Vogtle Unit 3 has entered commercial operation and is now serving customers and the State of Georgia. The new unit represents a long-term investment in the state's clean energy future and will provide reliable, emissions-free energy to customers for decades to come.
"The Plant Vogtle 3 & 4 nuclear expansion is another incredible example of how Georgia Power is building a reliable and resilient energy future for our state," said Kim Greene, chairman, president and CEO of Georgia Power. "It is important that we make these kinds of long-term investments and see them through so we can continue providing clean, safe, reliable and affordable energy to our 2.7 million customers. Today's achievement is a testament to our commitment to doing just that, and it marks the first day of the next 60 to 80 years that Vogtle Unit 3 will serve our customers with clean, reliable energy."
Vogtle Unit 3 is the first newly-constructed nuclear unit in the U.S. in over 30 years and can power an estimated 500,000 homes and businesses. Once all four units are online, the Plant Vogtle site will be the largest generator of clean energy in the nation and support continued growth in Georgia as more industries, businesses and families come to the state.
"Today is a historic day for the State of Georgia, Southern Company, and the entire energy sector, as we continue transforming the way we power the lives of millions of Americans," said Chris Womack, president and CEO of Southern Company. "With Unit 3 completed, and Unit 4 in the final stages of construction and testing, this project shows just how new nuclear can and will play a critical role in achieving a clean energy future for the United States. Bringing this unit safely into service is a credit to the hard work and dedication of our teams at Southern Company and the thousands of additional workers who have helped build that future at this site, as well as all of the partners who have helped make this day a reality."
Nuclear energy is the only zero-emission baseload energy source available today, offering high reliability, and efficient operations around the clock. Nuclear energy currently provides approximately 25% of Georgia Power's overall energy mix, including the existing units at Plant Vogtle and Georgia's other nuclear facility at Plant Hatch in Baxley, Georgia.
"The Vogtle expansion is an American energy success story and would not be possible without the support of strong public and private partners like our partners at North America's Building Trades Unions," said Tom Fanning, chairman of the Board of Directors for Southern Company. "We continue to appreciate their support and those who have stood with us at the local, state and federal levels to complete this new clean energy source to serve electric customers. Providing leadership in our industry and a commitment to safety and quality are in Southern Company's DNA. Today's milestone at the Vogtle expansion site underscores this legacy, and I couldn't be prouder of the dedication our teams have shown in seeing Unit 3 through to completion."
The final stages of construction and testing continue at Vogtle Unit 4, with the unit projected to be placed in service during the late fourth quarter 2023 or the first quarter of 2024. The unit completed hot functional testing in May, in significantly less time than Unit 3 as the team continues leveraging best practices and learnings from the earlier unit. The Vogtle site has also received nuclear fuel for Unit 4, with a total of 157 fuel assemblies necessary for the safe and reliable startup of the unit.
Also, last week, Georgia Power announced the receipt of the 103(g) finding from the Nuclear Regulatory Commission (NRC) for Vogtle Unit 4. This finding was confirmed in an official letter received by Southern Nuclear and signifies that the new unit has been constructed and will be operated in conformance with the Combined License and NRC regulations. No further NRC findings are necessary in order for Southern Nuclear to load fuel or begin the startup sequence for the new unit.
The new Vogtle units are an essential part of Georgia Power's commitment to delivering clean, safe, reliable and affordable energy to its 2.7 million customers. Southern Nuclear will operate the new units on behalf of the co-owners: Georgia Power, Oglethorpe Power, MEAG Power and Dalton Utilities.
About Georgia Power
Georgia Power is the largest electric subsidiary of Southern Company (NYSE: SO), America's premier energy company. Value, Reliability, Customer Service and Stewardship are the cornerstones of the company's promise to 2.7 million customers in all but four of Georgia's 159 counties. Committed to delivering clean, safe, reliable and affordable energy, Georgia Power maintains a diverse, innovative generation mix that includes nuclear, coal and natural gas, as well as renewables such as solar, hydroelectric and wind. Georgia Power focuses on delivering world-class service to its customers every day and the company is recognized by J.D. Power as an industry leader in customer satisfaction. For more information, visit www.GeorgiaPower.com and connect with the company on Facebook (Facebook.com/GeorgiaPower), Twitter (Twitter.com/GeorgiaPower) and Instagram (Instagram.com/ga_power).
Cautionary Note Regarding Forward-Looking Statements
Certain information contained in this release is forward-looking information based on current expectations and plans that involve risks and uncertainties. Forward-looking information includes, among other things, statements concerning the projected in-service date for Plant Vogtle Unit 4 and the future operations of Plant Vogtle Units 3 and 4. Georgia Power cautions that there are certain factors that can cause actual results to differ materially from the forward-looking information that has been provided. The reader is cautioned not to put undue reliance on this forward-looking information, which is not a guarantee of future performance and is subject to a number of uncertainties and other factors, many of which are outside the control of Georgia Power; accordingly, there can be no assurance that such suggested results will be realized. The following factors, in addition to those discussed in Georgia Power's Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent securities filings, could cause actual results to differ materially from management expectations as suggested by such forward-looking information: the ability to control costs and avoid cost and schedule overruns during the development, construction, and operation of facilities or other projects, including Plant Vogtle Unit 4, which includes components based on new technology that only within the last few years began initial operation in the global nuclear industry at this scale, due to current and/or future challenges which include, but are not limited to, changes in labor costs, availability and productivity, challenges with the management of contractors or vendors, subcontractor performance, adverse weather conditions, shortages, delays, increased costs, or inconsistent quality of equipment, materials, and labor, contractor or supplier delay, the impacts of inflation, delays due to judicial or regulatory action, nonperformance under construction, operating, or other agreements, operational readiness, including specialized operator training and required site safety programs, engineering or design problems or any remediation related thereto, design and other licensing-based compliance matters, challenges with start-up activities, including major equipment failure, or system integration, and/or operational performance, continued challenges related to the COVID-19 pandemic or future pandemic health events, continued public and policymaker support for projects, environmental and geological conditions, delays or increased costs to interconnect facilities to transmission grids, and increased financing costs as a result of changes in market interest rates or as a result of project delays; the ability to overcome or mitigate the current challenges, or challenges yet to be identified, at Plant Vogtle Unit 4, that could further impact the cost and schedule for the project; legal proceedings and regulatory approvals and actions related to construction projects, such as Plant Vogtle Unit 4, including Georgia Public Service Commission approvals and U.S. Nuclear Regulatory Commission ("NRC") actions; under certain specified circumstances, a decision by holders of more than 10% of the ownership interests of Plant Vogtle Unit 3 and 4 not to proceed with construction; the notices of tender by Oglethorpe Power Corporation and the City of Dalton of a portion of their ownership interests in Plant Vogtle Units 3 and 4 to Georgia Power, including related litigation; the ability to construct facilities in accordance with the requirements of permits and licenses (including satisfaction of NRC requirements), to satisfy any environmental performance standards and the requirements of tax credits and other incentives, and to integrate facilities into the Southern Company system upon completion of construction; the inherent risks involved in operating and constructing nuclear generating facilities; the ability of counterparties of Georgia Power to make payments as and when due and to perform as required; the direct or indirect effect on Georgia Power's business resulting from cyber intrusion or physical attack and the threat of cyber and physical attacks; catastrophic events such as fires, earthquakes, explosions, floods, tornadoes, hurricanes and other storms, droughts, pandemic health events, political unrest, wars or other similar occurrences; the potential effects of the continued COVID-19 pandemic; and the direct or indirect effects on Georgia Power's business resulting from incidents affecting the U.S. electric grid or operation of generating or storage resources. Georgia Power expressly disclaim any obligation to update any forward–looking information.
View original content to download multimedia:
SOURCE Georgia Power | https://www.kold.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ | 2023-07-31T11:57:23 | 0 | https://www.kold.com/prnewswire/2023/07/31/vogtle-unit-3-goes-into-operation/ |
- Revenue of RMB9,908 Million in the Second Quarter, Up 6.7% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 39.5% - Revenue of RMB18,871 Million in the First Half, Up 6.3% Year-over-Year;
Excluding COVID-19 Commercial Projects, Up 27.9% - Net Profit Attributable to Owners of the Company for the First Half Increased 14.6% to RMB 5,313 Million
- Diluted Earnings per Share (EPS) for the First Half Increased 20.9% to RMB1.79
- Adjusted Non-IFRS Net Profit Attributable to Owners of the Company for the First Half Increased 18.5% to RMB5,095 Million
- Adjusted Non-IFRS Diluted EPS for the First Half Increased 18.5% to RMB1.73[1]
- Free Cash Flow Achieved RMB2,926 Million for the First Half, Turned Positive and Grew Strongly
SHANGHAI, July 31, 2023 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, is pleased to announce its financial results for the first half ending June 30, 2023 ("Reporting Period").
This release provides a summary of the results and is not intended to be a comprehensive report. For additional information, please refer to the 2023 Interim Report and other relevant announcements published on the websites of the Shanghai Stock Exchange (www.sse.com.cn) and the Stock Exchange of Hong Kong (www.hkexnews.hk), and the designated media for dissemination of the relevant information. Investors are advised to exercise caution and be aware of the investment risks in trading Company shares.
All financial information disclosed in this press release is prepared based on International Financial Reporting Standards (IFRS), in currency of RMB.
The 2023 Interim Report of the Company has not been audited.
Second Quarter 2023 Financial Highlights
Revenue grew 6.7% year-over-year to RMB9,908 million, excluding COVID-19 commercial projects, revenue grew strongly by 39.5%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 2.6% year-over-year to RMB7,034 million, excluding COVID-19 commercial projects, revenue grew strongly by 51.6%. Adjusted non-IFRS gross profit grew 12.9% year-over-year to RMB3,216 million, with a gross profit margin of 45.7%.
- WuXi Testing revenue grew 23.6% year-over-year to RMB1,638 million and adjusted non-IFRS gross profit grew 36.2% year-over-year to RMB640 million, with a gross profit margin of 39.1%.
- WuXi Biology revenue grew 17.5% year-over-year to RMB656 million and adjusted non-IFRS gross profit grew 21.3% year-over-year to RMB 271 million, with a gross profit margin of 41.4%.
- WuXi ATU revenue grew 22.9% year-over-year to RMB389 million and adjusted non-IFRS gross profit was RMB(16) million, with a gross profit margin of (4.2)%
- WuXi DDSU revenue declined 17.9% year-over-year to RMB176 million and adjusted non-IFRS gross profit grew year-over-year 5.2% to RMB63 million, with a gross profit margin of 35.8%. Meanwhile, we received the first royalty income from customers in the second quarter, which is a breakthrough for DDSU.
Unit: RMB million
- IFRS gross profit increased 18.1% year-over-year to RMB4,030 million. Gross profit margin was 40.7%[2]
- Adjusted non-IFRS gross profit increased 16.4% year-over-year to RM4,177 million. Adjusted non-IFRS gross margin was 42.2%.
- Net profit attributable to owners of the Company increased 5.1% year-over-year to RMB3,145 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 22.4% year-over-year to RMB2,753 million.
First-Half 2023 Financial Highlights
Revenue grew 6.3% year-over-year to RMB18,871 million, excluding COVID-19 commercial projects, revenue grew strongly by 27.9%. This is primarily attributable to the Company's continued excellent execution of our unique Contract Research, Development and Manufacturing Organization (CRDMO) business model to achieve strong synergy and continuous growth:
- WuXi Chemistry revenue grew 3.8% year-over-year to RMB13,467 million, excluding COVID-19 commercial projects, revenue grew strongly by 36.1%. Adjusted non-IFRS gross profit grew 14.9% year-over-year to RMB6,103 million, with a gross profit margin of 45.3%.
- WuXi Testing revenue grew 18.7% year-over-year to RMB3,091 million and adjusted non-IFRS gross profit grew 26.1% year-over-year to RMB1,168 million, with a gross profit margin of 37.8%.
- WuXi Biology revenue grew 13.0% year-over-year to RMB1,233 million and adjusted non-IFRS gross profit grew 15.1% year-over-year to RMB511 million, with a gross profit margin of 41.5%.
- WuXi ATU revenue grew 16.0% year-over-year to RMB714 million and adjusted non-IFRS gross profit was RMB(40) million, with a gross profit margin of (5.7)%.
- WuXi DDSU revenue declined 24.9% year-over-year to RMB342 million and adjusted non-IFRS gross profit declined 26.2% year-over-year to RMB103 million, with a gross profit margin of 30.1%. Meanwhile, DDSU achieved a breakthrough in receiving the first royalty income from customers.
Unit: RMB million
- IFRS gross profit increased 17.6% year-over-year to RMB7,556 million. Gross profit margin was 40.0%[3].
- Adjusted non-IFRS gross profit increased 15.7% year-over-year to RMB7,855 million. Adjusted non-IFRS gross margin was 41.6%.
- Net profit attributable to owners of the Company increased 14.6% year-over-year to RMB 5,313 million.
- Adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year to RMB5,095 million.
- Diluted EPS increased 20.9% year-over-year to RMB1.79, while adjusted diluted non-IFRS EPS increased by 18.5% year-over-year to RMB1.73.
- Free cash flow achieved RMB2,926 million, turned positive and grew strongly year-over-year.
First-Half 2023 Business Operation Highlights
- As an industry innovation enabler, we grow together with our customers. In the first half of 2023, we added over 600 new customers, and in total we served more than 6,000 active customers over the past 12 months. Backlog grew 25% year-over-year excluding COVID-19 commercial projects. We continued to optimize our cross-platform synergies to better serve our customers worldwide, strengthen our unique competitive advantage as a fully integrated Contract Research, Development and Manufacturing Organization (CRDMO) and Contract Testing, Development and Manufacturing Organization (CTDMO) platform, and provide one-stop services for our customers from discovery to development and manufacturing. The diversified revenue streams from customers across regions ensure the stability and resilience of the Company's financial performance.
- WuXi Chemistry: Integrated CRDMO Business Model Drives Steady Growth, with Continued Expansion in New Modalities (WuXi TIDES)
- In the past 12 months, we successfully synthesized and delivered more than 420,000 new compounds to customers, which grew 20% year-over-year. Through our chemistry drug discovery services, we enabled our customers to accelerate their research while generating opportunities for our downstream business units. In the past 12 months, 120 molecules have transitioned from R to D&M, representing a year-on-year growth of 21%. Through our "follow-the-customer" and "follow-the-molecule" strategies, we established trusted partnerships with our global customers, supporting the sustainable growth of our CRDMO business.
- We continued executing our "long-tail" strategy. Demand from "long-tail" customers in discovery services of small molecule and new modalities continued to grow, with the number of new customers growing 17% year-over-year.
- In the first half of 2023, D&M services revenue grew 2.1% year-over-year to RMB9.67 billion. Excluding COVID-19 commercial projects, D&M services revenue grew strongly by 54.5%.
- In the first half of 2023, we added 583 molecules to our D&M pipeline. To date, our D&M pipeline consists of 2,819 molecules, including 56 commercial projects, 59 in phase III, 301 in phase II and 2,403 in phase I and pre-clinical stages, among which, 8 commercial and phase III projects were added in the first half of 2023.
- In the first half of 2023, TIDES revenue grew 37.9% year-over-year to RMB1.33 billion. As of June 30, 2023, backlog of TIDES grew strongly by 188% year-over-year. We expect revenue growth from TIDES business to exceed 70% in 2023.
- The number of TIDES D&M customers increased 25% year-over-year to 121, and the number of TIDES molecules increased 46% year-over-year to 207.
- WuXi Testing: Lab Testing Services Drive Steady Growth, Clinical Business Fully Recovered
- The Company provides a full range of laboratory testing services for our customers, including drug metabolism and pharmacokinetics (DMPK), toxicology, and bioanalysis for drug development testing, as well as medical device testing. We provide customers with high-quality services, realize "one report for global submission," and enable customers to save time, reduce costs and increase efficiency.
- H1 2023 revenue from drug safety evaluation services grew 24% year-over-year. We maintained our industry leadership position in Asia Pacific for drug safety evaluation services that meet global regulatory requirements. In the first half of 2023, new lab testing facilities in Qidong and Suzhou began operations as scheduled, ensuring the business growth to accelerate in the second half of 2023.
- Moreover, we continued to enhance capabilities related to new modalities, with comprehensive coverage such as target protein degradation, nucleic acids, conjugates, and cell and gene therapies (CGT), etc.
- SMO revenue grew strongly by 53.9% in Q2 2023 and 34.3% in H1 2023, maintaining a leadership position in China. In the first half of 2023, SMO supported 25 new drug approvals for customers.
- In the first half of 2023, clinical CRO enabled our customers to obtain 8 IND approvals and submit 3 NDA filings.
- WuXi Biology: Strong Contribution from New Modalities; Early Discovery Screening Platform Continued to Generate Downstream Opportunities
- WuXi ATU: CTDMO Business Model Drives Growth
- WuXi DDSU: the First Year to Receive New Drug Application (NDA) Approval of New Drugs Developed for Customers; Breakthrough to Receive the First Royalty Income
Our Commitment to ESG
As an industry innovation enabler, a trusted partner and a contributor to the global healthcare industry, the Company is committed to environmental protection and sustainability, and to being a good global corporate citizenship.
Our outstanding ESG performance has been recognized by major global ESG rating agencies, including MSCI, S&P Global, Sustainalytics, CDP and EcoVadis. In June 2023, we received the fourth "Silver" medal recognition from EcoVadis for our Couvet site in Switzerland.
By the first half of 2023, our carbon emission intensity, energy consumption intensity and water use intensity reduced by 20.1%, 18.4%, and 31.6%, respectively, as compared to the baseline year 2020.
As we continue to advance our sustainability strategy, we embrace our shared responsibility to be good stewards of the environment.
Management Comment
Dr. Ge Li, Chairman and CEO of WuXi AppTec, said, "We continued to achieve steady growth of revenue, net profit, and free cash flow in the first half of 2023. Our revenue increased 6.3% year-over-year to RMB18.87 billion, or 27.9% if excluding COVID-19 commercial projects. Our adjusted non-IFRS net profit attributable to owners of the Company increased 18.5% year-over-year, outpacing the revenue growth rate, and our free cash flow achieved RMB2.93 billion, as a result of the Company's pursuit of operational excellence and productivity."
"The Company's performance in the first half of 2023 demonstrated that WuXi AppTec's unique CRDMO and CTDMO business models can effectively meet the growing demands from customers worldwide and continue to drive solid growth for the Company. In 2023, we aim to deliver a 5-7% revenue growth, increase adjusted non-IFRS gross profit by 13-14%, and expand free cash flow by 750-850%. We remain committed to prioritizing our customers' needs and enhancing our capacity and capabilities as we support our customers' efforts to bring groundbreaking therapies to patients around the world. Together, we can realize our vision that 'every drug can be made and every disease can be treated'."
About WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com
Forward-Looking Statements
This press release may contain certain "forward-looking statements" which are not historical facts, but instead are predictions about future events based on our beliefs as well as assumptions made by and information currently available to our management. Although we believe that our predictions are reasonable, future events are inherently uncertain and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks relating to, among other things, the ability of our service offerings to compete effectively, our ability to meet timelines for the expansion of our service offerings, our ability to protect our customers' intellectual property, unforeseeable international tension, competition, the impact of emergencies and other force majeure. Our forward-looking statements in this press release speak only as of the date on which they are made, and we assume no obligation to update any forward-looking statements except as required by applicable law or listing rules. Accordingly, you are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section. All information provided in this press release is as of the date of this press release and are based on assumptions that we believe to be reasonable as of this date, and we do not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Use of Non-IFRS and Adjusted Non-IFRS Financial Measures
We provide non-IFRS gross profit and non-IFRS net profit attributable to owners of the Company, which exclude share-based compensation expenses, issuance expenses of convertible bonds, fair value gain or loss from derivative component of convertible bonds, foreign exchange-related gains or losses, amortization of intangible assets acquired in business combinations, non-financial assets impairment, etc. We also provide adjusted non-IFRS net profit attributable to owners of the Company and earnings per share, which further exclude realized and unrealized gains or losses from our venture capital investments and joint ventures. Neither is required by, or presented in accordance with IFRS.
We believe that the adjusted financial measures used in this press release are useful for understanding and assessing our core business performance and operating trends, and we believe that management and investors may benefit from referring to these adjusted financial measures in assessing our financial performance by eliminating the impact of certain unusual, non-recurring, non-cash and non-operating items that we do not consider indicative of the performance of our core business. Such adjusted non-IFRS net profit attributable to owners of the Company, the management of the Company believes, is widely accepted and adopted in the industry the Company is operating in. However, the presentation of these adjusted non-IFRS financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies.
For more information, please contact:
Ms. Ruijia Tang (for investors)
IR Director
Email: tang_ruijia@wuxiapptec.com
Mr. Davy Wu (for media)
PR Director
Email: davy_wu@wuxiapptec.com
View original content:
SOURCE WuXi AppTec | https://www.kold.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ | 2023-07-31T11:57:30 | 0 | https://www.kold.com/prnewswire/2023/07/31/wuxi-apptec-announced-strong-results-second-quarter-first-half-2023-top-an-exceptionally-strong-year-2022/ |
GUANGZHOU, China, July 31, 2023 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it has published its 2022 Environmental, Social and Governance ("ESG") report, outlining the Company's progress and performance in key ESG areas.
The report provides a comprehensive review of Yatsen's ESG initiatives and developments, including corporate governance, research and development, employee rights protection, human capital development, environmental sustainability and social responsibility, among others.
To view the report in full, please visit the ESG section on the Yatsen Investor Relations website. Alternatively, please click here for the English version and here for the Chinese version of the 2022 report.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands, including Perfect Diary, Little Ondine, Abby's Choice, Galénic, DR.WU (its mainland China business), Eve Lom, Pink Bear and EANTiM. The Company's flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly, both online and offline, with an expansive presence across all major e-commerce, social and content platforms in China.
For more information, please visit http://ir.yatsenglobal.com/.
For investor and media inquiries, please contact:
In China:
Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com
The Piacente Group, Inc
Hui Fan
Tel: +86-10-6508-0677
E-mail: yatsen@thepiacentegroup.com
In the United States:
The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: yatsen@thepiacentegroup.com
View original content:
SOURCE Yatsen Holding Limited | https://www.kold.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ | 2023-07-31T11:57:37 | 0 | https://www.kold.com/prnewswire/2023/07/31/yatsen-issues-2022-esg-report/ |
Leveraging artificial intelligence, Mumbai-based IT services firm Yodaplus is catalyzing industry transformations, from nutraceuticals to retail, by streamlining business operations and boosting decision-making capabilities.
MUMBAI, India, July 31, 2023 /PRNewswire/ -- Yodaplus, a Mumbai-based IT services firm, is at the forefront of empowering organizations worldwide with advanced technological capabilities. Today, the company sheds light on the evolving global landscape of Artificial Intelligence (AI) and its growing adoption within its service portfolio.
With its wide range of services and deep industry knowledge, Yodaplus has been a game changer – enabling organizations to focus on their core operations and achieve sustainable growth. And now, by integrating AI into services, Yodaplus helps businesses navigate the complex digital transformation landscape more efficiently, creating a competitive edge.
AI continues to transform business operations globally, powering automation, analytics, decision-making, and enhancing user experiences. This ultimately delivers safer and more effective products to meet the growing global demand.
Yodaplus is known for its expansive roster of clients - from development banks and blockchain companies to EdTech startups and HRMS providers. With such a diverse clientele, embracing AI is more necessary than a choice, and Yodaplus has promptly addressed this need.
"As we navigate the digital age, the integration of AI into our service offerings has become an undeniable necessity," commented Vishrut Srivastava, MD, Yodaplus. "AI is here to stay, poised to make our lives more efficient and free mankind from the burden of mundane tasks. At Yodaplus, we are committed to embracing AI to drive growth and innovation for our clients while we continue to explore new horizons in this transformative technological landscape."
In line with this commitment, Yodaplus has developed an AI engine transforming the global nutraceutical supply chain. Addressing the complexities of generating differentiated nutraceutical label claims necessitates a well-mapped global database and the application of AI. To solve this problem, Yodaplus developed an AI-driven smart labels function via the NutrifyGenie AI engine.
NutrifyGenie uses sophisticated algorithms that facilitate simplified and precise decision-making, authenticating label claim validation and enabling real-time regulatory compliance. This feature provides users with pre-made labels, including correct dosage values for nutraceutical products, significantly expediting product development.
Enabling companies to effortlessly commercialize their innovations in essential markets fulfills the continuously increasing demand for nutraceutical products. As the nutraceutical industry continues to grow, Yodaplus's AI engine will play a crucial role in accelerating the new product development process and helping businesses bring innovative and differentiated products to market faster than ever before.
Not just that, the company has also recently deployed advanced invoice parsing for a retail giant. This smart solution facilitates operations by accurately extracting and collating relevant information from invoices, thus automating a previously laborious task. Furthermore, Yodaplus uses sophisticated AI tools to assist an asset management client in conducting comprehensive financial records analysis, rendering them outstanding financial decision-making capabilities.
About Yodaplus
An ever-evolving, highly specialized technology solutions company, Yodaplus offers an array of services designed to address the unique needs of businesses globally, extending beyond its Mumbai base to the US, UK, UAE, and Singapore. The company's mission, steered by MD Vishrut Srivastava, is dedicated to providing top-tier IT services and aims to propel businesses toward unprecedented growth and success. With this commitment, Yodaplus becomes your duly trusted tech partner.
For more information about Yodaplus, please visit www.yodaplus.com.
Press Contact:
Amit Pareek
Senior Marketing Manager
amitp@yodaplus.com
Photo: https://mma.prnewswire.com/media/2163861/Vishrut_Srivatava_MD_Yodaplus.jpg
Logo: https://mma.prnewswire.com/media/2144978/4185052/Yodaplus_Logo.jpg
View original content:
SOURCE Yodaplus Technologies | https://www.kold.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ | 2023-07-31T11:57:43 | 1 | https://www.kold.com/prnewswire/2023/07/31/yodaplus-shaping-future-industries-with-powerful-ai-integration/ |
The cutting-edge platform empowers B2B SaaS start-ups to reduce churn, increase upsell, and boost NRR
WILMINGTON, Del., July 31, 2023 /PRNewswire/ -- ZapScale, a new-age customer success platform, is making waves in the industry by offering an unrivalled one-day onboarding experience along with the ability to track 150 customer data points for a comprehensive 360-degree view of customer health. This ground-breaking feature sets ZapScale apart from its competitors.
The secret behind ZapScale's lightning-fast onboarding lies in its comprehensive toolkit. With a robust framework of 40 pre-built KPI-based health frameworks, 60 pre-designed playbooks to automate CS ops, and seamless native integrations with all popular tools, ZapScale empowers businesses to gain complete visibility over customer data. With deep customer health insights, ZapScale's customers have seen an improvement in retention and increase in upsell opportunities.
Manasij Ganguli, Founder and CEO of ZapScale, shares his personal motivation for creating this game-changing platform: "ZapScale was born out of my passion to empower B2B SaaS start-ups with an efficient and effective CS platform. Having faced numerous customer success challenges in my previous start-up, which I successfully sold in 2019, I realized the critical need for a solution that could streamline, optimize, and accelerate CS operations.
For small to mid-sized businesses that have limited time and resources, implementing a CS platform has historically been a daunting task, taking weeks, if not months, to set up essential elements like customer health, playbooks, and integrations. ZapScale has addressed this challenge by offering a user-friendly and efficient implementation process, eliminating waste of time and resources. Now, businesses can seamlessly focus on their customers right from day 1."
ZapScale eliminates the traditional barriers and time-consuming processes associated with implementing CS platforms using key in-built features that facilitate custom mapping, support custom fields, and require no unique key to integrate applications, ensuring a tailored yet quick integration experience.
ZapScale is swiftly gaining traction in the market, with 30+ global companies already using the customer success platform. Starting at $249 per month, with a one-month free trial, ZapScale is helping businesses significantly improve their customer success initiatives.
For more information about ZapScale and to schedule a demo, visit www.zapscale.com.
Contact:
Nikita Kalra
Marketing Head, ZapScale
nikita@zapscale.com
Logo: https://mma.prnewswire.com/media/2097823/ZS_Logo.jpg
View original content:
SOURCE ZapScale | https://www.kold.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ | 2023-07-31T11:57:49 | 0 | https://www.kold.com/prnewswire/2023/07/31/zapscale-sets-new-industry-standard-with-easiest-customer-success-platform-one-day-onboarding/ |